cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
LUAD	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-25.08	2.81e-89	-0.88	-0.75	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-25.08	2.81e-89	-0.88	-0.75	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-24.73	1.32e-87	-0.88	-0.75	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-24.73	1.32e-87	-0.88	-0.75	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-24.35	7.81e-86	-0.87	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-24.35	7.81e-86	-0.87	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	24.23	3.06e-85	0.86	0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	24.23	3.06e-85	0.86	0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-24.2	4.35e-85	-0.88	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-24.2	4.35e-85	-0.88	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-24.2	4.35e-85	-0.88	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-24.2	4.35e-85	-0.88	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-24.18	5.01e-85	-0.87	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-24.18	5.01e-85	-0.87	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	23.79	3.77e-83	0.85	0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	23.79	3.77e-83	0.85	0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-23.59	3.13e-82	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-23.59	3.13e-82	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-23.5	8.52e-82	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-23.5	8.52e-82	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-23.41	2.24e-81	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-23.41	2.24e-81	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-23.33	5.85e-81	-0.85	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-23.33	5.85e-81	-0.85	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-23.24	1.55e-80	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-23.24	1.55e-80	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-23.23	1.66e-80	-0.86	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-23.23	1.66e-80	-0.86	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs4673363	MIMAT0014995	hsa-miR-3130-5p	-23.19	2.68e-80	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs4673363	MIMAT0014995_1	hsa-miR-3130-5p	-23.19	2.68e-80	-0.87	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs57600974	MIMAT0014995	hsa-miR-3130-5p	-23.06	1.12e-79	-0.86	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs57600974	MIMAT0014995_1	hsa-miR-3130-5p	-23.06	1.12e-79	-0.86	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-22.82	1.54e-78	-0.86	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-22.82	1.54e-78	-0.86	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-22.69	6.31e-78	-0.86	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-22.69	6.31e-78	-0.86	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-20.82	4.84e-69	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-20.82	4.84e-69	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-20.82	4.84e-69	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-20.82	4.84e-69	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-20.49	1.89e-67	-0.84	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-20.49	1.89e-67	-0.84	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-19.7	1.02e-63	-0.83	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-19.7	1.02e-63	-0.83	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-18.62	1.27e-58	-0.83	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-18.62	1.27e-58	-0.83	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.748	rs12470963	MIMAT0014995	hsa-miR-3130-5p	-18.37	1.94e-57	-0.85	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.748	rs12470963	MIMAT0014995_1	hsa-miR-3130-5p	-18.37	1.94e-57	-0.85	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-12.42	6.43e-31	-0.84	-0.49	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-12.42	6.43e-31	-0.84	-0.49	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-11.96	4.85e-29	-0.79	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-11.96	4.85e-29	-0.79	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-11.63	1e-27	-0.82	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-11.63	1e-27	-0.82	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
LUAD	cis	rs75358501	1	rs75358501	MIMAT0014995	hsa-miR-3130-5p	-11.48	3.91e-27	-0.81	-0.46	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783276~206783296:-
LUAD	cis	rs75358501	1	rs75358501	MIMAT0014995_1	hsa-miR-3130-5p	-11.48	3.91e-27	-0.81	-0.46	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783246~206783266:+
LUAD	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	10.67	5.55e-24	0.63	0.44	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	10.6	9.73e-24	0.63	0.44	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	10.37	6.96e-23	0.62	0.43	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	10.35	8.54e-23	0.61	0.43	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	10.27	1.77e-22	0.62	0.42	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	10.15	4.57e-22	0.61	0.42	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	10.15	4.57e-22	0.61	0.42	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	10.03	1.27e-21	0.58	0.42	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	10	1.62e-21	0.59	0.42	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	9.91	3.62e-21	0.57	0.41	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	9.91	3.62e-21	0.57	0.41	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	9.6	4.54e-20	0.57	0.4	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	9.6	4.59e-20	0.56	0.4	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	9.53	7.83e-20	0.56	0.4	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	9.53	8.2e-20	0.57	0.4	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	9.5	1.01e-19	0.56	0.4	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	9.5	1.04e-19	0.55	0.4	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	9.48	1.17e-19	0.54	0.4	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	9.44	1.7e-19	0.55	0.4	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	9.41	2e-19	0.55	0.4	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	9.39	2.37e-19	0.54	0.39	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
LUAD	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	9.16	1.56e-18	0.54	0.39	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	8.93	8.98e-18	0.54	0.38	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	8.92	9.84e-18	0.54	0.38	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.706	rs35759252	MIMAT0003242	hsa-miR-577	8.72	4.64e-17	0.64	0.37	Hemoglobin concentration;	chr4:114608520	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-8.69	5.65e-17	-0.42	-0.37	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	8.68	6.45e-17	0.64	0.37	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-8.61	1.08e-16	-0.46	-0.37	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.706	rs35571359	MIMAT0003242	hsa-miR-577	8.56	1.49e-16	0.63	0.36	Hemoglobin concentration;	chr4:114606130	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	8.52	2.05e-16	0.55	0.36	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-8.45	3.6e-16	-0.41	-0.36	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	8.43	3.96e-16	0.51	0.36	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	8.42	4.47e-16	0.55	0.36	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	8.39	5.5e-16	0.55	0.36	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	8.39	5.5e-16	0.55	0.36	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	8.39	5.5e-16	0.55	0.36	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-8.39	5.52e-16	-0.41	-0.36	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	8.38	5.96e-16	0.55	0.36	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	8.38	5.96e-16	0.55	0.36	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	8.38	5.96e-16	0.55	0.36	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	8.36	6.64e-16	0.55	0.36	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	8.36	6.64e-16	0.55	0.36	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	8.35	7.15e-16	0.55	0.36	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	8.34	7.89e-16	0.55	0.36	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	8.31	1.02e-15	0.54	0.35	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	8.31	1.02e-15	0.54	0.35	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	8.31	1.02e-15	0.54	0.35	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	8.3	1.08e-15	0.54	0.35	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
LUAD	cis	rs1163656	0.559	rs17007699	MIMAT0003287	hsa-miR-618	-8.3	1.1e-15	-0.59	-0.35	Dental caries;	chr12:80930007	chr12:80935796~80935818:-
LUAD	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	8.29	1.15e-15	0.54	0.35	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	8.29	1.15e-15	0.54	0.35	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	8.29	1.15e-15	0.54	0.35	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	8.29	1.15e-15	0.54	0.35	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	8.27	1.37e-15	0.54	0.35	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	8.27	1.37e-15	0.54	0.35	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-8.25	1.49e-15	-0.41	-0.35	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	8.23	1.76e-15	0.54	0.35	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	8.23	1.81e-15	0.54	0.35	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
LUAD	cis	rs1163656	0.559	rs17007693	MIMAT0003287	hsa-miR-618	-8.22	1.9e-15	-0.59	-0.35	Dental caries;	chr12:80925305	chr12:80935796~80935818:-
LUAD	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	8.21	2.04e-15	0.53	0.35	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	8.21	2.04e-15	0.53	0.35	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	8.2	2.29e-15	0.53	0.35	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	8.2	2.29e-15	0.53	0.35	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	8.16	3.02e-15	0.54	0.35	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	8.16	3.02e-15	0.54	0.35	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	8.16	3.02e-15	0.54	0.35	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	8.16	3.02e-15	0.54	0.35	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
LUAD	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-8.12	4.03e-15	-0.51	-0.35	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
LUAD	cis	rs6841433	0.718	rs7656139	MIMAT0003242	hsa-miR-577	-8.11	4.19e-15	-0.43	-0.35	Hemoglobin concentration;	chr4:114672622	chr4:114656774~114656794:+
LUAD	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-8.11	4.26e-15	-0.51	-0.35	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
LUAD	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	8.11	4.36e-15	0.53	0.35	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	8.11	4.36e-15	0.53	0.35	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	8.11	4.36e-15	0.53	0.35	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.75	rs6857337	MIMAT0003242	hsa-miR-577	8.1	4.47e-15	0.42	0.35	Hemoglobin concentration;	chr4:114667805	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	8.1	4.66e-15	0.53	0.35	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	8.1	4.66e-15	0.53	0.35	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	8.1	4.66e-15	0.53	0.35	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	8.1	4.66e-15	0.53	0.35	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	8.1	4.66e-15	0.53	0.35	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	8.08	5.31e-15	0.53	0.35	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	8.08	5.31e-15	0.53	0.35	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-8.07	5.54e-15	-0.43	-0.35	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
LUAD	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-8.05	6.75e-15	-0.51	-0.35	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
LUAD	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	8	9.64e-15	0.52	0.34	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	8	9.64e-15	0.52	0.34	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	8	9.77e-15	0.52	0.34	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-7.99	1.02e-14	-0.52	-0.34	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	7.98	1.07e-14	0.53	0.34	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	7.98	1.07e-14	0.6	0.34	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	7.98	1.08e-14	0.52	0.34	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	7.98	1.08e-14	0.52	0.34	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	7.98	1.08e-14	0.52	0.34	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	7.98	1.08e-14	0.52	0.34	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	7.98	1.08e-14	0.52	0.34	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	7.98	1.08e-14	0.52	0.34	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	7.98	1.08e-14	0.52	0.34	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	7.98	1.08e-14	0.52	0.34	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	7.94	1.48e-14	0.53	0.34	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
LUAD	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-7.86	2.64e-14	-0.27	-0.34	Migraine;	chr10:103338267	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-7.86	2.65e-14	-0.26	-0.34	Migraine;	chr10:103415374	chr10:103394301~103394322:-
LUAD	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	7.85	2.76e-14	0.52	0.34	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	7.85	2.76e-14	0.52	0.34	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-7.85	2.8e-14	-0.33	-0.34	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-7.83	3.08e-14	-0.33	-0.34	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-7.82	3.35e-14	-0.33	-0.34	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
LUAD	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	7.82	3.35e-14	0.49	0.34	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
LUAD	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-7.82	3.42e-14	-0.26	-0.34	Migraine;	chr10:103394332	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-7.82	3.43e-14	-0.27	-0.34	Migraine;	chr10:103338267	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-7.82	3.49e-14	-0.26	-0.34	Migraine;	chr10:103295206	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-7.82	3.49e-14	-0.26	-0.34	Migraine;	chr10:103296155	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-7.82	3.49e-14	-0.26	-0.34	Migraine;	chr10:103315955	chr10:103394341~103394361:-
LUAD	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	7.8	3.78e-14	0.66	0.34	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
LUAD	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-7.8	3.97e-14	-0.26	-0.34	Migraine;	chr10:103286250	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-7.8	3.97e-14	-0.26	-0.34	Migraine;	chr10:103286932	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-7.8	3.99e-14	-0.27	-0.34	Migraine;	chr10:103394332	chr10:103394301~103394322:-
LUAD	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-7.79	4.31e-14	-0.33	-0.34	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	7.78	4.57e-14	0.51	0.33	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-7.77	4.71e-14	-0.42	-0.33	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-7.77	4.97e-14	-0.33	-0.33	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	7.76	5.02e-14	0.33	0.33	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-7.75	5.68e-14	-0.27	-0.33	Migraine;	chr10:103295206	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-7.75	5.68e-14	-0.27	-0.33	Migraine;	chr10:103296155	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-7.75	5.68e-14	-0.27	-0.33	Migraine;	chr10:103315955	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-7.75	5.72e-14	-0.26	-0.33	Migraine;	chr10:103365694	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-7.75	5.72e-14	-0.26	-0.33	Migraine;	chr10:103369141	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-7.74	5.85e-14	-0.27	-0.33	Migraine;	chr10:103286250	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-7.74	5.85e-14	-0.27	-0.33	Migraine;	chr10:103286932	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-7.74	5.92e-14	-0.26	-0.33	Migraine;	chr10:103365694	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-7.74	5.92e-14	-0.26	-0.33	Migraine;	chr10:103369141	chr10:103394301~103394322:-
LUAD	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-7.74	5.96e-14	-0.33	-0.33	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-7.74	5.96e-14	-0.33	-0.33	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-7.74	5.96e-14	-0.33	-0.33	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	7.71	7.31e-14	0.26	0.33	Migraine;	chr10:103263177	chr10:103394301~103394322:-
LUAD	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	7.71	7.36e-14	0.49	0.33	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
LUAD	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	7.66	1.02e-13	0.56	0.33	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
LUAD	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-7.61	1.47e-13	-0.25	-0.33	Migraine;	chr10:103415374	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-7.57	1.94e-13	-0.26	-0.33	Migraine;	chr10:103254113	chr10:103394301~103394322:-
LUAD	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-7.57	1.99e-13	-0.49	-0.33	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
LUAD	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	7.54	2.33e-13	0.49	0.33	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-7.46	4.09e-13	-0.32	-0.32	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
LUAD	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	7.43	5.07e-13	0.36	0.32	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
LUAD	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-7.42	5.45e-13	-0.25	-0.32	Migraine;	chr10:103254113	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	7.36	7.9e-13	0.25	0.32	Migraine;	chr10:103236031	chr10:103394301~103394322:-
LUAD	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-7.35	8.72e-13	-0.31	-0.32	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-7.34	9.06e-13	-0.5	-0.32	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-7.34	9.43e-13	-0.31	-0.32	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
LUAD	cis	rs1163656	0.559	rs1163657	MIMAT0003287	hsa-miR-618	7.33	9.6e-13	0.51	0.32	Dental caries;	chr12:80943890	chr12:80935796~80935818:-
LUAD	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	7.33	9.62e-13	0.36	0.32	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
LUAD	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-7.32	1.03e-12	-0.31	-0.32	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	7.32	1.08e-12	0.46	0.32	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-7.29	1.25e-12	-0.31	-0.32	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-7.29	1.25e-12	-0.31	-0.32	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	7.29	1.28e-12	0.31	0.32	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
LUAD	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	7.28	1.34e-12	0.25	0.32	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
LUAD	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	7.26	1.62e-12	0.36	0.31	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
LUAD	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	7.26	1.62e-12	0.36	0.31	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
LUAD	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	7.26	1.62e-12	0.36	0.31	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
LUAD	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	7.23	1.86e-12	0.24	0.31	Migraine;	chr10:103263177	chr10:103394341~103394361:-
LUAD	cis	rs1163656	0.559	rs1183656	MIMAT0003287	hsa-miR-618	7.22	1.99e-12	0.5	0.31	Dental caries;	chr12:80944131	chr12:80935796~80935818:-
LUAD	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	7.19	2.57e-12	0.24	0.31	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
LUAD	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.67e-12	-0.31	-0.31	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.67e-12	-0.31	-0.31	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.67e-12	-0.31	-0.31	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
LUAD	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.67e-12	-0.31	-0.31	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.67e-12	-0.31	-0.31	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.67e-12	-0.31	-0.31	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.67e-12	-0.31	-0.31	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.67e-12	-0.31	-0.31	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.7e-12	-0.31	-0.31	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.7e-12	-0.31	-0.31	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-7.18	2.7e-12	-0.31	-0.31	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	7.17	2.89e-12	0.28	0.31	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-7.13	3.65e-12	-0.31	-0.31	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	7.1	4.46e-12	0.27	0.31	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-7.1	4.62e-12	-0.31	-0.31	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-7.1	4.62e-12	-0.31	-0.31	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-7.1	4.62e-12	-0.31	-0.31	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-7.1	4.62e-12	-0.31	-0.31	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
LUAD	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	7.09	4.79e-12	0.35	0.31	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
LUAD	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-7.09	4.96e-12	-0.3	-0.31	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-7.09	4.96e-12	-0.3	-0.31	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-7.07	5.34e-12	-0.3	-0.31	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	7.07	5.52e-12	0.28	0.31	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	7.05	6.47e-12	0.44	0.31	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-7.04	6.78e-12	-0.3	-0.31	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	7.03	7.03e-12	0.27	0.31	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	7.01	8.16e-12	0.28	0.31	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	7.01	8.16e-12	0.28	0.31	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-7	8.59e-12	-0.3	-0.3	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-7	8.59e-12	-0.3	-0.3	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-7	8.59e-12	-0.3	-0.3	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.632	rs13106767	MIMAT0003242	hsa-miR-577	-6.99	9.33e-12	-0.36	-0.3	Hemoglobin concentration;	chr4:114635719	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.632	rs35717197	MIMAT0003242	hsa-miR-577	-6.99	9.33e-12	-0.36	-0.3	Hemoglobin concentration;	chr4:114639584	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-6.98	9.62e-12	-0.3	-0.3	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	6.98	9.82e-12	0.24	0.3	Migraine;	chr10:103236031	chr10:103394341~103394361:-
LUAD	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-6.96	1.09e-11	-0.27	-0.3	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.632	rs13152031	MIMAT0003242	hsa-miR-577	-6.93	1.37e-11	-0.35	-0.3	Hemoglobin concentration;	chr4:114644503	chr4:114656774~114656794:+
LUAD	cis	rs6543140	0.964	rs6543144	MIMAT0019927	hsa-miR-4772-3p	-6.92	1.47e-11	-0.29	-0.3	Blood protein levels;	chr2:102476116	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.561	rs13148598	MIMAT0003242	hsa-miR-577	-6.91	1.51e-11	-0.36	-0.3	Hemoglobin concentration;	chr4:114676939	chr4:114656774~114656794:+
LUAD	cis	rs1163656	0.592	rs1795514	MIMAT0003287	hsa-miR-618	6.9	1.66e-11	0.45	0.3	Dental caries;	chr12:80939088	chr12:80935796~80935818:-
LUAD	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	6.89	1.78e-11	0.27	0.3	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	6.89	1.78e-11	0.27	0.3	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	6.89	1.78e-11	0.27	0.3	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
LUAD	cis	rs17639215	0.55	rs9679297	MIMAT0019927	hsa-miR-4772-3p	-6.89	1.79e-11	-0.31	-0.3	Serum protein levels (sST2);	chr2:102298109	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	6.88	1.87e-11	0.27	0.3	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.632	rs4834428	MIMAT0003242	hsa-miR-577	-6.86	2.19e-11	-0.35	-0.3	Hemoglobin concentration;	chr4:114683908	chr4:114656774~114656794:+
LUAD	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	6.81	2.98e-11	0.27	0.3	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	6.81	2.98e-11	0.27	0.3	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	6.81	2.98e-11	0.27	0.3	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	6.81	2.98e-11	0.27	0.3	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	6.81	2.98e-11	0.27	0.3	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	6.81	2.98e-11	0.27	0.3	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	6.81	2.98e-11	0.27	0.3	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	6.81	2.98e-11	0.27	0.3	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
LUAD	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	6.78	3.54e-11	0.27	0.3	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.632	rs7679995	MIMAT0003242	hsa-miR-577	-6.77	3.74e-11	-0.35	-0.3	Hemoglobin concentration;	chr4:114665137	chr4:114656774~114656794:+
LUAD	cis	rs6841433	0.632	rs6533807	MIMAT0003242	hsa-miR-577	-6.74	4.58e-11	-0.35	-0.29	Hemoglobin concentration;	chr4:114699454	chr4:114656774~114656794:+
LUAD	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-6.67	7.17e-11	-0.4	-0.29	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
LUAD	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-6.5	2.07e-10	-0.38	-0.28	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
LUAD	cis	rs950880	0.71	rs3771172	MIMAT0019927	hsa-miR-4772-3p	6.39	3.94e-10	0.29	0.28	Serum protein levels (sST2);	chr2:102369352	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs3771171	MIMAT0019927	hsa-miR-4772-3p	6.37	4.39e-10	0.29	0.28	Serum protein levels (sST2);	chr2:102369490	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs2160202	MIMAT0019927	hsa-miR-4772-3p	6.37	4.39e-10	0.29	0.28	Serum protein levels (sST2);	chr2:102369694	chr2:102432336~102432357:+
LUAD	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-6.25	9.11e-10	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
LUAD	cis	rs950880	0.71	rs11693955	MIMAT0019927	hsa-miR-4772-3p	6.23	1.04e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102412705	chr2:102432336~102432357:+
LUAD	cis	rs6543140	0.693	rs7579737	MIMAT0019927	hsa-miR-4772-3p	-6.21	1.13e-09	-0.26	-0.27	Blood protein levels;	chr2:102370901	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs67723747	MIMAT0019927	hsa-miR-4772-3p	6.17	1.45e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102353347	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs56386507	MIMAT0019927	hsa-miR-4772-3p	6.17	1.45e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102354705	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs1362349	MIMAT0019927	hsa-miR-4772-3p	6.17	1.46e-09	0.25	0.27	Serum protein levels (sST2);	chr2:102335512	chr2:102432336~102432357:+
LUAD	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-6.16	1.52e-09	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-6.15	1.67e-09	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
LUAD	cis	rs950880	0.744	rs3771156	MIMAT0019927	hsa-miR-4772-3p	6.14	1.75e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102420217	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	6.12	2e-09	0.25	0.27	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	6.09	2.34e-09	0.25	0.27	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.632	rs4585328	MIMAT0003242	hsa-miR-577	-6.06	2.81e-09	-0.32	-0.27	Hemoglobin concentration;	chr4:114613660	chr4:114656774~114656794:+
LUAD	cis	rs950880	0.56	rs12712140	MIMAT0019927	hsa-miR-4772-3p	6.05	2.96e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102334602	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.58	rs1997467	MIMAT0019927	hsa-miR-4772-3p	6.05	2.96e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102334613	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs1997466	MIMAT0019927	hsa-miR-4772-3p	6.05	2.96e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102335007	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs1362350	MIMAT0019927	hsa-miR-4772-3p	6.05	2.97e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102335338	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs55883125	MIMAT0019927	hsa-miR-4772-3p	6.04	3.13e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102407871	chr2:102432336~102432357:+
LUAD	cis	rs76886731	1	rs76886731	MIMAT0019927	hsa-miR-4772-3p	6.04	3.15e-09	0.24	0.27	Leprosy;	chr2:102328956	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.632	rs7685523	MIMAT0003242	hsa-miR-577	-6.03	3.19e-09	-0.32	-0.27	Hemoglobin concentration;	chr4:114621913	chr4:114656774~114656794:+
LUAD	cis	rs950880	0.56	rs1420090	MIMAT0019927	hsa-miR-4772-3p	6.03	3.24e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102302845	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs7565653	MIMAT0019927	hsa-miR-4772-3p	6.03	3.24e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102302966	chr2:102432336~102432357:+
LUAD	cis	rs17639215	0.55	rs4851003	MIMAT0019927	hsa-miR-4772-3p	-6.03	3.29e-09	-0.28	-0.27	Serum protein levels (sST2);	chr2:102292817	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.542	rs1420091	MIMAT0019927	hsa-miR-4772-3p	6.02	3.54e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102300774	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs4399750	MIMAT0019927	hsa-miR-4772-3p	6.02	3.54e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102301328	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.645	rs4851006	MIMAT0019927	hsa-miR-4772-3p	6.01	3.6e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102408278	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs2270298	MIMAT0019927	hsa-miR-4772-3p	6.01	3.71e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102375619	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs17027037	MIMAT0019927	hsa-miR-4772-3p	6.01	3.71e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102378424	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs2080289	MIMAT0019927	hsa-miR-4772-3p	6.01	3.71e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102378560	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs3821203	MIMAT0019927	hsa-miR-4772-3p	6.01	3.71e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102380412	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs3771162	MIMAT0019927	hsa-miR-4772-3p	6.01	3.71e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102380714	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs11465633	MIMAT0019927	hsa-miR-4772-3p	6.01	3.71e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102381273	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs1035130	MIMAT0019927	hsa-miR-4772-3p	6.01	3.71e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102384942	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.542	rs7568913	MIMAT0019927	hsa-miR-4772-3p	5.99	4.04e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102303577	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-5.99	4.11e-09	-0.19	-0.26	Migraine;	chr10:103292867	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-5.99	4.11e-09	-0.19	-0.26	Migraine;	chr10:103293183	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-5.99	4.11e-09	-0.19	-0.26	Migraine;	chr10:103293219	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-5.99	4.15e-09	-0.19	-0.26	Migraine;	chr10:103289348	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.542	rs10179654	MIMAT0019927	hsa-miR-4772-3p	5.99	4.16e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102305323	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-5.99	4.21e-09	-0.19	-0.26	Migraine;	chr10:103283532	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-5.99	4.21e-09	-0.19	-0.26	Migraine;	chr10:103284207	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.71	rs2287035	MIMAT0019927	hsa-miR-4772-3p	5.97	4.61e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102394070	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.677	rs17027087	MIMAT0019927	hsa-miR-4772-3p	5.97	4.75e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102399458	chr2:102432336~102432357:+
LUAD	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	5.96	4.93e-09	0.35	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	5.96	4.93e-09	0.35	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
LUAD	cis	rs950880	0.56	rs4090473	MIMAT0019927	hsa-miR-4772-3p	5.96	4.97e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102306527	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs2110660	MIMAT0019927	hsa-miR-4772-3p	5.96	5.03e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102302141	chr2:102432336~102432357:+
LUAD	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	5.94	5.42e-09	0.32	0.26	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
LUAD	cis	rs950880	0.56	rs66780767	MIMAT0019927	hsa-miR-4772-3p	5.94	5.55e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102323249	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs4142132	MIMAT0019927	hsa-miR-4772-3p	5.93	5.86e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102321022	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs17027071	MIMAT0019927	hsa-miR-4772-3p	5.92	6.3e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102396214	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs12466380	MIMAT0019927	hsa-miR-4772-3p	5.91	6.35e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102332479	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.517	rs1420088	MIMAT0019927	hsa-miR-4772-3p	5.91	6.4e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102322974	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs11123920	MIMAT0019927	hsa-miR-4772-3p	5.91	6.4e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102323373	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs11676075	MIMAT0019927	hsa-miR-4772-3p	5.91	6.4e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102324755	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.518	rs12996772	MIMAT0019927	hsa-miR-4772-3p	5.91	6.4e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102330741	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.904	rs4918007	MIMAT0005951	hsa-miR-1307-3p	5.91	6.68e-09	0.2	0.26	Migraine;	chr10:103347713	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.71	rs12469506	MIMAT0019927	hsa-miR-4772-3p	5.9	6.86e-09	0.27	0.26	Serum protein levels (sST2);	chr2:102349411	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs1558622	MIMAT0019927	hsa-miR-4772-3p	5.9	7.01e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102313687	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs10189202	MIMAT0019927	hsa-miR-4772-3p	5.9	7.01e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102313920	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs10191914	MIMAT0019927	hsa-miR-4772-3p	5.9	7.01e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102314197	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs4851570	MIMAT0019927	hsa-miR-4772-3p	5.89	7.11e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102389927	chr2:102432336~102432357:+
LUAD	cis	rs6841433	0.632	rs7699896	MIMAT0003242	hsa-miR-577	5.89	7.4e-09	0.31	0.26	Hemoglobin concentration;	chr4:114617357	chr4:114656774~114656794:+
LUAD	cis	rs950880	0.71	rs3821204	MIMAT0019927	hsa-miR-4772-3p	5.89	7.48e-09	0.27	0.26	Serum protein levels (sST2);	chr2:102343821	chr2:102432336~102432357:+
LUAD	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-5.88	7.71e-09	-0.33	-0.26	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
LUAD	cis	rs950880	0.56	rs11685480	MIMAT0019927	hsa-miR-4772-3p	5.88	7.72e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102310626	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs11678975	MIMAT0019927	hsa-miR-4772-3p	5.87	7.93e-09	0.27	0.26	Serum protein levels (sST2);	chr2:102427279	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs11683700	MIMAT0019927	hsa-miR-4772-3p	5.86	8.81e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102380345	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-5.85	8.89e-09	-0.19	-0.26	Migraine;	chr10:103299082	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.904	rs10883863	MIMAT0005951	hsa-miR-1307-3p	5.84	9.45e-09	0.19	0.26	Migraine;	chr10:103402122	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-5.84	9.66e-09	-0.19	-0.26	Migraine;	chr10:103395309	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.71	rs1135354	MIMAT0019927	hsa-miR-4772-3p	5.83	9.97e-09	0.25	0.26	Serum protein levels (sST2);	chr2:102397842	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-5.83	1.02e-08	-0.19	-0.26	Migraine;	chr10:103353944	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-5.83	1.02e-08	-0.19	-0.26	Migraine;	chr10:103356299	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-5.83	1.02e-08	-0.19	-0.26	Migraine;	chr10:103358705	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-5.83	1.04e-08	-0.19	-0.26	Migraine;	chr10:103384531	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.71	rs3732123	MIMAT0019927	hsa-miR-4772-3p	5.82	1.08e-08	0.25	0.26	Serum protein levels (sST2);	chr2:102401617	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-5.82	1.09e-08	-0.19	-0.26	Migraine;	chr10:103395888	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-5.81	1.15e-08	-0.19	-0.26	Migraine;	chr10:103348698	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-5.81	1.15e-08	-0.19	-0.26	Migraine;	chr10:103358719	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.71	rs17027060	MIMAT0019927	hsa-miR-4772-3p	5.81	1.17e-08	0.25	0.26	Serum protein levels (sST2);	chr2:102391107	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs66919607	MIMAT0019927	hsa-miR-4772-3p	5.81	1.17e-08	0.25	0.26	Serum protein levels (sST2);	chr2:102392509	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-5.8	1.17e-08	-0.19	-0.26	Migraine;	chr10:103386935	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-5.8	1.2e-08	-0.19	-0.26	Migraine;	chr10:103379204	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.71	rs66566526	MIMAT0019927	hsa-miR-4772-3p	5.8	1.2e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102431342	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-5.79	1.26e-08	-0.19	-0.26	Migraine;	chr10:103367951	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.56	rs12476925	MIMAT0019927	hsa-miR-4772-3p	5.79	1.3e-08	0.23	0.26	Serum protein levels (sST2);	chr2:102308089	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs12476968	MIMAT0019927	hsa-miR-4772-3p	5.79	1.3e-08	0.23	0.26	Serum protein levels (sST2);	chr2:102308202	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.668	rs3732126	MIMAT0019927	hsa-miR-4772-3p	5.78	1.32e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102397502	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs3732125	MIMAT0019927	hsa-miR-4772-3p	5.78	1.32e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102397503	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs4851582	MIMAT0019927	hsa-miR-4772-3p	5.78	1.35e-08	0.25	0.26	Serum protein levels (sST2);	chr2:102435098	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs55742125	MIMAT0019927	hsa-miR-4772-3p	5.78	1.37e-08	0.25	0.26	Serum protein levels (sST2);	chr2:102403322	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs17027006	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.39e-08	-0.26	-0.26	Serum protein levels (sST2);	chr2:102348872	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.542	rs12996505	MIMAT0019927	hsa-miR-4772-3p	5.77	1.42e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102315342	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-5.77	1.42e-08	-0.19	-0.25	Migraine;	chr10:103367521	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.56	rs10183388	MIMAT0019927	hsa-miR-4772-3p	5.76	1.47e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102315787	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.593	rs887971	MIMAT0019927	hsa-miR-4772-3p	5.75	1.62e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102424707	chr2:102432336~102432357:+
LUAD	cis	rs75358501	0.551	rs16838710	MIMAT0014995	hsa-miR-3130-5p	5.74	1.65e-08	0.3	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.551	rs16838710	MIMAT0014995_1	hsa-miR-3130-5p	5.74	1.65e-08	0.3	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783246~206783266:+
LUAD	cis	rs950880	0.71	rs56258475	MIMAT0019927	hsa-miR-4772-3p	5.74	1.68e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102382852	chr2:102432336~102432357:+
LUAD	cis	rs1163656	0.819	rs1795515	MIMAT0003287	hsa-miR-618	5.74	1.7e-08	0.32	0.25	Dental caries;	chr12:80941888	chr12:80935796~80935818:-
LUAD	cis	rs950880	0.71	rs3732129	MIMAT0019927	hsa-miR-4772-3p	5.74	1.7e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102341072	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs11681718	MIMAT0019927	hsa-miR-4772-3p	5.74	1.71e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102434684	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-5.72	1.92e-08	-0.18	-0.25	Migraine;	chr10:103279822	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.56	rs10178436	MIMAT0019927	hsa-miR-4772-3p	5.7	2.11e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102310051	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs3771150	MIMAT0019927	hsa-miR-4772-3p	5.69	2.19e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102444391	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.593	rs887972	MIMAT0019927	hsa-miR-4772-3p	5.69	2.21e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102424485	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs1558620	MIMAT0019927	hsa-miR-4772-3p	5.69	2.23e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102314935	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	5.69	2.24e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	5.69	2.24e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	5.69	2.27e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	5.69	2.27e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	5.69	2.27e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs12905	MIMAT0019927	hsa-miR-4772-3p	5.69	2.27e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102343547	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs3771177	MIMAT0019927	hsa-miR-4772-3p	5.67	2.47e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102339400	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	5.67	2.5e-08	0.19	0.25	Migraine;	chr10:103367830	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.71	rs10490204	MIMAT0019927	hsa-miR-4772-3p	5.65	2.7e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102440074	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-5.65	2.77e-08	-0.18	-0.25	Migraine;	chr10:103273871	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	5.64	2.91e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs56117144	MIMAT0019927	hsa-miR-4772-3p	5.62	3.19e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102458191	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs57081652	MIMAT0019927	hsa-miR-4772-3p	5.62	3.19e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102458921	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.542	rs6543118	MIMAT0019927	hsa-miR-4772-3p	5.62	3.29e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102313009	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-5.61	3.34e-08	-0.18	-0.25	Migraine;	chr10:103297804	chr10:103394301~103394322:-
LUAD	cis	rs79387448	0.626	rs80256362	MIMAT0019926	hsa-miR-4772-5p	-5.61	3.44e-08	-0.46	-0.25	Gut microbiota (bacterial taxa);	chr2:102409041	chr2:102432300~102432321:+
LUAD	cis	rs950880	0.542	rs953934	MIMAT0019927	hsa-miR-4772-3p	5.61	3.45e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102315833	chr2:102432336~102432357:+
LUAD	cis	rs1163656	0.819	rs1716537	MIMAT0003287	hsa-miR-618	5.6	3.61e-08	0.32	0.25	Dental caries;	chr12:80940959	chr12:80935796~80935818:-
LUAD	cis	rs12712135	0.525	rs11123917	MIMAT0019927	hsa-miR-4772-3p	5.6	3.67e-08	0.22	0.25	Blood protein levels;	chr2:102275189	chr2:102432336~102432357:+
LUAD	cis	rs4921799	0.662	rs17125108	MIMAT0015020	hsa-miR-548v	-5.59	3.77e-08	-0.27	-0.25	Lung cancer;Adenocarcinoma;	chr8:17680832	chr8:17681588~17681609:-
LUAD	cis	rs950880	0.71	rs4140785	MIMAT0019927	hsa-miR-4772-3p	5.59	3.8e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102472057	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-5.59	3.86e-08	-0.18	-0.25	Migraine;	chr10:103375562	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-5.59	3.88e-08	-0.18	-0.25	Migraine;	chr10:103389790	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-5.58	4.11e-08	-0.18	-0.25	Migraine;	chr10:103241568	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.56	rs6733174	MIMAT0019927	hsa-miR-4772-3p	5.56	4.37e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102312552	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs17027166	MIMAT0019927	hsa-miR-4772-3p	5.56	4.41e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102438960	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-5.56	4.44e-08	-0.18	-0.25	Migraine;	chr10:103284400	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.56	rs1420102	MIMAT0019927	hsa-miR-4772-3p	5.56	4.44e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102332359	chr2:102432336~102432357:+
LUAD	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	5.56	4.56e-08	0.33	0.25	Asthma;	chr2:102344364	chr2:102432300~102432321:+
LUAD	cis	rs950880	0.542	rs1558621	MIMAT0019927	hsa-miR-4772-3p	5.54	5.06e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102313847	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-5.54	5.07e-08	-0.18	-0.25	Migraine;	chr10:103297804	chr10:103394341~103394361:-
LUAD	cis	rs950880	0.71	rs56331791	MIMAT0019927	hsa-miR-4772-3p	5.52	5.65e-08	0.25	0.24	Serum protein levels (sST2);	chr2:102431697	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.836	rs11191649	MIMAT0005951	hsa-miR-1307-3p	-5.51	5.74e-08	-0.18	-0.24	Migraine;	chr10:103307280	chr10:103394301~103394322:-
LUAD	cis	rs4921799	0.662	rs17690083	MIMAT0015020	hsa-miR-548v	-5.51	5.8e-08	-0.26	-0.24	Lung cancer;Adenocarcinoma;	chr8:17680756	chr8:17681588~17681609:-
LUAD	cis	rs4921799	0.618	rs35985354	MIMAT0015020	hsa-miR-548v	-5.51	5.8e-08	-0.26	-0.24	Lung cancer;Adenocarcinoma;	chr8:17680894	chr8:17681588~17681609:-
LUAD	cis	rs4921799	0.662	rs57661227	MIMAT0015020	hsa-miR-548v	-5.51	5.8e-08	-0.26	-0.24	Lung cancer;Adenocarcinoma;	chr8:17680912	chr8:17681588~17681609:-
LUAD	cis	rs75358501	0.551	rs28619220	MIMAT0014995	hsa-miR-3130-5p	-5.51	5.81e-08	-0.31	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.551	rs28619220	MIMAT0014995_1	hsa-miR-3130-5p	-5.51	5.81e-08	-0.31	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783246~206783266:+
LUAD	cis	rs950880	0.56	rs971764	MIMAT0019927	hsa-miR-4772-3p	5.51	6.01e-08	0.22	0.24	Serum protein levels (sST2);	chr2:102321875	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs10189711	MIMAT0019927	hsa-miR-4772-3p	5.5	6.28e-08	0.22	0.24	Serum protein levels (sST2);	chr2:102314421	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs11679191	MIMAT0019927	hsa-miR-4772-3p	5.5	6.36e-08	0.22	0.24	Serum protein levels (sST2);	chr2:102310340	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.56	rs11685424	MIMAT0019927	hsa-miR-4772-3p	5.5	6.36e-08	0.22	0.24	Serum protein levels (sST2);	chr2:102310521	chr2:102432336~102432357:+
LUAD	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-5.49	6.56e-08	-0.18	-0.24	Migraine;	chr10:103273258	chr10:103394301~103394322:-
LUAD	cis	rs75358501	0.551	rs12471939	MIMAT0014995	hsa-miR-3130-5p	-5.49	6.59e-08	-0.31	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.551	rs12471939	MIMAT0014995_1	hsa-miR-3130-5p	-5.49	6.59e-08	-0.31	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783246~206783266:+
LUAD	cis	rs950880	0.56	rs6721346	MIMAT0019927	hsa-miR-4772-3p	5.49	6.62e-08	0.22	0.24	Serum protein levels (sST2);	chr2:102309860	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.638	rs11465670	MIMAT0019926	hsa-miR-4772-5p	-5.48	6.72e-08	-0.43	-0.24	Gut microbiota (bacterial taxa);	chr2:102417980	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.638	rs74731686	MIMAT0019926	hsa-miR-4772-5p	-5.48	6.82e-08	-0.44	-0.24	Gut microbiota (bacterial taxa);	chr2:102427521	chr2:102432300~102432321:+
LUAD	cis	rs950880	0.56	rs6706844	MIMAT0019927	hsa-miR-4772-3p	5.48	6.91e-08	0.22	0.24	Serum protein levels (sST2);	chr2:102323952	chr2:102432336~102432357:+
LUAD	cis	rs75358501	0.551	rs79761690	MIMAT0014995	hsa-miR-3130-5p	-5.48	6.99e-08	-0.3	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.551	rs79761690	MIMAT0014995_1	hsa-miR-3130-5p	-5.48	6.99e-08	-0.3	-0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783246~206783266:+
LUAD	cis	rs950880	0.71	rs2287034	MIMAT0019927	hsa-miR-4772-3p	-5.48	7.02e-08	-0.24	-0.24	Serum protein levels (sST2);	chr2:102394128	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.638	rs116055209	MIMAT0019926	hsa-miR-4772-5p	-5.47	7.15e-08	-0.44	-0.24	Gut microbiota (bacterial taxa);	chr2:102415729	chr2:102432300~102432321:+
LUAD	cis	rs950880	0.71	rs873022	MIMAT0019927	hsa-miR-4772-3p	5.47	7.2e-08	0.25	0.24	Serum protein levels (sST2);	chr2:102339223	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	5.47	7.38e-08	0.17	0.24	Migraine;	chr10:103238157	chr10:103394301~103394322:-
LUAD	cis	rs953492	0.574	rs2087563	MIMAT0019761	hsa-miR-4677-3p	-5.46	7.5e-08	-0.23	-0.24	Diastolic blood pressure;	chr1:243254761	chr1:243346225~243346246:+
LUAD	cis	rs950880	0.542	rs12712135	MIMAT0019927	hsa-miR-4772-3p	5.46	7.63e-08	0.22	0.24	Serum protein levels (sST2);	chr2:102314488	chr2:102432336~102432357:+
LUAD	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-5.45	7.89e-08	-0.17	-0.24	Migraine;	chr10:103279291	chr10:103394301~103394322:-
LUAD	cis	rs4921799	0.64	rs28716839	MIMAT0015020	hsa-miR-548v	-5.45	8.01e-08	-0.26	-0.24	Lung cancer;Adenocarcinoma;	chr8:17680463	chr8:17681588~17681609:-
LUAD	cis	rs950880	0.56	rs1558619	MIMAT0019927	hsa-miR-4772-3p	5.44	8.47e-08	0.22	0.24	Serum protein levels (sST2);	chr2:102315090	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.638	rs7600961	MIMAT0019926	hsa-miR-4772-5p	-5.43	8.95e-08	-0.43	-0.24	Gut microbiota (bacterial taxa);	chr2:102418995	chr2:102432300~102432321:+
LUAD	cis	rs1163656	0.819	rs1185534	MIMAT0003287	hsa-miR-618	5.43	9.11e-08	0.31	0.24	Dental caries;	chr12:80944374	chr12:80935796~80935818:-
LUAD	cis	rs4921799	0.662	rs11203898	MIMAT0015020	hsa-miR-548v	-5.42	9.4e-08	-0.26	-0.24	Lung cancer;Adenocarcinoma;	chr8:17679823	chr8:17681588~17681609:-
LUAD	cis	rs4921799	0.662	rs11987569	MIMAT0015020	hsa-miR-548v	-5.42	9.4e-08	-0.26	-0.24	Lung cancer;Adenocarcinoma;	chr8:17680140	chr8:17681588~17681609:-
LUAD	cis	rs12712135	0.706	rs6543114	MIMAT0019927	hsa-miR-4772-3p	5.41	1.01e-07	0.25	0.24	Blood protein levels;	chr2:102309534	chr2:102432336~102432357:+
LUAD	cis	rs1163656	1	rs1163656	MIMAT0003287	hsa-miR-618	-5.38	1.17e-07	-0.32	-0.24	Dental caries;	chr12:80943679	chr12:80935796~80935818:-
LUAD	cis	rs1867631	0.585	rs6670827	MIMAT0014979	hsa-miR-3117-3p	-5.37	1.22e-07	-0.28	-0.24	Menopause (age at onset);	chr1:66661323	chr1:66628485~66628505:+
LUAD	cis	rs950880	0.767	rs1420098	MIMAT0019927	hsa-miR-4772-3p	5.37	1.24e-07	0.22	0.24	Serum protein levels (sST2);	chr2:102367819	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.699	rs1882348	MIMAT0019927	hsa-miR-4772-3p	5.37	1.24e-07	0.22	0.24	Serum protein levels (sST2);	chr2:102368211	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.767	rs4851569	MIMAT0019927	hsa-miR-4772-3p	5.37	1.25e-07	0.22	0.24	Serum protein levels (sST2);	chr2:102366787	chr2:102432336~102432357:+
LUAD	cis	rs4921799	0.662	rs7465342	MIMAT0015020	hsa-miR-548v	5.36	1.29e-07	0.26	0.24	Lung cancer;Adenocarcinoma;	chr8:17679039	chr8:17681588~17681609:-
LUAD	cis	rs950880	0.71	rs55927292	MIMAT0019927	hsa-miR-4772-3p	5.36	1.32e-07	0.23	0.24	Serum protein levels (sST2);	chr2:102348401	chr2:102432336~102432357:+
LUAD	cis	rs4921799	0.64	rs10112153	MIMAT0015020	hsa-miR-548v	-5.34	1.43e-07	-0.25	-0.24	Lung cancer;Adenocarcinoma;	chr8:17679023	chr8:17681588~17681609:-
LUAD	cis	rs4921799	0.64	rs10109250	MIMAT0015020	hsa-miR-548v	-5.34	1.43e-07	-0.25	-0.24	Lung cancer;Adenocarcinoma;	chr8:17679026	chr8:17681588~17681609:-
LUAD	cis	rs6703335	0.696	rs10927003	MIMAT0019761	hsa-miR-4677-3p	-5.34	1.43e-07	-0.22	-0.24	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243381548	chr1:243346225~243346246:+
LUAD	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	5.34	1.44e-07	0.18	0.24	Migraine;	chr10:103347713	chr10:103394341~103394361:-
LUAD	cis	rs1014286	0.66	rs1476999	MIMAT0019926	hsa-miR-4772-5p	5.34	1.47e-07	0.28	0.24	Serum protein levels (sST2);	chr2:102515220	chr2:102432300~102432321:+
LUAD	cis	rs1014286	0.706	rs2216000	MIMAT0019926	hsa-miR-4772-5p	5.34	1.47e-07	0.28	0.24	Serum protein levels (sST2);	chr2:102516181	chr2:102432300~102432321:+
LUAD	cis	rs1014286	0.665	rs1523204	MIMAT0019926	hsa-miR-4772-5p	5.34	1.47e-07	0.28	0.24	Serum protein levels (sST2);	chr2:102519178	chr2:102432300~102432321:+
LUAD	cis	rs1014286	0.706	rs2058656	MIMAT0019926	hsa-miR-4772-5p	5.34	1.47e-07	0.28	0.24	Serum protein levels (sST2);	chr2:102520567	chr2:102432300~102432321:+
LUAD	cis	rs1014286	0.706	rs4851612	MIMAT0019926	hsa-miR-4772-5p	5.34	1.47e-07	0.28	0.24	Serum protein levels (sST2);	chr2:102521421	chr2:102432300~102432321:+
LUAD	cis	rs950880	0.56	rs974389	MIMAT0019927	hsa-miR-4772-3p	-5.33	1.49e-07	-0.21	-0.24	Serum protein levels (sST2);	chr2:102320521	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-5.33	1.5e-07	-0.17	-0.24	Migraine;	chr10:103317367	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-5.33	1.5e-07	-0.17	-0.24	Migraine;	chr10:103319682	chr10:103394301~103394322:-
LUAD	cis	rs1867631	0.585	rs11208940	MIMAT0014979	hsa-miR-3117-3p	5.32	1.61e-07	0.28	0.24	Menopause (age at onset);	chr1:66661559	chr1:66628485~66628505:+
LUAD	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-5.31	1.7e-07	-0.17	-0.24	Migraine;	chr10:103309363	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.767	rs2287037	MIMAT0019927	hsa-miR-4772-3p	5.31	1.72e-07	0.22	0.24	Serum protein levels (sST2);	chr2:102362568	chr2:102432336~102432357:+
LUAD	cis	rs4921799	0.597	rs35034557	MIMAT0015020	hsa-miR-548v	-5.3	1.75e-07	-0.25	-0.24	Lung cancer;Adenocarcinoma;	chr8:17679136	chr8:17681588~17681609:-
LUAD	cis	rs4921799	0.686	rs10112397	MIMAT0015020	hsa-miR-548v	-5.3	1.75e-07	-0.25	-0.24	Lung cancer;Adenocarcinoma;	chr8:17679195	chr8:17681588~17681609:-
LUAD	cis	rs4921799	0.513	rs10112412	MIMAT0015020	hsa-miR-548v	-5.3	1.75e-07	-0.25	-0.24	Lung cancer;Adenocarcinoma;	chr8:17679236	chr8:17681588~17681609:-
LUAD	cis	rs4921799	0.577	rs10112413	MIMAT0015020	hsa-miR-548v	-5.3	1.75e-07	-0.25	-0.24	Lung cancer;Adenocarcinoma;	chr8:17679238	chr8:17681588~17681609:-
LUAD	cis	rs950880	0.71	rs56166614	MIMAT0019927	hsa-miR-4772-3p	5.3	1.76e-07	0.23	0.24	Serum protein levels (sST2);	chr2:102439636	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.638	rs11465698	MIMAT0019926	hsa-miR-4772-5p	-5.3	1.77e-07	-0.43	-0.24	Gut microbiota (bacterial taxa);	chr2:102438117	chr2:102432300~102432321:+
LUAD	cis	rs950880	0.677	rs56224165	MIMAT0019927	hsa-miR-4772-3p	5.3	1.78e-07	0.24	0.24	Serum protein levels (sST2);	chr2:102308763	chr2:102432336~102432357:+
LUAD	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-5.29	1.84e-07	-0.17	-0.24	Migraine;	chr10:103273985	chr10:103394301~103394322:-
LUAD	cis	rs1014286	0.706	rs4851608	MIMAT0019926	hsa-miR-4772-5p	5.28	1.92e-07	0.27	0.23	Serum protein levels (sST2);	chr2:102509525	chr2:102432300~102432321:+
LUAD	cis	rs950880	0.71	rs11694360	MIMAT0019927	hsa-miR-4772-3p	5.27	2.02e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102444687	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs7597017	MIMAT0019927	hsa-miR-4772-3p	5.27	2.02e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102445656	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.677	rs4851585	MIMAT0019927	hsa-miR-4772-3p	5.27	2.02e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102446294	chr2:102432336~102432357:+
LUAD	cis	rs1867631	0.585	rs12094526	MIMAT0014979	hsa-miR-3117-3p	-5.27	2.03e-07	-0.28	-0.23	Menopause (age at onset);	chr1:66660431	chr1:66628485~66628505:+
LUAD	cis	rs6429422	0.769	rs10926973	MIMAT0019761	hsa-miR-4677-3p	5.27	2.08e-07	0.23	0.23	Cognitive ability (multi-trait analysis);	chr1:243225068	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.769	rs10926972	MIMAT0019761	hsa-miR-4677-3p	5.26	2.17e-07	0.23	0.23	Cognitive ability (multi-trait analysis);	chr1:243222334	chr1:243346225~243346246:+
LUAD	cis	rs950880	0.71	rs17027179	MIMAT0019927	hsa-miR-4772-3p	5.26	2.17e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102440699	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs55645612	MIMAT0019927	hsa-miR-4772-3p	5.26	2.17e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102439201	chr2:102432336~102432357:+
LUAD	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-5.24	2.4e-07	-0.3	-0.23	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
LUAD	cis	rs950880	0.767	rs6710885	MIMAT0019927	hsa-miR-4772-3p	-5.23	2.47e-07	-0.21	-0.23	Serum protein levels (sST2);	chr2:102361077	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs4851011	MIMAT0019927	hsa-miR-4772-3p	-5.23	2.54e-07	-0.23	-0.23	Serum protein levels (sST2);	chr2:102473219	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs11123927	MIMAT0019927	hsa-miR-4772-3p	5.23	2.56e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102442343	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs10490203	MIMAT0019927	hsa-miR-4772-3p	5.23	2.56e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102442777	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs4851583	MIMAT0019927	hsa-miR-4772-3p	5.23	2.56e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102443840	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-5.23	2.6e-07	-0.17	-0.23	Migraine;	chr10:103309363	chr10:103394341~103394361:-
LUAD	cis	rs4921799	0.662	rs10888142	MIMAT0015020	hsa-miR-548v	-5.22	2.61e-07	-0.25	-0.23	Lung cancer;Adenocarcinoma;	chr8:17679605	chr8:17681588~17681609:-
LUAD	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-5.22	2.67e-07	-0.17	-0.23	Migraine;	chr10:103279822	chr10:103394341~103394361:-
LUAD	cis	rs1014286	0.73	rs2215998	MIMAT0019926	hsa-miR-4772-5p	5.22	2.71e-07	0.27	0.23	Serum protein levels (sST2);	chr2:102549584	chr2:102432300~102432321:+
LUAD	cis	rs2871473	1	rs1030024	MIMAT0019926	hsa-miR-4772-5p	5.22	2.72e-07	0.32	0.23	Blood protein levels;	chr2:102489310	chr2:102432300~102432321:+
LUAD	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-5.21	2.86e-07	-0.17	-0.23	Migraine;	chr10:103317367	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-5.21	2.86e-07	-0.17	-0.23	Migraine;	chr10:103319682	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-5.21	2.88e-07	-0.17	-0.23	Migraine;	chr10:103299551	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	5.2	2.98e-07	0.16	0.23	Migraine;	chr10:103261506	chr10:103394301~103394322:-
LUAD	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	5.2	3.03e-07	0.29	0.23	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
LUAD	cis	rs75358501	0.551	rs10171736	MIMAT0014995	hsa-miR-3130-5p	-5.19	3.04e-07	-0.27	-0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.551	rs10171736	MIMAT0014995_1	hsa-miR-3130-5p	-5.19	3.04e-07	-0.27	-0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783246~206783266:+
LUAD	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-5.19	3.04e-07	-0.29	-0.23	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
LUAD	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-5.19	3.09e-07	-0.16	-0.23	Migraine;	chr10:103273871	chr10:103394341~103394361:-
LUAD	cis	rs1867631	0.585	rs6694782	MIMAT0014979	hsa-miR-3117-3p	5.19	3.1e-07	0.27	0.23	Menopause (age at onset);	chr1:66661079	chr1:66628485~66628505:+
LUAD	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	5.19	3.11e-07	0.29	0.23	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
LUAD	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-5.19	3.16e-07	-0.17	-0.23	Migraine;	chr10:103305652	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-5.18	3.35e-07	-0.17	-0.23	Migraine;	chr10:103299551	chr10:103394341~103394361:-
LUAD	cis	rs79387448	0.638	rs6759588	MIMAT0019926	hsa-miR-4772-5p	-5.17	3.45e-07	-0.44	-0.23	Gut microbiota (bacterial taxa);	chr2:102423699	chr2:102432300~102432321:+
LUAD	cis	rs950880	0.645	rs11679889	MIMAT0019927	hsa-miR-4772-3p	5.17	3.46e-07	0.24	0.23	Serum protein levels (sST2);	chr2:102324549	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.796	rs12987977	MIMAT0019927	hsa-miR-4772-3p	5.16	3.55e-07	0.22	0.23	Serum protein levels (sST2);	chr2:102358876	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-5.16	3.57e-07	-0.17	-0.23	Migraine;	chr10:103395888	chr10:103394341~103394361:-
LUAD	cis	rs9807989	0.839	rs10182710	MIMAT0019927	hsa-miR-4772-3p	-5.16	3.61e-07	-0.22	-0.23	Asthma;	chr2:102364846	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs13392100	MIMAT0019927	hsa-miR-4772-3p	-5.16	3.61e-07	-0.22	-0.23	Asthma;	chr2:102365634	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs12470867	MIMAT0019927	hsa-miR-4772-3p	5.15	3.72e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102309906	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-5.15	3.75e-07	-0.17	-0.23	Migraine;	chr10:103292867	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-5.15	3.75e-07	-0.17	-0.23	Migraine;	chr10:103293183	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-5.15	3.75e-07	-0.17	-0.23	Migraine;	chr10:103293219	chr10:103394341~103394361:-
LUAD	cis	rs953492	0.7	rs3904682	MIMAT0019761	hsa-miR-4677-3p	-5.15	3.8e-07	-0.22	-0.23	Diastolic blood pressure;	chr1:243256127	chr1:243346225~243346246:+
LUAD	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-5.15	3.85e-07	-0.17	-0.23	Migraine;	chr10:103289348	chr10:103394341~103394361:-
LUAD	cis	rs75358501	0.551	rs13394079	MIMAT0014995	hsa-miR-3130-5p	-5.15	3.89e-07	-0.29	-0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783276~206783296:-
LUAD	cis	rs75358501	0.551	rs13394079	MIMAT0014995_1	hsa-miR-3130-5p	-5.15	3.89e-07	-0.29	-0.23	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783246~206783266:+
LUAD	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-5.15	3.9e-07	-0.16	-0.23	Migraine;	chr10:103284400	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-5.14	3.96e-07	-0.17	-0.23	Migraine;	chr10:103395309	chr10:103394341~103394361:-
LUAD	cis	rs1014286	0.706	rs10194822	MIMAT0019926	hsa-miR-4772-5p	-5.14	4.01e-07	-0.26	-0.23	Serum protein levels (sST2);	chr2:102549045	chr2:102432300~102432321:+
LUAD	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-5.14	4.11e-07	-0.16	-0.23	Migraine;	chr10:103262005	chr10:103394301~103394322:-
LUAD	cis	rs953492	0.565	rs10926991	MIMAT0019761	hsa-miR-4677-3p	5.13	4.12e-07	0.23	0.23	Diastolic blood pressure;	chr1:243329265	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.831	rs2802723	MIMAT0019761	hsa-miR-4677-3p	-5.13	4.15e-07	-0.22	-0.23	Diastolic blood pressure;	chr1:243335010	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.507	rs3732124	MIMAT0019927	hsa-miR-4772-3p	5.13	4.19e-07	0.2	0.23	Asthma;	chr2:102401592	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs3771166	MIMAT0019927	hsa-miR-4772-3p	-5.13	4.19e-07	-0.22	-0.23	Asthma;	chr2:102369762	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs1420099	MIMAT0019927	hsa-miR-4772-3p	-5.12	4.35e-07	-0.22	-0.23	Asthma;	chr2:102364083	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-5.12	4.46e-07	-0.17	-0.23	Migraine;	chr10:103307280	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-5.11	4.59e-07	-0.16	-0.23	Migraine;	chr10:103278698	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-5.11	4.59e-07	-0.16	-0.23	Migraine;	chr10:103270083	chr10:103394341~103394361:-
LUAD	cis	rs4921799	0.662	rs7462063	MIMAT0015020	hsa-miR-548v	-5.11	4.72e-07	-0.25	-0.23	Lung cancer;Adenocarcinoma;	chr8:17678838	chr8:17681588~17681609:-
LUAD	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-5.11	4.78e-07	-0.16	-0.23	Migraine;	chr10:103283532	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-5.11	4.78e-07	-0.16	-0.23	Migraine;	chr10:103284207	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	5.09	5.23e-07	0.16	0.23	Migraine;	chr10:103244344	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-5.08	5.43e-07	-0.16	-0.23	Migraine;	chr10:103270083	chr10:103394301~103394322:-
LUAD	cis	rs9807989	0.801	rs11123925	MIMAT0019927	hsa-miR-4772-3p	-5.08	5.43e-07	-0.22	-0.23	Asthma;	chr2:102361051	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs10204837	MIMAT0019927	hsa-miR-4772-3p	-5.08	5.43e-07	-0.22	-0.23	Asthma;	chr2:102361270	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs3755276	MIMAT0019927	hsa-miR-4772-3p	-5.08	5.43e-07	-0.22	-0.23	Asthma;	chr2:102361999	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs9308857	MIMAT0019927	hsa-miR-4772-3p	-5.08	5.43e-07	-0.22	-0.23	Asthma;	chr2:102363164	chr2:102432336~102432357:+
LUAD	cis	rs1014286	0.641	rs10172553	MIMAT0019926	hsa-miR-4772-5p	5.08	5.44e-07	0.26	0.23	Serum protein levels (sST2);	chr2:102536516	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.638	rs6741230	MIMAT0019926	hsa-miR-4772-5p	-5.08	5.5e-07	-0.4	-0.23	Gut microbiota (bacterial taxa);	chr2:102453171	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.638	rs78123896	MIMAT0019926	hsa-miR-4772-5p	-5.08	5.5e-07	-0.4	-0.23	Gut microbiota (bacterial taxa);	chr2:102458957	chr2:102432300~102432321:+
LUAD	cis	rs1014286	0.706	rs6761291	MIMAT0019926	hsa-miR-4772-5p	5.07	5.61e-07	0.26	0.23	Serum protein levels (sST2);	chr2:102538610	chr2:102432300~102432321:+
LUAD	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-5.07	5.65e-07	-0.16	-0.23	Migraine;	chr10:103305652	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-5.07	5.65e-07	-0.16	-0.23	Migraine;	chr10:103278698	chr10:103394341~103394361:-
LUAD	cis	rs9807989	0.801	rs10176664	MIMAT0019927	hsa-miR-4772-3p	-5.07	5.66e-07	-0.22	-0.23	Asthma;	chr2:102359712	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs6543123	MIMAT0019927	hsa-miR-4772-3p	-5.07	5.66e-07	-0.22	-0.23	Asthma;	chr2:102360736	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-5.06	5.89e-07	-0.16	-0.23	Migraine;	chr10:103348698	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-5.06	5.89e-07	-0.16	-0.23	Migraine;	chr10:103358719	chr10:103394341~103394361:-
LUAD	cis	rs9807989	0.839	rs1974675	MIMAT0019927	hsa-miR-4772-3p	-5.06	6.01e-07	-0.22	-0.23	Asthma;	chr2:102369915	chr2:102432336~102432357:+
LUAD	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-5.06	6.04e-07	-0.29	-0.23	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
LUAD	cis	rs9807989	0.801	rs10173193	MIMAT0019927	hsa-miR-4772-3p	-5.06	6.12e-07	-0.21	-0.23	Asthma;	chr2:102358590	chr2:102432336~102432357:+
LUAD	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-5.05	6.16e-07	-0.16	-0.23	Migraine;	chr10:103279291	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.771	rs10883857	MIMAT0022727	hsa-miR-1307-5p	5.05	6.17e-07	0.16	0.22	Migraine;	chr10:103367830	chr10:103394341~103394361:-
LUAD	cis	rs950880	0.71	rs11693204	MIMAT0019927	hsa-miR-4772-3p	5.05	6.24e-07	0.23	0.22	Serum protein levels (sST2);	chr2:102319514	chr2:102432336~102432357:+
LUAD	cis	rs17027258	0.697	rs1468789	MIMAT0019927	hsa-miR-4772-3p	5.04	6.51e-07	0.25	0.22	White blood cell types;	chr2:102476044	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-5.04	6.55e-07	-0.16	-0.22	Migraine;	chr10:103353944	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-5.04	6.55e-07	-0.16	-0.22	Migraine;	chr10:103356299	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-5.04	6.55e-07	-0.16	-0.22	Migraine;	chr10:103358705	chr10:103394341~103394361:-
LUAD	cis	rs6703335	0.687	rs4658560	MIMAT0019761	hsa-miR-4677-3p	5.04	6.58e-07	0.21	0.22	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243355389	chr1:243346225~243346246:+
LUAD	cis	rs6703335	0.687	rs10754803	MIMAT0019761	hsa-miR-4677-3p	-5.04	6.77e-07	-0.21	-0.22	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243349745	chr1:243346225~243346246:+
LUAD	cis	rs1018697	0.966	rs1953930	MIMAT0005951	hsa-miR-1307-3p	5.03	6.87e-07	0.16	0.22	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	5.03	6.98e-07	0.16	0.22	Migraine;	chr10:103248169	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	5.03	6.98e-07	0.16	0.22	Migraine;	chr10:103249329	chr10:103394301~103394322:-
LUAD	cis	rs9807989	0.507	rs10439410	MIMAT0019927	hsa-miR-4772-3p	5.03	7.11e-07	0.2	0.22	Asthma;	chr2:102374328	chr2:102432336~102432357:+
LUAD	cis	rs1014286	0.706	rs4851615	MIMAT0019926	hsa-miR-4772-5p	-5.02	7.48e-07	-0.26	-0.22	Serum protein levels (sST2);	chr2:102530540	chr2:102432300~102432321:+
LUAD	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-5.01	7.58e-07	-0.28	-0.22	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
LUAD	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-5.01	7.58e-07	-0.28	-0.22	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
LUAD	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-5.01	7.64e-07	-0.16	-0.22	Migraine;	chr10:103262005	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-5.01	7.85e-07	-0.16	-0.22	Migraine;	chr10:103367521	chr10:103394341~103394361:-
LUAD	cis	rs950880	0.71	rs17026974	MIMAT0019927	hsa-miR-4772-3p	-5	7.88e-07	-0.23	-0.22	Serum protein levels (sST2);	chr2:102335900	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.767	rs11123923	MIMAT0019927	hsa-miR-4772-3p	5	7.89e-07	0.21	0.22	Serum protein levels (sST2);	chr2:102351384	chr2:102432336~102432357:+
LUAD	cis	rs8064299	0.967	rs880827	MIMAT0017994	hsa-miR-3615	5	8.04e-07	0.2	0.22	Monocyte count;	chr17:74771296	chr17:74748663~74748683:+
LUAD	cis	rs950880	0.71	rs11123929	MIMAT0019927	hsa-miR-4772-3p	5	8.08e-07	0.22	0.22	Serum protein levels (sST2);	chr2:102450683	chr2:102432336~102432357:+
LUAD	cis	rs1018697	1	rs2150928	MIMAT0005951	hsa-miR-1307-3p	5	8.25e-07	0.16	0.22	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394301~103394322:-
LUAD	cis	rs9807989	0.839	rs1362348	MIMAT0019927	hsa-miR-4772-3p	-4.99	8.51e-07	-0.21	-0.22	Asthma;	chr2:102368164	chr2:102432336~102432357:+
LUAD	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-4.99	8.57e-07	-0.28	-0.22	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
LUAD	cis	rs1018697	1	rs11191397	MIMAT0005951	hsa-miR-1307-3p	4.99	8.61e-07	0.16	0.22	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394301~103394322:-
LUAD	cis	rs953492	0.565	rs2275155	MIMAT0019761	hsa-miR-4677-3p	4.99	8.64e-07	0.22	0.22	Diastolic blood pressure;	chr1:243330605	chr1:243346225~243346246:+
LUAD	cis	rs8064299	0.967	rs3744208	MIMAT0017994	hsa-miR-3615	-4.99	8.66e-07	-0.21	-0.22	Monocyte count;	chr17:74771426	chr17:74748663~74748683:+
LUAD	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-4.98	8.7e-07	-0.16	-0.22	Migraine;	chr10:103367951	chr10:103394341~103394361:-
LUAD	cis	rs6429422	0.706	rs4658552	MIMAT0019761	hsa-miR-4677-3p	4.98	8.85e-07	0.22	0.22	Cognitive ability (multi-trait analysis);	chr1:243249634	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.698	rs58823746	MIMAT0019761	hsa-miR-4677-3p	-4.98	8.96e-07	-0.21	-0.22	Diastolic blood pressure;	chr1:243280874	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.698	rs61833914	MIMAT0019761	hsa-miR-4677-3p	-4.98	8.97e-07	-0.21	-0.22	Diastolic blood pressure;	chr1:243276745	chr1:243346225~243346246:+
LUAD	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-4.97	9.12e-07	-0.16	-0.22	Migraine;	chr10:103379204	chr10:103394341~103394361:-
LUAD	cis	rs9807989	0.507	rs6758936	MIMAT0019927	hsa-miR-4772-3p	4.97	9.21e-07	0.2	0.22	Asthma;	chr2:102374909	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-4.97	9.28e-07	-0.16	-0.22	Migraine;	chr10:103299082	chr10:103394341~103394361:-
LUAD	cis	rs1018697	1	rs7911528	MIMAT0005951	hsa-miR-1307-3p	4.97	9.28e-07	0.16	0.22	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394301~103394322:-
LUAD	cis	rs1018697	1	rs6584525	MIMAT0005951	hsa-miR-1307-3p	4.97	9.28e-07	0.16	0.22	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394301~103394322:-
LUAD	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-4.97	9.32e-07	-0.16	-0.22	Migraine;	chr10:103273258	chr10:103394341~103394361:-
LUAD	cis	rs950880	0.767	rs12999364	MIMAT0019927	hsa-miR-4772-3p	4.97	9.41e-07	0.21	0.22	Serum protein levels (sST2);	chr2:102357669	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.767	rs12998521	MIMAT0019927	hsa-miR-4772-3p	4.97	9.41e-07	0.21	0.22	Serum protein levels (sST2);	chr2:102357957	chr2:102432336~102432357:+
LUAD	cis	rs1018697	1	rs1018696	MIMAT0005951	hsa-miR-1307-3p	4.96	9.7e-07	0.16	0.22	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394301~103394322:-
LUAD	cis	rs6703335	0.735	rs10927011	MIMAT0019761	hsa-miR-4677-3p	-4.96	9.78e-07	-0.2	-0.22	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243415810	chr1:243346225~243346246:+
LUAD	cis	rs950880	0.71	rs11123928	MIMAT0019927	hsa-miR-4772-3p	4.95	1.02e-06	0.22	0.22	Serum protein levels (sST2);	chr2:102444826	chr2:102432336~102432357:+
LUAD	cis	rs1018697	1	rs10786710	MIMAT0005951	hsa-miR-1307-3p	4.95	1.02e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394301~103394322:-
LUAD	cis	rs1018697	1	rs7080587	MIMAT0005951	hsa-miR-1307-3p	4.95	1.02e-06	0.17	0.22	Colorectal adenoma (advanced);	chr10:102785517	chr10:103394301~103394322:-
LUAD	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.04e-06	-0.16	-0.22	Migraine;	chr10:103386935	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-4.94	1.06e-06	-0.16	-0.22	Migraine;	chr10:103389790	chr10:103394341~103394361:-
LUAD	cis	rs1018697	1	rs7073114	MIMAT0005951	hsa-miR-1307-3p	4.94	1.08e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394301~103394322:-
LUAD	cis	rs9807989	0.507	rs4851004	MIMAT0019927	hsa-miR-4772-3p	4.94	1.09e-06	0.19	0.22	Asthma;	chr2:102393077	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.701	rs3752659	MIMAT0019926	hsa-miR-4772-5p	-4.94	1.11e-06	-0.39	-0.22	Gut microbiota (bacterial taxa);	chr2:102385138	chr2:102432300~102432321:+
LUAD	cis	rs9807989	0.507	rs1420105	MIMAT0019927	hsa-miR-4772-3p	-4.93	1.12e-06	-0.2	-0.22	Asthma;	chr2:102418659	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-4.92	1.16e-06	-0.16	-0.22	Migraine;	chr10:103384531	chr10:103394341~103394361:-
LUAD	cis	rs79387448	0.638	rs13405222	MIMAT0019926	hsa-miR-4772-5p	-4.92	1.17e-06	-0.41	-0.22	Gut microbiota (bacterial taxa);	chr2:102365431	chr2:102432300~102432321:+
LUAD	cis	rs9807989	0.507	rs1420097	MIMAT0019927	hsa-miR-4772-3p	4.92	1.18e-06	0.2	0.22	Asthma;	chr2:102392894	chr2:102432336~102432357:+
LUAD	cis	rs1014286	0.706	rs10196579	MIMAT0019926	hsa-miR-4772-5p	4.92	1.18e-06	0.26	0.22	Serum protein levels (sST2);	chr2:102553722	chr2:102432300~102432321:+
LUAD	cis	rs1014286	0.706	rs2310295	MIMAT0019926	hsa-miR-4772-5p	4.92	1.18e-06	0.26	0.22	Serum protein levels (sST2);	chr2:102554607	chr2:102432300~102432321:+
LUAD	cis	rs9663711	1	rs9663711	MIMAT0005951	hsa-miR-1307-3p	4.92	1.18e-06	0.16	0.22	Carotid plaque burden;	chr10:102787871	chr10:103394301~103394322:-
LUAD	cis	rs1018697	1	rs7092051	MIMAT0005951	hsa-miR-1307-3p	4.92	1.18e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394301~103394322:-
LUAD	cis	rs1018697	1	rs7092346	MIMAT0005951	hsa-miR-1307-3p	4.92	1.18e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.614	rs60038017	MIMAT0019927	hsa-miR-4772-3p	4.92	1.18e-06	0.22	0.22	Serum protein levels (sST2);	chr2:102459541	chr2:102432336~102432357:+
LUAD	cis	rs1867631	0.585	rs12062570	MIMAT0014979	hsa-miR-3117-3p	-4.91	1.25e-06	-0.26	-0.22	Menopause (age at onset);	chr1:66620602	chr1:66628485~66628505:+
LUAD	cis	rs6429422	0.613	rs12749004	MIMAT0019761	hsa-miR-4677-3p	4.91	1.27e-06	0.21	0.22	Cognitive ability (multi-trait analysis);	chr1:243245850	chr1:243346225~243346246:+
LUAD	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-4.91	1.28e-06	-0.16	-0.22	Migraine;	chr10:103273985	chr10:103394341~103394361:-
LUAD	cis	rs1018697	0.966	rs6584526	MIMAT0005951	hsa-miR-1307-3p	4.9	1.33e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394301~103394322:-
LUAD	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-4.9	1.34e-06	-0.28	-0.22	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
LUAD	cis	rs1712517	0.904	rs10883863	MIMAT0022727	hsa-miR-1307-5p	4.9	1.34e-06	0.16	0.22	Migraine;	chr10:103402122	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	4.9	1.35e-06	0.16	0.22	Migraine;	chr10:103241753	chr10:103394301~103394322:-
LUAD	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-4.89	1.37e-06	-0.28	-0.22	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
LUAD	cis	rs9807989	0.507	rs3755266	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma;	chr2:102426252	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs2110659	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma;	chr2:102427407	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs7605284	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma;	chr2:102427715	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.584	rs12712149	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102428733	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.584	rs7559845	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102429754	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs6755905	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma;	chr2:102431747	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.527	rs6756161	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102431957	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs6726985	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma;	chr2:102432120	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs2310300	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma;	chr2:102432614	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs7581119	MIMAT0019927	hsa-miR-4772-3p	-4.89	1.4e-06	-0.19	-0.22	Asthma;	chr2:102433405	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.645	rs56044378	MIMAT0019927	hsa-miR-4772-3p	4.88	1.42e-06	0.22	0.22	Serum protein levels (sST2);	chr2:102448907	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.565	rs885088	MIMAT0019927	hsa-miR-4772-3p	-4.88	1.45e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102422584	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-4.88	1.46e-06	-0.16	-0.22	Migraine;	chr10:103375562	chr10:103394341~103394361:-
LUAD	cis	rs9807989	0.507	rs10203558	MIMAT0019927	hsa-miR-4772-3p	-4.88	1.46e-06	-0.19	-0.22	Asthma;	chr2:102411180	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs10200952	MIMAT0019927	hsa-miR-4772-3p	-4.88	1.46e-06	-0.19	-0.22	Asthma;	chr2:102411191	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.548	rs6543127	MIMAT0019927	hsa-miR-4772-3p	-4.88	1.47e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102411841	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs2293224	MIMAT0019927	hsa-miR-4772-3p	-4.88	1.47e-06	-0.19	-0.22	Asthma;	chr2:102419319	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs6743516	MIMAT0019927	hsa-miR-4772-3p	-4.88	1.47e-06	-0.19	-0.22	Asthma;	chr2:102419875	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.565	rs1420100	MIMAT0019927	hsa-miR-4772-3p	-4.88	1.47e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102420542	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.527	rs3771155	MIMAT0019927	hsa-miR-4772-3p	-4.88	1.47e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102421366	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.524	rs4851576	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.53e-06	-0.19	-0.22	Asthma;	chr2:102412435	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs4851577	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.53e-06	-0.19	-0.22	Asthma;	chr2:102412461	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs4851579	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.53e-06	-0.19	-0.22	Asthma;	chr2:102412524	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.565	rs10206291	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.53e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102422403	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.565	rs3771154	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.53e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102422900	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.524	rs6759479	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.53e-06	-0.19	-0.22	Asthma;	chr2:102423587	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs6543133	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.53e-06	-0.19	-0.22	Asthma;	chr2:102423717	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	4.87	1.53e-06	0.15	0.22	Migraine;	chr10:103261506	chr10:103394341~103394361:-
LUAD	cis	rs1018697	0.966	rs11191396	MIMAT0005951	hsa-miR-1307-3p	4.87	1.53e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394301~103394322:-
LUAD	cis	rs1018697	1	rs4919677	MIMAT0005951	hsa-miR-1307-3p	4.87	1.53e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394301~103394322:-
LUAD	cis	rs1018697	1	rs4919678	MIMAT0005951	hsa-miR-1307-3p	4.87	1.53e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394301~103394322:-
LUAD	cis	rs9807989	0.507	rs6745614	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.55e-06	-0.19	-0.22	Asthma;	chr2:102374753	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	4.86	1.57e-06	0.16	0.22	Migraine;	chr10:103237257	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.71	rs17027230	MIMAT0019927	hsa-miR-4772-3p	4.86	1.6e-06	0.22	0.22	Serum protein levels (sST2);	chr2:102462870	chr2:102432336~102432357:+
LUAD	cis	rs1018697	0.966	rs10748831	MIMAT0005951	hsa-miR-1307-3p	4.86	1.62e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394301~103394322:-
LUAD	cis	rs6429422	0.769	rs3904683	MIMAT0019761	hsa-miR-4677-3p	4.85	1.66e-06	0.21	0.22	Cognitive ability (multi-trait analysis);	chr1:243253223	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.5	rs6669104	MIMAT0019761	hsa-miR-4677-3p	4.85	1.68e-06	0.21	0.22	Diastolic blood pressure;	chr1:243232817	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.83	rs2451669	MIMAT0019761	hsa-miR-4677-3p	-4.85	1.69e-06	-0.2	-0.22	Diastolic blood pressure;	chr1:243329822	chr1:243346225~243346246:+
LUAD	cis	rs2871473	0.951	rs1030025	MIMAT0019926	hsa-miR-4772-5p	-4.84	1.72e-06	-0.3	-0.22	Blood protein levels;	chr2:102489152	chr2:102432300~102432321:+
LUAD	cis	rs9807989	0.729	rs10170583	MIMAT0019927	hsa-miR-4772-3p	-4.84	1.72e-06	-0.2	-0.22	Asthma;	chr2:102358304	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.701	rs76943877	MIMAT0019926	hsa-miR-4772-5p	-4.83	1.81e-06	-0.4	-0.22	Gut microbiota (bacterial taxa);	chr2:102354217	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.576	rs11902044	MIMAT0019926	hsa-miR-4772-5p	-4.83	1.81e-06	-0.4	-0.22	Gut microbiota (bacterial taxa);	chr2:102356074	chr2:102432300~102432321:+
LUAD	cis	rs9807989	0.507	rs1592459	MIMAT0019927	hsa-miR-4772-3p	-4.83	1.83e-06	-0.19	-0.22	Asthma;	chr2:102415109	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs1592458	MIMAT0019927	hsa-miR-4772-3p	-4.83	1.83e-06	-0.19	-0.22	Asthma;	chr2:102415289	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.565	rs1035125	MIMAT0019927	hsa-miR-4772-3p	-4.83	1.83e-06	-0.19	-0.22	Asthma (childhood onset);	chr2:102417379	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs2160201	MIMAT0019927	hsa-miR-4772-3p	-4.83	1.83e-06	-0.19	-0.22	Asthma;	chr2:102417501	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs1833174	MIMAT0019927	hsa-miR-4772-3p	-4.83	1.83e-06	-0.19	-0.22	Asthma;	chr2:102418383	chr2:102432336~102432357:+
LUAD	cis	rs6703335	0.735	rs12129652	MIMAT0019761	hsa-miR-4677-3p	4.83	1.86e-06	0.2	0.22	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243412167	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.769	rs12097743	MIMAT0019761	hsa-miR-4677-3p	4.83	1.86e-06	0.21	0.22	Cognitive ability (multi-trait analysis);	chr1:243248084	chr1:243346225~243346246:+
LUAD	cis	rs950880	0.71	rs56043441	MIMAT0019927	hsa-miR-4772-3p	4.83	1.86e-06	0.22	0.22	Serum protein levels (sST2);	chr2:102470923	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	4.82	1.91e-06	0.15	0.22	Migraine;	chr10:103240612	chr10:103394301~103394322:-
LUAD	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-4.82	1.92e-06	-0.28	-0.22	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
LUAD	cis	rs1018697	1	rs7086400	MIMAT0005951	hsa-miR-1307-3p	4.81	2.03e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394301~103394322:-
LUAD	cis	rs6429422	0.769	rs10926971	MIMAT0019761	hsa-miR-4677-3p	-4.81	2.05e-06	-0.21	-0.21	Cognitive ability (multi-trait analysis);	chr1:243218052	chr1:243346225~243346246:+
LUAD	cis	rs950880	0.71	rs17027255	MIMAT0019927	hsa-miR-4772-3p	4.8	2.11e-06	0.21	0.21	Serum protein levels (sST2);	chr2:102473668	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.71	rs17027258	MIMAT0019927	hsa-miR-4772-3p	4.8	2.11e-06	0.21	0.21	Serum protein levels (sST2);	chr2:102475081	chr2:102432336~102432357:+
LUAD	cis	rs6429422	0.769	rs12079702	MIMAT0019761	hsa-miR-4677-3p	4.8	2.11e-06	0.21	0.21	Cognitive ability (multi-trait analysis);	chr1:243222658	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.708	rs6543124	MIMAT0019927	hsa-miR-4772-3p	-4.8	2.13e-06	-0.21	-0.21	Asthma;	chr2:102370999	chr2:102432336~102432357:+
LUAD	cis	rs953492	0.863	rs2802722	MIMAT0019761	hsa-miR-4677-3p	-4.79	2.19e-06	-0.19	-0.21	Diastolic blood pressure;	chr1:243335231	chr1:243346225~243346246:+
LUAD	cis	rs10021731	0.577	rs34941812	MIMAT0003242	hsa-miR-577	-4.79	2.22e-06	-0.24	-0.21	Optic disc area;	chr4:114673260	chr4:114656774~114656794:+
LUAD	cis	rs8064299	0.967	rs878906	MIMAT0017994	hsa-miR-3615	-4.78	2.3e-06	-0.2	-0.21	Monocyte count;	chr17:74773195	chr17:74748663~74748683:+
LUAD	cis	rs10021731	0.597	rs11098263	MIMAT0003242	hsa-miR-577	-4.78	2.31e-06	-0.23	-0.21	Optic disc area;	chr4:114686481	chr4:114656774~114656794:+
LUAD	cis	rs2871473	1	rs2871473	MIMAT0019926	hsa-miR-4772-5p	-4.78	2.31e-06	-0.3	-0.21	Blood protein levels;	chr2:102490821	chr2:102432300~102432321:+
LUAD	cis	rs9807989	0.524	rs7594402	MIMAT0019927	hsa-miR-4772-3p	-4.78	2.31e-06	-0.19	-0.21	Asthma;	chr2:102404807	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs6710034	MIMAT0019927	hsa-miR-4772-3p	-4.78	2.31e-06	-0.19	-0.21	Asthma;	chr2:102407218	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs1420096	MIMAT0019927	hsa-miR-4772-3p	-4.78	2.31e-06	-0.19	-0.21	Asthma;	chr2:102394452	chr2:102432336~102432357:+
LUAD	cis	rs8064299	0.967	rs878907	MIMAT0017994	hsa-miR-3615	-4.78	2.33e-06	-0.2	-0.21	Monocyte count;	chr17:74773555	chr17:74748663~74748683:+
LUAD	cis	rs953492	0.831	rs2636320	MIMAT0019761	hsa-miR-4677-3p	-4.78	2.36e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243337754	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.769	rs2171973	MIMAT0019761	hsa-miR-4677-3p	4.77	2.45e-06	0.21	0.21	Cognitive ability (multi-trait analysis);	chr1:243220334	chr1:243346225~243346246:+
LUAD	cis	rs1018697	0.966	rs1475643	MIMAT0005951	hsa-miR-1307-3p	4.77	2.5e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.553	rs2293225	MIMAT0019927	hsa-miR-4772-3p	4.76	2.54e-06	0.23	0.21	Serum protein levels (sST2);	chr2:102419429	chr2:102432336~102432357:+
LUAD	cis	rs953492	0.831	rs2783964	MIMAT0019761	hsa-miR-4677-3p	-4.76	2.56e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243337362	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.831	rs2783965	MIMAT0019761	hsa-miR-4677-3p	-4.76	2.58e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243337095	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.507	rs2041739	MIMAT0019927	hsa-miR-4772-3p	4.76	2.6e-06	0.19	0.21	Asthma;	chr2:102377873	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.524	rs6543126	MIMAT0019927	hsa-miR-4772-3p	-4.75	2.65e-06	-0.19	-0.21	Asthma;	chr2:102410644	chr2:102432336~102432357:+
LUAD	cis	rs8064299	0.967	rs7420	MIMAT0017994	hsa-miR-3615	4.75	2.65e-06	0.2	0.21	Monocyte count;	chr17:74769076	chr17:74748663~74748683:+
LUAD	cis	rs8064299	0.967	rs878905	MIMAT0017994	hsa-miR-3615	-4.75	2.65e-06	-0.2	-0.21	Monocyte count;	chr17:74773272	chr17:74748663~74748683:+
LUAD	cis	rs9807989	0.507	rs6710528	MIMAT0019927	hsa-miR-4772-3p	4.75	2.69e-06	0.19	0.21	Asthma;	chr2:102399682	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.553	rs3755272	MIMAT0019927	hsa-miR-4772-3p	4.75	2.71e-06	0.23	0.21	Serum protein levels (sST2);	chr2:102417365	chr2:102432336~102432357:+
LUAD	cis	rs1018697	0.966	rs10748832	MIMAT0005951	hsa-miR-1307-3p	4.75	2.74e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394301~103394322:-
LUAD	cis	rs79387448	0.701	rs10515921	MIMAT0019926	hsa-miR-4772-5p	-4.75	2.75e-06	-0.4	-0.21	Gut microbiota (bacterial taxa);	chr2:102364558	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.701	rs11465584	MIMAT0019926	hsa-miR-4772-5p	-4.75	2.75e-06	-0.4	-0.21	Gut microbiota (bacterial taxa);	chr2:102366169	chr2:102432300~102432321:+
LUAD	cis	rs1018697	1	rs7909612	MIMAT0005951	hsa-miR-1307-3p	4.74	2.77e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394301~103394322:-
LUAD	cis	rs953492	0.831	rs2783966	MIMAT0019761	hsa-miR-4677-3p	-4.74	2.78e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243336645	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.613	rs12749011	MIMAT0019761	hsa-miR-4677-3p	4.74	2.79e-06	0.21	0.21	Cognitive ability (multi-trait analysis);	chr1:243245861	chr1:243346225~243346246:+
LUAD	cis	rs4988958	0.584	rs7589142	MIMAT0019927	hsa-miR-4772-3p	-4.74	2.81e-06	-0.19	-0.21	Asthma (childhood onset);	chr2:102408200	chr2:102432336~102432357:+
LUAD	cis	rs1558648	0.858	rs13014004	MIMAT0019926	hsa-miR-4772-5p	4.74	2.84e-06	0.35	0.21	Serum protein levels (sST2);	chr2:102224207	chr2:102432300~102432321:+
LUAD	cis	rs953492	0.831	rs2636319	MIMAT0019761	hsa-miR-4677-3p	-4.74	2.84e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243337745	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.769	rs12080886	MIMAT0019761	hsa-miR-4677-3p	4.74	2.88e-06	0.21	0.21	Cognitive ability (multi-trait analysis);	chr1:243222734	chr1:243346225~243346246:+
LUAD	cis	rs6681460	0.966	rs10789214	MIMAT0014979	hsa-miR-3117-3p	-4.73	2.91e-06	-0.27	-0.21	Presence of antiphospholipid antibodies;	chr1:66681134	chr1:66628485~66628505:+
LUAD	cis	rs953492	0.765	rs3818802	MIMAT0019761	hsa-miR-4677-3p	-4.73	2.91e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243286579	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.765	rs10926982	MIMAT0019761	hsa-miR-4677-3p	-4.73	2.91e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243289562	chr1:243346225~243346246:+
LUAD	cis	rs1867631	0.585	rs5008753	MIMAT0014979	hsa-miR-3117-3p	-4.73	3e-06	-0.25	-0.21	Menopause (age at onset);	chr1:66626565	chr1:66628485~66628505:+
LUAD	cis	rs1558648	0.858	rs12996377	MIMAT0019926	hsa-miR-4772-5p	4.72	3.05e-06	0.35	0.21	Serum protein levels (sST2);	chr2:102214018	chr2:102432300~102432321:+
LUAD	cis	rs6429422	0.769	rs6668649	MIMAT0019761	hsa-miR-4677-3p	4.72	3.06e-06	0.21	0.21	Cognitive ability (multi-trait analysis);	chr1:243253490	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.507	rs1420094	MIMAT0019927	hsa-miR-4772-3p	-4.72	3.15e-06	-0.19	-0.21	Asthma;	chr2:102399227	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs4851571	MIMAT0019927	hsa-miR-4772-3p	-4.72	3.15e-06	-0.19	-0.21	Asthma;	chr2:102402540	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs4851572	MIMAT0019927	hsa-miR-4772-3p	-4.72	3.15e-06	-0.19	-0.21	Asthma;	chr2:102402571	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs1035129	MIMAT0019927	hsa-miR-4772-3p	-4.72	3.15e-06	-0.19	-0.21	Asthma;	chr2:102403325	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.524	rs2110662	MIMAT0019927	hsa-miR-4772-3p	-4.72	3.15e-06	-0.19	-0.21	Asthma;	chr2:102403679	chr2:102432336~102432357:+
LUAD	cis	rs10021731	0.597	rs12508215	MIMAT0003242	hsa-miR-577	-4.72	3.17e-06	-0.23	-0.21	Optic disc area;	chr4:114699103	chr4:114656774~114656794:+
LUAD	cis	rs4921799	0.662	rs12680944	MIMAT0015020	hsa-miR-548v	-4.71	3.19e-06	-0.22	-0.21	Lung cancer;Adenocarcinoma;	chr8:17677530	chr8:17681588~17681609:-
LUAD	cis	rs1018697	0.897	rs2150929	MIMAT0005951	hsa-miR-1307-3p	4.71	3.25e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394301~103394322:-
LUAD	cis	rs4988958	0.565	rs6732138	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma (childhood onset);	chr2:102393202	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs10208196	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma;	chr2:102379885	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs7584093	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma;	chr2:102381261	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs3213732	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma;	chr2:102381819	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs10204757	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma;	chr2:102382514	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.524	rs7591246	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma;	chr2:102382943	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.565	rs6760621	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma (childhood onset);	chr2:102383492	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.527	rs11465641	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma (childhood onset);	chr2:102384408	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.525	rs3771159	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma (childhood onset);	chr2:102388498	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.501	rs11903946	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma;	chr2:102388870	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs6706002	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma;	chr2:102389644	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs6749014	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma;	chr2:102389988	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.565	rs12712146	MIMAT0019927	hsa-miR-4772-3p	-4.71	3.26e-06	-0.19	-0.21	Asthma (childhood onset);	chr2:102392254	chr2:102432336~102432357:+
LUAD	cis	rs6429422	0.769	rs12723863	MIMAT0019761	hsa-miR-4677-3p	4.7	3.36e-06	0.2	0.21	Cognitive ability (multi-trait analysis);	chr1:243251389	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.763	rs3904685	MIMAT0019761	hsa-miR-4677-3p	4.7	3.36e-06	0.2	0.21	Cognitive ability (multi-trait analysis);	chr1:243251410	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.932	rs2636323	MIMAT0019761	hsa-miR-4677-3p	-4.7	3.38e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243318254	chr1:243346225~243346246:+
LUAD	cis	rs79387448	0.701	rs11465596	MIMAT0019926	hsa-miR-4772-5p	-4.7	3.39e-06	-0.4	-0.21	Gut microbiota (bacterial taxa);	chr2:102370633	chr2:102432300~102432321:+
LUAD	cis	rs6429422	0.769	rs12744216	MIMAT0019761	hsa-miR-4677-3p	4.7	3.39e-06	0.21	0.21	Cognitive ability (multi-trait analysis);	chr1:243239991	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.769	rs6689352	MIMAT0019761	hsa-miR-4677-3p	4.7	3.39e-06	0.21	0.21	Cognitive ability (multi-trait analysis);	chr1:243244480	chr1:243346225~243346246:+
LUAD	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	4.7	3.4e-06	0.15	0.21	Migraine;	chr10:103244344	chr10:103394341~103394361:-
LUAD	cis	rs79387448	0.626	rs80277428	MIMAT0019926	hsa-miR-4772-5p	-4.7	3.41e-06	-0.4	-0.21	Gut microbiota (bacterial taxa);	chr2:102463596	chr2:102432300~102432321:+
LUAD	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	4.69	3.5e-06	0.21	0.21	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
LUAD	cis	rs4700319	0.793	rs6450500	MIMAT0003247	hsa-miR-582-5p	-4.69	3.59e-06	-0.32	-0.21	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59039728	chr5:59703666~59703688:-
LUAD	cis	rs79387448	0.655	rs3771167	MIMAT0019926	hsa-miR-4772-5p	-4.69	3.64e-06	-0.38	-0.21	Gut microbiota (bacterial taxa);	chr2:102369728	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.592	rs6728945	MIMAT0019926	hsa-miR-4772-5p	-4.69	3.65e-06	-0.38	-0.21	Gut microbiota (bacterial taxa);	chr2:102370011	chr2:102432300~102432321:+
LUAD	cis	rs1558648	1	rs1558648	MIMAT0019926	hsa-miR-4772-5p	4.69	3.65e-06	0.35	0.21	Serum protein levels (sST2);	chr2:102193708	chr2:102432300~102432321:+
LUAD	cis	rs953492	0.565	rs10926988	MIMAT0019761	hsa-miR-4677-3p	4.68	3.71e-06	0.21	0.21	Diastolic blood pressure;	chr1:243319977	chr1:243346225~243346246:+
LUAD	cis	rs1018697	1	rs7896903	MIMAT0005951	hsa-miR-1307-3p	4.68	3.71e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394301~103394322:-
LUAD	cis	rs953492	0.698	rs7521079	MIMAT0019761	hsa-miR-4677-3p	-4.67	3.89e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243280002	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.839	rs7603730	MIMAT0019927	hsa-miR-4772-3p	-4.67	3.96e-06	-0.2	-0.21	Asthma;	chr2:102357911	chr2:102432336~102432357:+
LUAD	cis	rs1014286	0.706	rs10171438	MIMAT0019926	hsa-miR-4772-5p	-4.67	3.96e-06	-0.24	-0.21	Serum protein levels (sST2);	chr2:102558917	chr2:102432300~102432321:+
LUAD	cis	rs1018697	1	rs10748830	MIMAT0005951	hsa-miR-1307-3p	4.67	3.98e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394301~103394322:-
LUAD	cis	rs6681460	0.966	rs10889642	MIMAT0014979	hsa-miR-3117-3p	-4.66	4.06e-06	-0.27	-0.21	Presence of antiphospholipid antibodies;	chr1:66677651	chr1:66628485~66628505:+
LUAD	cis	rs8064299	1	rs8064299	MIMAT0017994	hsa-miR-3615	-4.66	4.06e-06	-0.19	-0.21	Monocyte count;	chr17:74766507	chr17:74748663~74748683:+
LUAD	cis	rs953492	0.565	rs10926989	MIMAT0019761	hsa-miR-4677-3p	4.66	4.11e-06	0.21	0.21	Diastolic blood pressure;	chr1:243320066	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.932	rs2783972	MIMAT0019761	hsa-miR-4677-3p	-4.66	4.17e-06	-0.2	-0.21	Diastolic blood pressure;	chr1:243318129	chr1:243346225~243346246:+
LUAD	cis	rs6681460	1	rs10889641	MIMAT0014979	hsa-miR-3117-3p	-4.65	4.34e-06	-0.26	-0.21	Presence of antiphospholipid antibodies;	chr1:66672684	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.966	rs7519747	MIMAT0014979	hsa-miR-3117-3p	-4.65	4.35e-06	-0.26	-0.21	Presence of antiphospholipid antibodies;	chr1:66675040	chr1:66628485~66628505:+
LUAD	cis	rs1867631	0.585	rs4655642	MIMAT0014979	hsa-miR-3117-3p	-4.65	4.37e-06	-0.25	-0.21	Menopause (age at onset);	chr1:66624400	chr1:66628485~66628505:+
LUAD	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	4.65	4.37e-06	0.25	0.21	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
LUAD	cis	rs1014286	0.706	rs4851019	MIMAT0019926	hsa-miR-4772-5p	4.65	4.39e-06	0.24	0.21	Serum protein levels (sST2);	chr2:102561106	chr2:102432300~102432321:+
LUAD	cis	rs6681460	0.966	rs6588215	MIMAT0014979	hsa-miR-3117-3p	-4.64	4.43e-06	-0.26	-0.21	Presence of antiphospholipid antibodies;	chr1:66676266	chr1:66628485~66628505:+
LUAD	cis	rs6584202	0.589	rs10883094	MIMAT0005878	hsa-miR-1287-5p	4.64	4.45e-06	0.22	0.21	Obesity-related traits;	chr10:98428349	chr10:98395271~98395292:-
LUAD	cis	rs1867631	0.585	rs4655639	MIMAT0014979	hsa-miR-3117-3p	-4.64	4.45e-06	-0.25	-0.21	Menopause (age at onset);	chr1:66623407	chr1:66628485~66628505:+
LUAD	cis	rs4700319	0.938	rs1006431	MIMAT0003247	hsa-miR-582-5p	-4.64	4.59e-06	-0.32	-0.21	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59041143	chr5:59703666~59703688:-
LUAD	cis	rs6011674	0.901	rs75320186	MIMAT0016888	hsa-miR-4326	-4.63	4.7e-06	-0.46	-0.21	Response to cytadine analogues (cytosine arabinoside);	chr20:63235164	chr20:63286818~63286837:+
LUAD	cis	rs953492	0.731	rs10803133	MIMAT0019761	hsa-miR-4677-3p	4.63	4.74e-06	0.19	0.21	Diastolic blood pressure;	chr1:243290712	chr1:243346225~243346246:+
LUAD	cis	rs4700319	0.941	rs1498606	MIMAT0003247	hsa-miR-582-5p	4.63	4.75e-06	0.31	0.21	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59041722	chr5:59703666~59703688:-
LUAD	cis	rs2992632	0.826	rs12023775	MIMAT0019761	hsa-miR-4677-3p	-4.62	4.86e-06	-0.2	-0.21	Educational attainment (years of education);	chr1:243384043	chr1:243346225~243346246:+
LUAD	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	4.62	4.94e-06	0.15	0.21	Migraine;	chr10:103248169	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	4.62	4.94e-06	0.15	0.21	Migraine;	chr10:103249329	chr10:103394341~103394361:-
LUAD	cis	rs7123876	0.587	rs11600831	MIMAT0000250	hsa-miR-139-5p	-4.62	5.03e-06	-0.28	-0.21	Body mass index;	chr11:72649176	chr11:72615102~72615124:-
LUAD	cis	rs4921799	0.662	rs35211928	MIMAT0015020	hsa-miR-548v	-4.61	5.08e-06	-0.21	-0.21	Lung cancer;Adenocarcinoma;	chr8:17677494	chr8:17681588~17681609:-
LUAD	cis	rs6429422	0.736	rs6662991	MIMAT0019761	hsa-miR-4677-3p	4.61	5.21e-06	0.2	0.21	Cognitive ability (multi-trait analysis);	chr1:243246906	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.728	rs7528764	MIMAT0019761	hsa-miR-4677-3p	4.6	5.38e-06	0.2	0.21	Cognitive ability (multi-trait analysis);	chr1:243217180	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.769	rs2171972	MIMAT0019761	hsa-miR-4677-3p	-4.6	5.43e-06	-0.2	-0.21	Cognitive ability (multi-trait analysis);	chr1:243220359	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.773	rs72823661	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102352256	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.801	rs72823663	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102352278	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.811	rs67088699	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102352291	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.773	rs5010059	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102352366	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs11695627	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102353645	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.801	rs7558339	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102353783	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.811	rs7608638	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102353829	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.811	rs4485584	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102354290	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.811	rs4485585	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102354299	chr2:102432336~102432357:+
LUAD	cis	rs9807989	1	rs9807989	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102354740	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs9808453	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102354846	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs4851565	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102355021	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.765	rs9807962	MIMAT0019927	hsa-miR-4772-3p	-4.59	5.62e-06	-0.19	-0.21	Asthma;	chr2:102355204	chr2:102432336~102432357:+
LUAD	cis	rs953492	0.932	rs2490391	MIMAT0019761	hsa-miR-4677-3p	-4.59	5.65e-06	-0.19	-0.21	Diastolic blood pressure;	chr1:243306367	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.932	rs2932634	MIMAT0019761	hsa-miR-4677-3p	-4.59	5.65e-06	-0.19	-0.21	Diastolic blood pressure;	chr1:243307151	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.5	rs4658548	MIMAT0019761	hsa-miR-4677-3p	4.59	5.69e-06	0.2	0.21	Diastolic blood pressure;	chr1:243230791	chr1:243346225~243346246:+
LUAD	cis	rs953492	1	rs2783971	MIMAT0019761	hsa-miR-4677-3p	-4.58	5.81e-06	-0.19	-0.21	Diastolic blood pressure;	chr1:243311234	chr1:243346225~243346246:+
LUAD	cis	rs1018697	1	rs7088711	MIMAT0005951	hsa-miR-1307-3p	-4.58	5.91e-06	-0.15	-0.2	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394301~103394322:-
LUAD	cis	rs953492	0.644	rs3896337	MIMAT0019761	hsa-miR-4677-3p	-4.58	5.92e-06	-0.2	-0.2	Diastolic blood pressure;	chr1:243250764	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.728	rs7518350	MIMAT0019761	hsa-miR-4677-3p	-4.58	5.95e-06	-0.19	-0.2	Cognitive ability (multi-trait analysis);	chr1:243217211	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.518	rs12065580	MIMAT0019761	hsa-miR-4677-3p	4.58	6.02e-06	0.21	0.2	Diastolic blood pressure;	chr1:243334806	chr1:243346225~243346246:+
LUAD	cis	rs79387448	0.614	rs6719130	MIMAT0019926	hsa-miR-4772-5p	-4.58	6.05e-06	-0.38	-0.2	Gut microbiota (bacterial taxa);	chr2:102341776	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.638	rs76255660	MIMAT0019926	hsa-miR-4772-5p	-4.57	6.08e-06	-0.39	-0.2	Gut microbiota (bacterial taxa);	chr2:102474569	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.614	rs985523	MIMAT0019926	hsa-miR-4772-5p	-4.57	6.12e-06	-0.38	-0.2	Gut microbiota (bacterial taxa);	chr2:102337916	chr2:102432300~102432321:+
LUAD	cis	rs8064299	0.934	rs895692	MIMAT0017994	hsa-miR-3615	-4.57	6.17e-06	-0.19	-0.2	Monocyte count;	chr17:74770113	chr17:74748663~74748683:+
LUAD	cis	rs6681460	0.966	rs4655650	MIMAT0014979	hsa-miR-3117-3p	-4.57	6.22e-06	-0.26	-0.2	Presence of antiphospholipid antibodies;	chr1:66676603	chr1:66628485~66628505:+
LUAD	cis	rs953492	0.565	rs11809042	MIMAT0019761	hsa-miR-4677-3p	4.56	6.42e-06	0.21	0.2	Diastolic blood pressure;	chr1:243309362	chr1:243346225~243346246:+
LUAD	cis	rs79387448	0.701	rs11465586	MIMAT0019926	hsa-miR-4772-5p	-4.56	6.44e-06	-0.37	-0.2	Gut microbiota (bacterial taxa);	chr2:102366249	chr2:102432300~102432321:+
LUAD	cis	rs9807989	0.507	rs2287033	MIMAT0019927	hsa-miR-4772-3p	4.56	6.45e-06	0.18	0.2	Asthma;	chr2:102394777	chr2:102432336~102432357:+
LUAD	cis	rs1712517	0.873	rs7894240	MIMAT0022727	hsa-miR-1307-5p	4.56	6.57e-06	0.14	0.2	Migraine;	chr10:103240612	chr10:103394341~103394361:-
LUAD	cis	rs950880	0.553	rs2241116	MIMAT0019927	hsa-miR-4772-3p	4.55	6.96e-06	0.22	0.2	Serum protein levels (sST2);	chr2:102386805	chr2:102432336~102432357:+
LUAD	cis	rs953492	0.644	rs12145759	MIMAT0019761	hsa-miR-4677-3p	-4.54	6.98e-06	-0.2	-0.2	Diastolic blood pressure;	chr1:243248103	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.839	rs4988957	MIMAT0019927	hsa-miR-4772-3p	4.54	7.07e-06	0.19	0.2	Asthma;	chr2:102351615	chr2:102432336~102432357:+
LUAD	cis	rs953492	0.644	rs10926974	MIMAT0019761	hsa-miR-4677-3p	-4.54	7.17e-06	-0.2	-0.2	Diastolic blood pressure;	chr1:243233024	chr1:243346225~243346246:+
LUAD	cis	rs6681460	0.966	rs10889644	MIMAT0014979	hsa-miR-3117-3p	-4.54	7.22e-06	-0.26	-0.2	Presence of antiphospholipid antibodies;	chr1:66679639	chr1:66628485~66628505:+
LUAD	cis	rs953492	0.524	rs12085949	MIMAT0019761	hsa-miR-4677-3p	4.53	7.4e-06	0.2	0.2	Diastolic blood pressure;	chr1:243304387	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.541	rs12758920	MIMAT0019761	hsa-miR-4677-3p	4.53	7.4e-06	0.2	0.2	Diastolic blood pressure;	chr1:243305727	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.5	rs1565440	MIMAT0019761	hsa-miR-4677-3p	4.53	7.43e-06	0.19	0.2	Diastolic blood pressure;	chr1:243224486	chr1:243346225~243346246:+
LUAD	cis	rs79387448	0.655	rs11891827	MIMAT0019926	hsa-miR-4772-5p	-4.53	7.49e-06	-0.39	-0.2	Gut microbiota (bacterial taxa);	chr2:102334722	chr2:102432300~102432321:+
LUAD	cis	rs953492	0.541	rs10926987	MIMAT0019761	hsa-miR-4677-3p	4.53	7.5e-06	0.2	0.2	Diastolic blood pressure;	chr1:243308647	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.565	rs12061451	MIMAT0019761	hsa-miR-4677-3p	4.53	7.5e-06	0.2	0.2	Diastolic blood pressure;	chr1:243308885	chr1:243346225~243346246:+
LUAD	cis	rs7123876	0.587	rs55765314	MIMAT0000250	hsa-miR-139-5p	-4.52	7.84e-06	-0.28	-0.2	Body mass index;	chr11:72649891	chr11:72615102~72615124:-
LUAD	cis	rs7123876	0.587	rs61895588	MIMAT0000250	hsa-miR-139-5p	-4.52	7.84e-06	-0.28	-0.2	Body mass index;	chr11:72649942	chr11:72615102~72615124:-
LUAD	cis	rs953492	0.5	rs6662118	MIMAT0019761	hsa-miR-4677-3p	4.52	7.88e-06	0.19	0.2	Diastolic blood pressure;	chr1:243222005	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.769	rs4565697	MIMAT0019761	hsa-miR-4677-3p	4.51	8e-06	0.19	0.2	Cognitive ability (multi-trait analysis);	chr1:243215685	chr1:243346225~243346246:+
LUAD	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	4.51	8.09e-06	0.14	0.2	Migraine;	chr10:103238157	chr10:103394341~103394361:-
LUAD	cis	rs4921799	0.662	rs34285970	MIMAT0015020	hsa-miR-548v	-4.51	8.2e-06	-0.21	-0.2	Lung cancer;Adenocarcinoma;	chr8:17677418	chr8:17681588~17681609:-
LUAD	cis	rs7477	0.875	rs62074191	MIMAT0005942	hsa-miR-1288-3p	4.51	8.21e-06	0.23	0.2	Amyotrophic lateral sclerosis;	chr17:16341539	chr17:16282058~16282078:+
LUAD	cis	rs9807989	0.839	rs6749114	MIMAT0019927	hsa-miR-4772-3p	-4.5	8.65e-06	-0.19	-0.2	Asthma;	chr2:102351127	chr2:102432336~102432357:+
LUAD	cis	rs6681460	0.901	rs1570815	MIMAT0014979	hsa-miR-3117-3p	-4.49	8.76e-06	-0.26	-0.2	Presence of antiphospholipid antibodies;	chr1:66673984	chr1:66628485~66628505:+
LUAD	cis	rs1014286	0.706	rs10202404	MIMAT0019926	hsa-miR-4772-5p	-4.49	8.83e-06	-0.23	-0.2	Serum protein levels (sST2);	chr2:102560955	chr2:102432300~102432321:+
LUAD	cis	rs9807989	0.507	rs13021177	MIMAT0019927	hsa-miR-4772-3p	-4.49	8.92e-06	-0.18	-0.2	Asthma;	chr2:102440033	chr2:102432336~102432357:+
LUAD	cis	rs953492	0.565	rs12759571	MIMAT0019761	hsa-miR-4677-3p	4.49	9.02e-06	0.2	0.2	Diastolic blood pressure;	chr1:243305392	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.565	rs68192516	MIMAT0019761	hsa-miR-4677-3p	4.49	9.05e-06	0.2	0.2	Diastolic blood pressure;	chr1:243321824	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.644	rs10926976	MIMAT0019761	hsa-miR-4677-3p	-4.48	9.2e-06	-0.19	-0.2	Diastolic blood pressure;	chr1:243239419	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.765	rs2171975	MIMAT0019761	hsa-miR-4677-3p	4.48	9.22e-06	0.19	0.2	Diastolic blood pressure;	chr1:243283692	chr1:243346225~243346246:+
LUAD	cis	rs4921799	0.662	rs34105101	MIMAT0015020	hsa-miR-548v	-4.48	9.23e-06	-0.21	-0.2	Lung cancer;Adenocarcinoma;	chr8:17675909	chr8:17681588~17681609:-
LUAD	cis	rs9807989	0.801	rs4851566	MIMAT0019927	hsa-miR-4772-3p	-4.48	9.34e-06	-0.19	-0.2	Asthma;	chr2:102356339	chr2:102432336~102432357:+
LUAD	cis	rs6537837	0.517	rs559479	MIMAT0000227	hsa-miR-197-3p	-4.48	9.41e-06	-0.16	-0.2	Major depressive disorder;	chr1:109595914	chr1:109598940~109598961:+
LUAD	cis	rs6584202	0.589	rs10883094	MIMAT0026738	hsa-miR-1287-3p	4.48	9.45e-06	0.16	0.2	Obesity-related traits;	chr10:98428349	chr10:98395232~98395253:-
LUAD	cis	rs950880	1	rs13019081	MIMAT0019927	hsa-miR-4772-3p	-4.47	9.67e-06	-0.19	-0.2	Serum protein levels (sST2);	chr2:102334362	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs6734762	MIMAT0019927	hsa-miR-4772-3p	-4.46	1e-05	-0.18	-0.2	Asthma;	chr2:102446466	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs11465721	MIMAT0019927	hsa-miR-4772-3p	-4.46	1e-05	-0.18	-0.2	Asthma;	chr2:102446780	chr2:102432336~102432357:+
LUAD	cis	rs4988958	0.565	rs3755265	MIMAT0019927	hsa-miR-4772-3p	-4.46	1.01e-05	-0.18	-0.2	Asthma (childhood onset);	chr2:102436356	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.655	rs79144324	MIMAT0019926	hsa-miR-4772-5p	-4.46	1.01e-05	-0.38	-0.2	Gut microbiota (bacterial taxa);	chr2:102316354	chr2:102432300~102432321:+
LUAD	cis	rs6429422	0.803	rs3897821	MIMAT0019761	hsa-miR-4677-3p	4.45	1.05e-05	0.2	0.2	Cognitive ability (multi-trait analysis);	chr1:243257086	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.811	rs11688559	MIMAT0019927	hsa-miR-4772-3p	-4.45	1.07e-05	-0.19	-0.2	Asthma;	chr2:102353453	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.811	rs11688568	MIMAT0019927	hsa-miR-4772-3p	-4.45	1.07e-05	-0.19	-0.2	Asthma;	chr2:102353489	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.811	rs11688573	MIMAT0019927	hsa-miR-4772-3p	-4.45	1.07e-05	-0.19	-0.2	Asthma;	chr2:102353511	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.811	rs11689730	MIMAT0019927	hsa-miR-4772-3p	-4.45	1.07e-05	-0.19	-0.2	Asthma;	chr2:102353524	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.655	rs17639215	MIMAT0019926	hsa-miR-4772-5p	-4.45	1.07e-05	-0.38	-0.2	Gut microbiota (bacterial taxa);	chr2:102336984	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.592	rs76362690	MIMAT0019926	hsa-miR-4772-5p	-4.45	1.09e-05	-0.38	-0.2	Gut microbiota (bacterial taxa);	chr2:102335017	chr2:102432300~102432321:+
LUAD	cis	rs6681460	0.966	rs10889643	MIMAT0014979	hsa-miR-3117-3p	-4.45	1.09e-05	-0.26	-0.2	Presence of antiphospholipid antibodies;	chr1:66677685	chr1:66628485~66628505:+
LUAD	cis	rs953492	0.83	rs2636321	MIMAT0019761	hsa-miR-4677-3p	-4.44	1.09e-05	-0.19	-0.2	Diastolic blood pressure;	chr1:243301114	chr1:243346225~243346246:+
LUAD	cis	rs6681460	1	rs4655648	MIMAT0014979	hsa-miR-3117-3p	-4.44	1.1e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66648626	chr1:66628485~66628505:+
LUAD	cis	rs4851551	0.867	rs3917289	MIMAT0019926	hsa-miR-4772-5p	4.44	1.11e-05	0.42	0.2	Blood protein levels;	chr2:102165451	chr2:102432300~102432321:+
LUAD	cis	rs2992632	0.826	rs58560561	MIMAT0019761	hsa-miR-4677-3p	-4.44	1.11e-05	-0.19	-0.2	Educational attainment (years of education);	chr1:243374427	chr1:243346225~243346246:+
LUAD	cis	rs6681460	0.966	rs10789215	MIMAT0014979	hsa-miR-3117-3p	4.44	1.12e-05	0.25	0.2	Presence of antiphospholipid antibodies;	chr1:66685502	chr1:66628485~66628505:+
LUAD	cis	rs9807989	0.765	rs13424006	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.15e-05	-0.19	-0.2	Asthma;	chr2:102350776	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.765	rs6751967	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.15e-05	-0.19	-0.2	Asthma;	chr2:102350953	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.765	rs6751977	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.15e-05	-0.19	-0.2	Asthma;	chr2:102350970	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.765	rs6704565	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.15e-05	-0.19	-0.2	Asthma;	chr2:102350971	chr2:102432336~102432357:+
LUAD	cis	rs953492	0.765	rs10926981	MIMAT0019761	hsa-miR-4677-3p	-4.43	1.16e-05	-0.19	-0.2	Diastolic blood pressure;	chr1:243288103	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.801	rs6752482	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.17e-05	-0.19	-0.2	Asthma;	chr2:102351398	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs4988956	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.17e-05	-0.19	-0.2	Asthma;	chr2:102351547	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs10192036	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.17e-05	-0.19	-0.2	Asthma;	chr2:102351751	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs10204137	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.17e-05	-0.19	-0.2	Asthma;	chr2:102351752	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs4988958	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.17e-05	-0.19	-0.2	Asthma;	chr2:102351825	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs10192157	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.17e-05	-0.19	-0.2	Asthma;	chr2:102351896	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.839	rs10206753	MIMAT0019927	hsa-miR-4772-3p	-4.43	1.17e-05	-0.19	-0.2	Asthma;	chr2:102351902	chr2:102432336~102432357:+
LUAD	cis	rs6681460	1	rs6659968	MIMAT0014979	hsa-miR-3117-3p	-4.43	1.17e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66657776	chr1:66628485~66628505:+
LUAD	cis	rs6681460	1	rs2031478	MIMAT0014979	hsa-miR-3117-3p	-4.43	1.17e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66658059	chr1:66628485~66628505:+
LUAD	cis	rs6429422	0.763	rs12079656	MIMAT0019761	hsa-miR-4677-3p	4.43	1.18e-05	0.19	0.2	Cognitive ability (multi-trait analysis);	chr1:243289817	chr1:243346225~243346246:+
LUAD	cis	rs6681460	1	rs6670378	MIMAT0014979	hsa-miR-3117-3p	-4.43	1.19e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66660902	chr1:66628485~66628505:+
LUAD	cis	rs17151904	0.778	rs10499566	MIMAT0000243	hsa-miR-148a-3p	-4.42	1.22e-05	-0.24	-0.2	Carotid atherosclerosis in HIV infection;	chr7:25568818	chr7:25949922~25949943:-
LUAD	cis	rs2277912	0.865	rs111954117	MIMAT0014995	hsa-miR-3130-5p	4.42	1.22e-05	0.24	0.2	Height;	chr2:206793017	chr2:206783276~206783296:-
LUAD	cis	rs2277912	0.865	rs111954117	MIMAT0014995_1	hsa-miR-3130-5p	4.42	1.22e-05	0.24	0.2	Height;	chr2:206793017	chr2:206783246~206783266:+
LUAD	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-4.42	1.25e-05	-0.14	-0.2	Migraine;	chr10:103241568	chr10:103394341~103394361:-
LUAD	cis	rs6681460	1	rs1325263	MIMAT0014979	hsa-miR-3117-3p	-4.41	1.26e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66664108	chr1:66628485~66628505:+
LUAD	cis	rs6681460	1	rs2147777	MIMAT0014979	hsa-miR-3117-3p	-4.41	1.27e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66663571	chr1:66628485~66628505:+
LUAD	cis	rs6681460	1	rs6680876	MIMAT0014979	hsa-miR-3117-3p	-4.41	1.27e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66663799	chr1:66628485~66628505:+
LUAD	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	4.41	1.28e-05	0.14	0.2	Migraine;	chr10:103241753	chr10:103394341~103394361:-
LUAD	cis	rs9807989	0.839	rs4988955	MIMAT0019927	hsa-miR-4772-3p	-4.41	1.28e-05	-0.19	-0.2	Asthma;	chr2:102351468	chr2:102432336~102432357:+
LUAD	cis	rs6681460	1	rs6656550	MIMAT0014979	hsa-miR-3117-3p	-4.4	1.31e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66656869	chr1:66628485~66628505:+
LUAD	cis	rs9868809	0.772	rs13070798	MIMAT0001343	hsa-miR-425-3p	4.4	1.31e-05	0.25	0.2	Inflammatory bowel disease;Crohn's disease;Ulcerative colitis;	chr3:48668501	chr3:49020159~49020180:-
LUAD	cis	rs6681460	1	rs1329978	MIMAT0014979	hsa-miR-3117-3p	-4.4	1.33e-05	-0.25	-0.2	Presence of antiphospholipid antibodies;	chr1:66650548	chr1:66628485~66628505:+
LUAD	cis	rs6429422	0.84	rs6682448	MIMAT0019761	hsa-miR-4677-3p	4.4	1.33e-05	0.19	0.2	Cognitive ability (multi-trait analysis);	chr1:243287653	chr1:243346225~243346246:+
LUAD	cis	rs950880	0.767	rs12712142	MIMAT0019927	hsa-miR-4772-3p	-4.4	1.33e-05	-0.18	-0.2	Serum protein levels (sST2);	chr2:102344124	chr2:102432336~102432357:+
LUAD	cis	rs6429422	0.8	rs12074660	MIMAT0019761	hsa-miR-4677-3p	4.4	1.34e-05	0.19	0.2	Cognitive ability (multi-trait analysis);	chr1:243288672	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.83	rs2484639	MIMAT0019761	hsa-miR-4677-3p	-4.39	1.38e-05	-0.18	-0.2	Diastolic blood pressure;	chr1:243299065	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.565	rs10158537	MIMAT0019761	hsa-miR-4677-3p	4.38	1.47e-05	0.2	0.2	Diastolic blood pressure;	chr1:243324884	chr1:243346225~243346246:+
LUAD	cis	rs9807989	0.801	rs6734742	MIMAT0019927	hsa-miR-4772-3p	-4.38	1.49e-05	-0.19	-0.2	Asthma;	chr2:102351397	chr2:102432336~102432357:+
LUAD	cis	rs9807989	0.507	rs4479442	MIMAT0019927	hsa-miR-4772-3p	-4.38	1.49e-05	-0.17	-0.2	Asthma;	chr2:102437614	chr2:102432336~102432357:+
LUAD	cis	rs7477	1	rs7477	MIMAT0005942	hsa-miR-1288-3p	4.37	1.51e-05	0.23	0.2	Amyotrophic lateral sclerosis;	chr17:16342702	chr17:16282058~16282078:+
LUAD	cis	rs4851551	0.543	rs62156407	MIMAT0019926	hsa-miR-4772-5p	4.37	1.54e-05	0.43	0.2	Blood protein levels;	chr2:102208162	chr2:102432300~102432321:+
LUAD	cis	rs4921799	0.711	rs28660237	MIMAT0015020	hsa-miR-548v	-4.36	1.62e-05	-0.21	-0.2	Lung cancer;Adenocarcinoma;	chr8:17674217	chr8:17681588~17681609:-
LUAD	cis	rs1018697	0.966	rs10748831	MIMAT0022727	hsa-miR-1307-5p	4.35	1.63e-05	0.14	0.2	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	4.35	1.63e-05	0.14	0.2	Migraine;	chr10:103242040	chr10:103394301~103394322:-
LUAD	cis	rs2277912	1	rs17214385	MIMAT0014995	hsa-miR-3130-5p	4.35	1.65e-05	0.28	0.2	Height;	chr2:206816879	chr2:206783276~206783296:-
LUAD	cis	rs2277912	1	rs17214385	MIMAT0014995_1	hsa-miR-3130-5p	4.35	1.65e-05	0.28	0.2	Height;	chr2:206816879	chr2:206783246~206783266:+
LUAD	cis	rs75358501	0.688	rs2287629	MIMAT0014994	hsa-miR-3130-3p	-4.35	1.69e-05	-0.27	-0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.688	rs2287629	MIMAT0014994_1	hsa-miR-3130-3p	-4.35	1.69e-05	-0.27	-0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783277~206783297:+
LUAD	cis	rs6681460	0.932	rs2146904	MIMAT0014979	hsa-miR-3117-3p	4.34	1.7e-05	0.24	0.19	Presence of antiphospholipid antibodies;	chr1:66694653	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.966	rs1325261	MIMAT0014979	hsa-miR-3117-3p	-4.34	1.74e-05	-0.25	-0.19	Presence of antiphospholipid antibodies;	chr1:66644833	chr1:66628485~66628505:+
LUAD	cis	rs6429422	0.8	rs12091558	MIMAT0019761	hsa-miR-4677-3p	-4.34	1.77e-05	-0.19	-0.19	Cognitive ability (multi-trait analysis);	chr1:243290608	chr1:243346225~243346246:+
LUAD	cis	rs7477	0.935	rs72838750	MIMAT0005942	hsa-miR-1288-3p	4.33	1.78e-05	0.22	0.19	Amyotrophic lateral sclerosis;	chr17:16339679	chr17:16282058~16282078:+
LUAD	cis	rs9807989	0.507	rs2058659	MIMAT0019927	hsa-miR-4772-3p	4.33	1.79e-05	0.17	0.19	Asthma;	chr2:102438096	chr2:102432336~102432357:+
LUAD	cis	rs6681460	1	rs2872078	MIMAT0014979	hsa-miR-3117-3p	-4.33	1.8e-05	-0.25	-0.19	Presence of antiphospholipid antibodies;	chr1:66661684	chr1:66628485~66628505:+
LUAD	cis	rs75358501	0.748	rs12470963	MIMAT0014994	hsa-miR-3130-3p	4.33	1.8e-05	0.31	0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.748	rs12470963	MIMAT0014994_1	hsa-miR-3130-3p	4.33	1.8e-05	0.31	0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783277~206783297:+
LUAD	cis	rs6429422	0.8	rs10803132	MIMAT0019761	hsa-miR-4677-3p	4.33	1.8e-05	0.19	0.19	Cognitive ability (multi-trait analysis);	chr1:243273964	chr1:243346225~243346246:+
LUAD	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-4.33	1.84e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
LUAD	cis	rs953492	1	rs953492	MIMAT0019761	hsa-miR-4677-3p	-4.33	1.84e-05	-0.18	-0.19	Diastolic blood pressure;	chr1:243307890	chr1:243346225~243346246:+
LUAD	cis	rs9663711	1	rs9663711	MIMAT0022727	hsa-miR-1307-5p	4.33	1.85e-05	0.14	0.19	Carotid plaque burden;	chr10:102787871	chr10:103394341~103394361:-
LUAD	cis	rs6429422	0.84	rs12740033	MIMAT0019761	hsa-miR-4677-3p	4.32	1.86e-05	0.19	0.19	Cognitive ability (multi-trait analysis);	chr1:243281814	chr1:243346225~243346246:+
LUAD	cis	rs6681460	0.837	rs6669023	MIMAT0014979	hsa-miR-3117-3p	-4.32	1.87e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66706185	chr1:66628485~66628505:+
LUAD	cis	rs79387448	0.655	rs79091585	MIMAT0019926	hsa-miR-4772-5p	-4.32	1.88e-05	-0.37	-0.19	Gut microbiota (bacterial taxa);	chr2:102300783	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.638	rs13405222	MIMAT0019927	hsa-miR-4772-3p	-4.32	1.88e-05	-0.29	-0.19	Gut microbiota (bacterial taxa);	chr2:102365431	chr2:102432336~102432357:+
LUAD	cis	rs4700319	1	rs4700319	MIMAT0003247	hsa-miR-582-5p	-4.32	1.89e-05	-0.28	-0.19	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59037981	chr5:59703666~59703688:-
LUAD	cis	rs6681460	1	rs6680944	MIMAT0014979	hsa-miR-3117-3p	-4.32	1.89e-05	-0.25	-0.19	Presence of antiphospholipid antibodies;	chr1:66656882	chr1:66628485~66628505:+
LUAD	cis	rs1018697	0.966	rs6584526	MIMAT0022727	hsa-miR-1307-5p	4.32	1.9e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394341~103394361:-
LUAD	cis	rs6681460	1	rs6681460	MIMAT0014979	hsa-miR-3117-3p	4.31	1.95e-05	0.24	0.19	Presence of antiphospholipid antibodies;	chr1:66657374	chr1:66628485~66628505:+
LUAD	cis	rs4700319	0.838	rs11738454	MIMAT0003247	hsa-miR-582-5p	-4.31	1.95e-05	-0.29	-0.19	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59046293	chr5:59703666~59703688:-
LUAD	cis	rs953492	0.583	rs10803125	MIMAT0019761	hsa-miR-4677-3p	-4.31	1.95e-05	-0.19	-0.19	Diastolic blood pressure;	chr1:243217074	chr1:243346225~243346246:+
LUAD	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-4.31	1.97e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
LUAD	cis	rs4851551	0.619	rs34722443	MIMAT0019926	hsa-miR-4772-5p	4.3	2.03e-05	0.43	0.19	Blood protein levels;	chr2:102223859	chr2:102432300~102432321:+
LUAD	cis	rs6429422	0.84	rs10926979	MIMAT0019761	hsa-miR-4677-3p	4.3	2.04e-05	0.19	0.19	Cognitive ability (multi-trait analysis);	chr1:243269839	chr1:243346225~243346246:+
LUAD	cis	rs6429422	0.84	rs10803131	MIMAT0019761	hsa-miR-4677-3p	4.3	2.04e-05	0.19	0.19	Cognitive ability (multi-trait analysis);	chr1:243272320	chr1:243346225~243346246:+
LUAD	cis	rs6681460	1	rs1445575	MIMAT0014979	hsa-miR-3117-3p	-4.3	2.04e-05	-0.25	-0.19	Presence of antiphospholipid antibodies;	chr1:66586481	chr1:66628485~66628505:+
LUAD	cis	rs6429422	0.84	rs10926978	MIMAT0019761	hsa-miR-4677-3p	4.3	2.04e-05	0.19	0.19	Cognitive ability (multi-trait analysis);	chr1:243268352	chr1:243346225~243346246:+
LUAD	cis	rs6681460	1	rs9662962	MIMAT0014979	hsa-miR-3117-3p	-4.3	2.05e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66655681	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.966	rs9659879	MIMAT0014979	hsa-miR-3117-3p	-4.3	2.05e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66655751	chr1:66628485~66628505:+
LUAD	cis	rs6681460	1	rs7521111	MIMAT0014979	hsa-miR-3117-3p	-4.3	2.05e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66655951	chr1:66628485~66628505:+
LUAD	cis	rs6681460	1	rs7521123	MIMAT0014979	hsa-miR-3117-3p	-4.3	2.05e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66655980	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.934	rs4655628	MIMAT0014979	hsa-miR-3117-3p	-4.3	2.09e-05	-0.25	-0.19	Presence of antiphospholipid antibodies;	chr1:66586926	chr1:66628485~66628505:+
LUAD	cis	rs6681460	1	rs1536115	MIMAT0014979	hsa-miR-3117-3p	-4.3	2.1e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66655318	chr1:66628485~66628505:+
LUAD	cis	rs4921799	0.711	rs34097123	MIMAT0015020	hsa-miR-548v	-4.3	2.12e-05	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17673786	chr8:17681588~17681609:-
LUAD	cis	rs1018697	1	rs7909612	MIMAT0022727	hsa-miR-1307-5p	4.29	2.16e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394341~103394361:-
LUAD	cis	rs6681460	1	rs4655647	MIMAT0014979	hsa-miR-3117-3p	-4.29	2.19e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66640394	chr1:66628485~66628505:+
LUAD	cis	rs74233809	1	rs79237883	MIMAT0005951	hsa-miR-1307-3p	-4.28	2.25e-05	-0.25	-0.19	Birth weight;	chr10:103181189	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs34747231	MIMAT0005951	hsa-miR-1307-3p	-4.28	2.25e-05	-0.25	-0.19	Birth weight;	chr10:103182487	chr10:103394301~103394322:-
LUAD	cis	rs1018697	1	rs7088711	MIMAT0022727	hsa-miR-1307-5p	-4.28	2.25e-05	-0.14	-0.19	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394341~103394361:-
LUAD	cis	rs6681460	1	rs6697088	MIMAT0014979	hsa-miR-3117-3p	4.28	2.26e-05	0.24	0.19	Presence of antiphospholipid antibodies;	chr1:66579041	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-4.28	2.26e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.899	rs1280280	MIMAT0014979	hsa-miR-3117-3p	-4.28	2.28e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66708220	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.932	rs523956	MIMAT0014979	hsa-miR-3117-3p	4.28	2.29e-05	0.24	0.19	Presence of antiphospholipid antibodies;	chr1:66722593	chr1:66628485~66628505:+
LUAD	cis	rs4700319	0.793	rs6450500	MIMAT0004797	hsa-miR-582-3p	-4.27	2.35e-05	-0.3	-0.19	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59039728	chr5:59703630~59703651:-
LUAD	cis	rs74233809	0.901	rs12416331	MIMAT0005951	hsa-miR-1307-3p	-4.27	2.36e-05	-0.25	-0.19	Birth weight;	chr10:103169157	chr10:103394301~103394322:-
LUAD	cis	rs953492	0.591	rs10803123	MIMAT0019761	hsa-miR-4677-3p	-4.27	2.39e-05	-0.18	-0.19	Diastolic blood pressure;	chr1:243214590	chr1:243346225~243346246:+
LUAD	cis	rs4851551	0.867	rs3171845	MIMAT0019926	hsa-miR-4772-5p	4.26	2.42e-05	0.4	0.19	Blood protein levels;	chr2:102174921	chr2:102432300~102432321:+
LUAD	cis	rs4851551	0.867	rs3917330	MIMAT0019926	hsa-miR-4772-5p	4.26	2.42e-05	0.4	0.19	Blood protein levels;	chr2:102179965	chr2:102432300~102432321:+
LUAD	cis	rs4851551	0.867	rs3917331	MIMAT0019926	hsa-miR-4772-5p	4.26	2.42e-05	0.4	0.19	Blood protein levels;	chr2:102179966	chr2:102432300~102432321:+
LUAD	cis	rs1018697	0.966	rs1953930	MIMAT0022727	hsa-miR-1307-5p	4.25	2.52e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	4.25	2.52e-05	0.14	0.19	Migraine;	chr10:103237257	chr10:103394341~103394361:-
LUAD	cis	rs1867631	0.565	rs10749764	MIMAT0014979	hsa-miR-3117-3p	-4.25	2.52e-05	-0.23	-0.19	Menopause (age at onset);	chr1:66684023	chr1:66628485~66628505:+
LUAD	cis	rs4921799	0.64	rs11203895	MIMAT0015020	hsa-miR-548v	-4.24	2.68e-05	-0.2	-0.19	Lung cancer;Adenocarcinoma;	chr8:17678085	chr8:17681588~17681609:-
LUAD	cis	rs4851551	0.543	rs1997503	MIMAT0019926	hsa-miR-4772-5p	4.24	2.71e-05	0.37	0.19	Blood protein levels;	chr2:102192775	chr2:102432300~102432321:+
LUAD	cis	rs1867631	0.585	rs9787219	MIMAT0014979	hsa-miR-3117-3p	-4.24	2.71e-05	-0.23	-0.19	Menopause (age at onset);	chr1:66614476	chr1:66628485~66628505:+
LUAD	cis	rs1867631	0.585	rs11208922	MIMAT0014979	hsa-miR-3117-3p	-4.24	2.71e-05	-0.23	-0.19	Menopause (age at onset);	chr1:66614543	chr1:66628485~66628505:+
LUAD	cis	rs74233809	1	rs12220375	MIMAT0005951	hsa-miR-1307-3p	-4.24	2.72e-05	-0.24	-0.19	Birth weight;	chr10:103141734	chr10:103394301~103394322:-
LUAD	cis	rs6681460	0.966	rs10749765	MIMAT0014979	hsa-miR-3117-3p	-4.23	2.75e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66684597	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-4.23	2.77e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
LUAD	cis	rs79387448	0.655	rs75579337	MIMAT0019926	hsa-miR-4772-5p	-4.23	2.81e-05	-0.37	-0.19	Gut microbiota (bacterial taxa);	chr2:102300842	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.655	rs76930359	MIMAT0019926	hsa-miR-4772-5p	-4.23	2.81e-05	-0.37	-0.19	Gut microbiota (bacterial taxa);	chr2:102308224	chr2:102432300~102432321:+
LUAD	cis	rs4851551	0.543	rs11903354	MIMAT0019926	hsa-miR-4772-5p	4.23	2.82e-05	0.37	0.19	Blood protein levels;	chr2:102193968	chr2:102432300~102432321:+
LUAD	cis	rs1018697	1	rs2150928	MIMAT0022727	hsa-miR-1307-5p	4.23	2.83e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394341~103394361:-
LUAD	cis	rs953492	0.863	rs2490395	MIMAT0019761	hsa-miR-4677-3p	-4.23	2.83e-05	-0.17	-0.19	Diastolic blood pressure;	chr1:243295620	chr1:243346225~243346246:+
LUAD	cis	rs79387448	0.655	rs77763678	MIMAT0019926	hsa-miR-4772-5p	-4.23	2.84e-05	-0.37	-0.19	Gut microbiota (bacterial taxa);	chr2:102300289	chr2:102432300~102432321:+
LUAD	cis	rs1018697	1	rs7092051	MIMAT0022727	hsa-miR-1307-5p	4.23	2.85e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394341~103394361:-
LUAD	cis	rs1018697	1	rs7092346	MIMAT0022727	hsa-miR-1307-5p	4.23	2.85e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394341~103394361:-
LUAD	cis	rs1018697	1	rs11191397	MIMAT0022727	hsa-miR-1307-5p	4.23	2.85e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394341~103394361:-
LUAD	cis	rs4921799	0.64	rs11203894	MIMAT0015020	hsa-miR-548v	-4.22	2.87e-05	-0.2	-0.19	Lung cancer;Adenocarcinoma;	chr8:17677953	chr8:17681588~17681609:-
LUAD	cis	rs1018697	0.966	rs1475643	MIMAT0022727	hsa-miR-1307-5p	4.22	2.88e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394341~103394361:-
LUAD	cis	rs79387448	0.638	rs74731686	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.92e-05	-0.27	-0.19	Gut microbiota (bacterial taxa);	chr2:102427521	chr2:102432336~102432357:+
LUAD	cis	rs4921799	0.686	rs7459632	MIMAT0015020	hsa-miR-548v	4.22	2.93e-05	0.21	0.19	Lung cancer;Adenocarcinoma;	chr8:17678579	chr8:17681588~17681609:-
LUAD	cis	rs6681460	0.899	rs499263	MIMAT0014979	hsa-miR-3117-3p	-4.22	2.95e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66714254	chr1:66628485~66628505:+
LUAD	cis	rs1018697	1	rs7073114	MIMAT0022727	hsa-miR-1307-5p	4.22	2.96e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394341~103394361:-
LUAD	cis	rs6681460	0.932	rs492109	MIMAT0014979	hsa-miR-3117-3p	4.22	2.97e-05	0.24	0.19	Presence of antiphospholipid antibodies;	chr1:66721450	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-4.22	2.97e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
LUAD	cis	rs950880	0.767	rs6543119	MIMAT0019927	hsa-miR-4772-3p	4.22	2.98e-05	0.17	0.19	Serum protein levels (sST2);	chr2:102346612	chr2:102432336~102432357:+
LUAD	cis	rs950880	0.767	rs13017455	MIMAT0019927	hsa-miR-4772-3p	4.22	2.98e-05	0.17	0.19	Serum protein levels (sST2);	chr2:102348282	chr2:102432336~102432357:+
LUAD	cis	rs6681460	0.932	rs603750	MIMAT0014979	hsa-miR-3117-3p	-4.21	3.02e-05	-0.23	-0.19	Presence of antiphospholipid antibodies;	chr1:66711805	chr1:66628485~66628505:+
LUAD	cis	rs1018697	1	rs7911528	MIMAT0022727	hsa-miR-1307-5p	4.21	3.04e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394341~103394361:-
LUAD	cis	rs1018697	1	rs6584525	MIMAT0022727	hsa-miR-1307-5p	4.21	3.04e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394341~103394361:-
LUAD	cis	rs17151904	0.636	rs1995438	MIMAT0000243	hsa-miR-148a-3p	4.21	3.05e-05	0.19	0.19	Carotid atherosclerosis in HIV infection;	chr7:25598816	chr7:25949922~25949943:-
LUAD	cis	rs74233809	1	rs79082900	MIMAT0005951	hsa-miR-1307-3p	-4.2	3.12e-05	-0.24	-0.19	Birth weight;	chr10:103117545	chr10:103394301~103394322:-
LUAD	cis	rs2277912	1	rs72957112	MIMAT0014995	hsa-miR-3130-5p	4.2	3.17e-05	0.27	0.19	Height;	chr2:206830729	chr2:206783276~206783296:-
LUAD	cis	rs2277912	1	rs72957112	MIMAT0014995_1	hsa-miR-3130-5p	4.2	3.17e-05	0.27	0.19	Height;	chr2:206830729	chr2:206783246~206783266:+
LUAD	cis	rs4851551	0.543	rs11887842	MIMAT0019926	hsa-miR-4772-5p	4.2	3.18e-05	0.37	0.19	Blood protein levels;	chr2:102223018	chr2:102432300~102432321:+
LUAD	cis	rs6681460	1	rs964574	MIMAT0014979	hsa-miR-3117-3p	-4.2	3.18e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66597202	chr1:66628485~66628505:+
LUAD	cis	rs7123876	0.587	rs11601122	MIMAT0000250	hsa-miR-139-5p	-4.2	3.22e-05	-0.26	-0.19	Body mass index;	chr11:72651674	chr11:72615102~72615124:-
LUAD	cis	rs6681460	0.966	rs11208932	MIMAT0014979	hsa-miR-3117-3p	-4.2	3.22e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66632170	chr1:66628485~66628505:+
LUAD	cis	rs4700319	0.941	rs1498606	MIMAT0004797	hsa-miR-582-3p	4.2	3.23e-05	0.29	0.19	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59041722	chr5:59703630~59703651:-
LUAD	cis	rs74233809	1	rs11191555	MIMAT0005951	hsa-miR-1307-3p	-4.2	3.25e-05	-0.24	-0.19	Birth weight;	chr10:103097766	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs11191557	MIMAT0005951	hsa-miR-1307-3p	-4.2	3.25e-05	-0.24	-0.19	Birth weight;	chr10:103104857	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs11191558	MIMAT0005951	hsa-miR-1307-3p	-4.2	3.25e-05	-0.24	-0.19	Birth weight;	chr10:103104921	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs12413046	MIMAT0005951	hsa-miR-1307-3p	-4.2	3.25e-05	-0.24	-0.19	Birth weight;	chr10:103111447	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs10883832	MIMAT0005951	hsa-miR-1307-3p	-4.2	3.25e-05	-0.24	-0.19	Birth weight;	chr10:103111522	chr10:103394301~103394322:-
LUAD	cis	rs75358501	0.636	rs2287628	MIMAT0014994	hsa-miR-3130-3p	4.19	3.28e-05	0.26	0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs2287628	MIMAT0014994_1	hsa-miR-3130-3p	4.19	3.28e-05	0.26	0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783277~206783297:+
LUAD	cis	rs6681460	0.966	rs2025595	MIMAT0014979	hsa-miR-3117-3p	-4.19	3.35e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66686816	chr1:66628485~66628505:+
LUAD	cis	rs4921799	0.711	rs35627095	MIMAT0015020	hsa-miR-548v	-4.19	3.36e-05	-0.2	-0.19	Lung cancer;Adenocarcinoma;	chr8:17674109	chr8:17681588~17681609:-
LUAD	cis	rs6681460	0.932	rs618093	MIMAT0014979	hsa-miR-3117-3p	-4.19	3.37e-05	-0.23	-0.19	Presence of antiphospholipid antibodies;	chr1:66712745	chr1:66628485~66628505:+
LUAD	cis	rs4700319	0.938	rs1006431	MIMAT0004797	hsa-miR-582-3p	-4.19	3.37e-05	-0.3	-0.19	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59041143	chr5:59703630~59703651:-
LUAD	cis	rs74233809	1	rs77420391	MIMAT0005951	hsa-miR-1307-3p	-4.19	3.37e-05	-0.24	-0.19	Birth weight;	chr10:103186066	chr10:103394301~103394322:-
LUAD	cis	rs79387448	0.701	rs10515921	MIMAT0019927	hsa-miR-4772-3p	-4.19	3.37e-05	-0.28	-0.19	Gut microbiota (bacterial taxa);	chr2:102364558	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.701	rs11465584	MIMAT0019927	hsa-miR-4772-3p	-4.19	3.37e-05	-0.28	-0.19	Gut microbiota (bacterial taxa);	chr2:102366169	chr2:102432336~102432357:+
LUAD	cis	rs4700319	1	rs4700319	MIMAT0004797	hsa-miR-582-3p	-4.19	3.39e-05	-0.28	-0.19	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59037981	chr5:59703630~59703651:-
LUAD	cis	rs6681460	1	rs6689864	MIMAT0014979	hsa-miR-3117-3p	-4.18	3.41e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66602429	chr1:66628485~66628505:+
LUAD	cis	rs113745635	1	rs113745635	MIMAT0004700	hsa-miR-331-5p	4.18	3.42e-05	0.27	0.19	Lung function (FEV1/FVC);	chr12:95160995	chr12:95308445~95308466:+
LUAD	cis	rs79387448	0.745	rs17027442	MIMAT0019926	hsa-miR-4772-5p	4.18	3.43e-05	0.33	0.19	Gut microbiota (bacterial taxa);	chr2:102548489	chr2:102432300~102432321:+
LUAD	cis	rs12712133	0.75	rs1558625	MIMAT0019926	hsa-miR-4772-5p	4.18	3.45e-05	0.22	0.19	Primary biliary cholangitis;	chr2:102245704	chr2:102432300~102432321:+
LUAD	cis	rs4851551	0.543	rs35918372	MIMAT0019926	hsa-miR-4772-5p	4.18	3.46e-05	0.39	0.19	Blood protein levels;	chr2:102202803	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs11191593	MIMAT0005951	hsa-miR-1307-3p	-4.18	3.47e-05	-0.24	-0.19	Birth weight;	chr10:103179458	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs11191580	MIMAT0005951	hsa-miR-1307-3p	4.18	3.48e-05	0.24	0.19	Birth weight;	chr10:103146454	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs12219304	MIMAT0005951	hsa-miR-1307-3p	-4.17	3.56e-05	-0.24	-0.19	Birth weight;	chr10:103171827	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.767	rs13001714	MIMAT0019927	hsa-miR-4772-3p	4.17	3.57e-05	0.17	0.19	Serum protein levels (sST2);	chr2:102344025	chr2:102432336~102432357:+
LUAD	cis	rs7477	0.616	rs56326304	MIMAT0005942	hsa-miR-1288-3p	4.17	3.58e-05	0.23	0.19	Amyotrophic lateral sclerosis;	chr17:16320021	chr17:16282058~16282078:+
LUAD	cis	rs6703335	1	rs6703335	MIMAT0019761	hsa-miR-4677-3p	4.17	3.58e-05	0.17	0.19	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243445665	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.871	rs2484640	MIMAT0019761	hsa-miR-4677-3p	-4.17	3.6e-05	-0.17	-0.19	Diastolic blood pressure;	chr1:243299115	chr1:243346225~243346246:+
LUAD	cis	rs1018697	1	rs10786710	MIMAT0022727	hsa-miR-1307-5p	4.17	3.61e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394341~103394361:-
LUAD	cis	rs74233809	1	rs11191587	MIMAT0005951	hsa-miR-1307-3p	-4.17	3.63e-05	-0.24	-0.19	Birth weight;	chr10:103169959	chr10:103394301~103394322:-
LUAD	cis	rs6681460	1	rs6656912	MIMAT0014979	hsa-miR-3117-3p	-4.17	3.63e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66617988	chr1:66628485~66628505:+
LUAD	cis	rs79387448	0.655	rs3771167	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.69e-05	-0.27	-0.19	Gut microbiota (bacterial taxa);	chr2:102369728	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.592	rs6728945	MIMAT0019927	hsa-miR-4772-3p	-4.16	3.72e-05	-0.27	-0.19	Gut microbiota (bacterial taxa);	chr2:102370011	chr2:102432336~102432357:+
LUAD	cis	rs1018697	1	rs1018696	MIMAT0022727	hsa-miR-1307-5p	4.16	3.73e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394341~103394361:-
LUAD	cis	rs1018697	1	rs7086400	MIMAT0022727	hsa-miR-1307-5p	4.16	3.74e-05	0.14	0.19	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394341~103394361:-
LUAD	cis	rs6703335	1	rs2039839	MIMAT0019761	hsa-miR-4677-3p	-4.16	3.76e-05	-0.17	-0.19	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243435368	chr1:243346225~243346246:+
LUAD	cis	rs6681460	0.933	rs7554101	MIMAT0014979	hsa-miR-3117-3p	4.15	3.89e-05	0.23	0.19	Presence of antiphospholipid antibodies;	chr1:66690789	chr1:66628485~66628505:+
LUAD	cis	rs1018697	0.966	rs11191396	MIMAT0022727	hsa-miR-1307-5p	4.15	3.9e-05	0.13	0.19	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394341~103394361:-
LUAD	cis	rs1018697	1	rs4919677	MIMAT0022727	hsa-miR-1307-5p	4.15	3.9e-05	0.13	0.19	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394341~103394361:-
LUAD	cis	rs1018697	1	rs4919678	MIMAT0022727	hsa-miR-1307-5p	4.15	3.9e-05	0.13	0.19	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394341~103394361:-
LUAD	cis	rs79387448	0.638	rs7600961	MIMAT0019927	hsa-miR-4772-3p	-4.15	4e-05	-0.27	-0.19	Gut microbiota (bacterial taxa);	chr2:102418995	chr2:102432336~102432357:+
LUAD	cis	rs7123876	0.587	rs11604034	MIMAT0000250	hsa-miR-139-5p	-4.15	4.01e-05	-0.25	-0.19	Body mass index;	chr11:72653103	chr11:72615102~72615124:-
LUAD	cis	rs6537837	0.887	rs17024195	MIMAT0000227	hsa-miR-197-3p	-4.14	4.09e-05	-0.16	-0.19	Major depressive disorder;	chr1:109601133	chr1:109598940~109598961:+
LUAD	cis	rs75358501	0.636	rs725980	MIMAT0014994	hsa-miR-3130-3p	4.14	4.11e-05	0.26	0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs725980	MIMAT0014994_1	hsa-miR-3130-3p	4.14	4.11e-05	0.26	0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783277~206783297:+
LUAD	cis	rs4851551	0.543	rs17026757	MIMAT0019926	hsa-miR-4772-5p	4.14	4.14e-05	0.37	0.19	Blood protein levels;	chr2:102197452	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs11191575	MIMAT0005951	hsa-miR-1307-3p	-4.14	4.14e-05	-0.23	-0.19	Birth weight;	chr10:103138580	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs79993475	MIMAT0005951	hsa-miR-1307-3p	-4.14	4.14e-05	-0.23	-0.19	Birth weight;	chr10:103141274	chr10:103394301~103394322:-
LUAD	cis	rs1014286	1	rs4292112	MIMAT0019926	hsa-miR-4772-5p	4.14	4.19e-05	0.22	0.19	Serum protein levels (sST2);	chr2:102537321	chr2:102432300~102432321:+
LUAD	cis	rs6537837	0.887	rs1889470	MIMAT0000227	hsa-miR-197-3p	-4.13	4.22e-05	-0.16	-0.19	Major depressive disorder;	chr1:109598799	chr1:109598940~109598961:+
LUAD	cis	rs6681460	0.932	rs2044399	MIMAT0014979	hsa-miR-3117-3p	-4.13	4.24e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66588397	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.932	rs2044400	MIMAT0014979	hsa-miR-3117-3p	-4.13	4.24e-05	-0.24	-0.19	Presence of antiphospholipid antibodies;	chr1:66588398	chr1:66628485~66628505:+
LUAD	cis	rs7477	0.616	rs15739	MIMAT0005942	hsa-miR-1288-3p	4.13	4.31e-05	0.22	0.19	Amyotrophic lateral sclerosis;	chr17:16325918	chr17:16282058~16282078:+
LUAD	cis	rs79387448	0.701	rs11465586	MIMAT0019927	hsa-miR-4772-3p	-4.13	4.33e-05	-0.27	-0.19	Gut microbiota (bacterial taxa);	chr2:102366249	chr2:102432336~102432357:+
LUAD	cis	rs6681460	0.834	rs1280310	MIMAT0014979	hsa-miR-3117-3p	4.12	4.38e-05	0.24	0.19	Presence of antiphospholipid antibodies;	chr1:66751140	chr1:66628485~66628505:+
LUAD	cis	rs2277912	1	rs56243714	MIMAT0014995	hsa-miR-3130-5p	4.12	4.42e-05	0.26	0.19	Height;	chr2:206776345	chr2:206783276~206783296:-
LUAD	cis	rs2277912	1	rs56243714	MIMAT0014995_1	hsa-miR-3130-5p	4.12	4.42e-05	0.26	0.19	Height;	chr2:206776345	chr2:206783246~206783266:+
LUAD	cis	rs2277912	1	rs2277912	MIMAT0014995	hsa-miR-3130-5p	4.12	4.46e-05	0.26	0.19	Height;	chr2:206769512	chr2:206783276~206783296:-
LUAD	cis	rs2277912	1	rs2277912	MIMAT0014995_1	hsa-miR-3130-5p	4.12	4.46e-05	0.26	0.19	Height;	chr2:206769512	chr2:206783246~206783266:+
LUAD	cis	rs6681460	0.866	rs485521	MIMAT0014979	hsa-miR-3117-3p	4.12	4.49e-05	0.23	0.18	Presence of antiphospholipid antibodies;	chr1:66743879	chr1:66628485~66628505:+
LUAD	cis	rs75358501	0.636	rs10199766	MIMAT0014994	hsa-miR-3130-3p	4.12	4.51e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs10199766	MIMAT0014994_1	hsa-miR-3130-3p	4.12	4.51e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783277~206783297:+
LUAD	cis	rs1018697	1	rs7080587	MIMAT0022727	hsa-miR-1307-5p	4.12	4.54e-05	0.14	0.18	Colorectal adenoma (advanced);	chr10:102785517	chr10:103394341~103394361:-
LUAD	cis	rs6681460	0.932	rs665319	MIMAT0014979	hsa-miR-3117-3p	-4.12	4.55e-05	-0.23	-0.18	Presence of antiphospholipid antibodies;	chr1:66709805	chr1:66628485~66628505:+
LUAD	cis	rs75358501	0.636	rs7576591	MIMAT0014994	hsa-miR-3130-3p	4.11	4.57e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs7576591	MIMAT0014994_1	hsa-miR-3130-3p	4.11	4.57e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783277~206783297:+
LUAD	cis	rs6681460	0.8	rs539014	MIMAT0014979	hsa-miR-3117-3p	4.11	4.58e-05	0.24	0.18	Presence of antiphospholipid antibodies;	chr1:66746204	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.866	rs1856318	MIMAT0014979	hsa-miR-3117-3p	-4.11	4.59e-05	-0.24	-0.18	Presence of antiphospholipid antibodies;	chr1:66558532	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.932	rs4655640	MIMAT0014979	hsa-miR-3117-3p	-4.11	4.6e-05	-0.24	-0.18	Presence of antiphospholipid antibodies;	chr1:66623537	chr1:66628485~66628505:+
LUAD	cis	rs6429422	0.84	rs2275154	MIMAT0019761	hsa-miR-4677-3p	-4.11	4.67e-05	-0.18	-0.18	Cognitive ability (multi-trait analysis);	chr1:243270352	chr1:243346225~243346246:+
LUAD	cis	rs7123876	0.587	rs72962169	MIMAT0000250	hsa-miR-139-5p	-4.11	4.69e-05	-0.25	-0.18	Body mass index;	chr11:72654625	chr11:72615102~72615124:-
LUAD	cis	rs74233809	1	rs9633712	MIMAT0005951	hsa-miR-1307-3p	-4.11	4.71e-05	-0.23	-0.18	Birth weight;	chr10:103114004	chr10:103394301~103394322:-
LUAD	cis	rs74233809	0.786	rs11191564	MIMAT0005951	hsa-miR-1307-3p	-4.11	4.71e-05	-0.23	-0.18	Birth weight;	chr10:103118786	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs1060240	MIMAT0005951	hsa-miR-1307-3p	-4.11	4.71e-05	-0.23	-0.18	Birth weight;	chr10:103123580	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs10883835	MIMAT0005951	hsa-miR-1307-3p	-4.11	4.71e-05	-0.23	-0.18	Birth weight;	chr10:103124451	chr10:103394301~103394322:-
LUAD	cis	rs7477	0.616	rs11651955	MIMAT0005942	hsa-miR-1288-3p	4.1	4.75e-05	0.22	0.18	Amyotrophic lateral sclerosis;	chr17:16332148	chr17:16282058~16282078:+
LUAD	cis	rs79387448	0.701	rs3752659	MIMAT0019927	hsa-miR-4772-3p	-4.1	4.76e-05	-0.26	-0.18	Gut microbiota (bacterial taxa);	chr2:102385138	chr2:102432336~102432357:+
LUAD	cis	rs75358501	0.636	rs13427002	MIMAT0014994	hsa-miR-3130-3p	4.1	4.76e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs13427002	MIMAT0014994_1	hsa-miR-3130-3p	4.1	4.76e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783277~206783297:+
LUAD	cis	rs75358501	0.636	rs888621	MIMAT0014994	hsa-miR-3130-3p	-4.1	4.77e-05	-0.25	-0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs888621	MIMAT0014994_1	hsa-miR-3130-3p	-4.1	4.77e-05	-0.25	-0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783277~206783297:+
LUAD	cis	rs79387448	0.745	rs74560841	MIMAT0019926	hsa-miR-4772-5p	-4.1	4.79e-05	-0.35	-0.18	Gut microbiota (bacterial taxa);	chr2:102532751	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs11191505	MIMAT0005951	hsa-miR-1307-3p	-4.1	4.83e-05	-0.25	-0.18	Birth weight;	chr10:103007134	chr10:103394301~103394322:-
LUAD	cis	rs6681460	1	rs9662943	MIMAT0014979	hsa-miR-3117-3p	4.1	4.9e-05	0.23	0.18	Presence of antiphospholipid antibodies;	chr1:66655449	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.966	rs7524851	MIMAT0014979	hsa-miR-3117-3p	-4.1	4.92e-05	-0.23	-0.18	Presence of antiphospholipid antibodies;	chr1:66627335	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.966	rs4655646	MIMAT0014979	hsa-miR-3117-3p	-4.1	4.92e-05	-0.23	-0.18	Presence of antiphospholipid antibodies;	chr1:66628653	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.966	rs10749763	MIMAT0014979	hsa-miR-3117-3p	-4.1	4.94e-05	-0.24	-0.18	Presence of antiphospholipid antibodies;	chr1:66596443	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.932	rs524114	MIMAT0014979	hsa-miR-3117-3p	4.09	5e-05	0.23	0.18	Presence of antiphospholipid antibodies;	chr1:66722652	chr1:66628485~66628505:+
LUAD	cis	rs7123876	0.546	rs11604837	MIMAT0000250	hsa-miR-139-5p	-4.09	5.01e-05	-0.26	-0.18	Body mass index;	chr11:72648963	chr11:72615102~72615124:-
LUAD	cis	rs2277912	1	rs12620432	MIMAT0014995	hsa-miR-3130-5p	4.09	5.02e-05	0.26	0.18	Height;	chr2:206771794	chr2:206783276~206783296:-
LUAD	cis	rs2277912	1	rs12620432	MIMAT0014995_1	hsa-miR-3130-5p	4.09	5.02e-05	0.26	0.18	Height;	chr2:206771794	chr2:206783246~206783266:+
LUAD	cis	rs79387448	0.745	rs78136548	MIMAT0019926	hsa-miR-4772-5p	-4.09	5.1e-05	-0.36	-0.18	Gut microbiota (bacterial taxa);	chr2:102487281	chr2:102432300~102432321:+
LUAD	cis	rs12712133	0.552	rs10200945	MIMAT0019927	hsa-miR-4772-3p	4.09	5.11e-05	0.18	0.18	Primary biliary cholangitis;	chr2:102268297	chr2:102432336~102432357:+
LUAD	cis	rs953492	0.614	rs6429422	MIMAT0019761	hsa-miR-4677-3p	4.08	5.19e-05	0.18	0.18	Diastolic blood pressure;	chr1:243309499	chr1:243346225~243346246:+
LUAD	cis	rs4700319	0.887	rs16889129	MIMAT0003247	hsa-miR-582-5p	-4.08	5.2e-05	-0.27	-0.18	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59054055	chr5:59703666~59703688:-
LUAD	cis	rs7477	0.586	rs12948905	MIMAT0005942	hsa-miR-1288-3p	4.08	5.21e-05	0.22	0.18	Amyotrophic lateral sclerosis;	chr17:16321561	chr17:16282058~16282078:+
LUAD	cis	rs79387448	0.505	rs17027327	MIMAT0019926	hsa-miR-4772-5p	-4.08	5.34e-05	-0.31	-0.18	Gut microbiota (bacterial taxa);	chr2:102506054	chr2:102432300~102432321:+
LUAD	cis	rs6681460	0.834	rs2916	MIMAT0014979	hsa-miR-3117-3p	4.08	5.34e-05	0.24	0.18	Presence of antiphospholipid antibodies;	chr1:66751014	chr1:66628485~66628505:+
LUAD	cis	rs6681460	0.932	rs536410	MIMAT0014979	hsa-miR-3117-3p	-4.07	5.41e-05	-0.22	-0.18	Presence of antiphospholipid antibodies;	chr1:66725401	chr1:66628485~66628505:+
LUAD	cis	rs950880	1	rs13001325	MIMAT0019927	hsa-miR-4772-3p	4.07	5.49e-05	0.17	0.18	Serum protein levels (sST2);	chr2:102322576	chr2:102432336~102432357:+
LUAD	cis	rs2150052	0.589	rs824016	MIMAT0030017	hsa-miR-7702	-4.07	5.49e-05	-0.17	-0.18	Neutrophil percentage of white cells;Birth weight;	chr9:111242429	chr9:111271193~111271214:-
LUAD	cis	rs74233809	1	rs11191515	MIMAT0005951	hsa-miR-1307-3p	-4.07	5.5e-05	-0.25	-0.18	Birth weight;	chr10:103016770	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs11191454	MIMAT0005951	hsa-miR-1307-3p	-4.06	5.72e-05	-0.22	-0.18	Birth weight;	chr10:102900247	chr10:103394301~103394322:-
LUAD	cis	rs75358501	0.584	rs11894165	MIMAT0014994	hsa-miR-3130-3p	4.06	5.73e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.584	rs11894165	MIMAT0014994_1	hsa-miR-3130-3p	4.06	5.73e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783277~206783297:+
LUAD	cis	rs75358501	0.688	rs1862087	MIMAT0014994	hsa-miR-3130-3p	4.06	5.73e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.688	rs1862087	MIMAT0014994_1	hsa-miR-3130-3p	4.06	5.73e-05	0.26	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783277~206783297:+
LUAD	cis	rs79387448	0.745	rs72993720	MIMAT0019926	hsa-miR-4772-5p	-4.06	5.73e-05	-0.31	-0.18	Gut microbiota (bacterial taxa);	chr2:102504810	chr2:102432300~102432321:+
LUAD	cis	rs4700319	1	rs1498605	MIMAT0004797	hsa-miR-582-3p	-4.06	5.75e-05	-0.28	-0.18	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59037489	chr5:59703630~59703651:-
LUAD	cis	rs950880	1	rs12479210	MIMAT0019927	hsa-miR-4772-3p	4.06	5.78e-05	0.17	0.18	Serum protein levels (sST2);	chr2:102332701	chr2:102432336~102432357:+
LUAD	cis	rs6681460	0.866	rs996123	MIMAT0014979	hsa-miR-3117-3p	-4.05	5.89e-05	-0.23	-0.18	Presence of antiphospholipid antibodies;	chr1:66559660	chr1:66628485~66628505:+
LUAD	cis	rs7894407	0.76	rs1163085	MIMAT0005951	hsa-miR-1307-3p	-4.05	5.91e-05	-0.14	-0.18	White matter hyperintensity burden;	chr10:103279484	chr10:103394301~103394322:-
LUAD	cis	rs12712133	0.514	rs10188022	MIMAT0019927	hsa-miR-4772-3p	4.05	5.99e-05	0.17	0.18	Primary biliary cholangitis;	chr2:102258406	chr2:102432336~102432357:+
LUAD	cis	rs2277912	1	rs3762567	MIMAT0014995	hsa-miR-3130-5p	4.05	6.05e-05	0.26	0.18	Height;	chr2:206765614	chr2:206783276~206783296:-
LUAD	cis	rs2277912	1	rs3762567	MIMAT0014995_1	hsa-miR-3130-5p	4.05	6.05e-05	0.26	0.18	Height;	chr2:206765614	chr2:206783246~206783266:+
LUAD	cis	rs1014286	1	rs10490202	MIMAT0019926	hsa-miR-4772-5p	4.05	6.08e-05	0.21	0.18	Serum protein levels (sST2);	chr2:102544373	chr2:102432300~102432321:+
LUAD	cis	rs1018697	0.897	rs2150929	MIMAT0022727	hsa-miR-1307-5p	4.04	6.31e-05	0.13	0.18	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394341~103394361:-
LUAD	cis	rs80028505	0.908	rs7761118	MIMAT0022482	hsa-miR-5690	-4.03	6.42e-05	-0.31	-0.18	Foot ulcer in diabetes and neuropathy;	chr6:36100526	chr6:35664760~35664780:-
LUAD	cis	rs4700319	0.941	rs1498604	MIMAT0003247	hsa-miR-582-5p	-4.03	6.46e-05	-0.27	-0.18	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59037333	chr5:59703666~59703688:-
LUAD	cis	rs9469578	1	rs73743323	MIMAT0004567	hsa-miR-219a-1-3p	-4.03	6.49e-05	-0.38	-0.18	Phosphorus levels;	chr6:33737578	chr6:33207896~33207917:+
LUAD	cis	rs9469578	0.901	rs57303110	MIMAT0004567	hsa-miR-219a-1-3p	-4.03	6.49e-05	-0.38	-0.18	Phosphorus levels;	chr6:33738382	chr6:33207896~33207917:+
LUAD	cis	rs953492	0.51	rs10926958	MIMAT0019761	hsa-miR-4677-3p	4.03	6.55e-05	0.17	0.18	Diastolic blood pressure;	chr1:243174914	chr1:243346225~243346246:+
LUAD	cis	rs4700319	1	rs1498605	MIMAT0003247	hsa-miR-582-5p	-4.02	6.65e-05	-0.27	-0.18	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59037489	chr5:59703666~59703688:-
LUAD	cis	rs79387448	0.638	rs11465670	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.81e-05	-0.25	-0.18	Gut microbiota (bacterial taxa);	chr2:102417980	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.626	rs80256362	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.83e-05	-0.27	-0.18	Gut microbiota (bacterial taxa);	chr2:102409041	chr2:102432336~102432357:+
LUAD	cis	rs12712133	0.552	rs1115281	MIMAT0019927	hsa-miR-4772-3p	4.02	6.85e-05	0.17	0.18	Primary biliary cholangitis;	chr2:102274647	chr2:102432336~102432357:+
LUAD	cis	rs6703335	0.841	rs10803140	MIMAT0019761	hsa-miR-4677-3p	-4.01	6.97e-05	-0.16	-0.18	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243410087	chr1:243346225~243346246:+
LUAD	cis	rs6681460	0.932	rs2483705	MIMAT0014979	hsa-miR-3117-3p	4.01	7.03e-05	0.22	0.18	Presence of antiphospholipid antibodies;	chr1:66725497	chr1:66628485~66628505:+
LUAD	cis	rs74233809	1	rs11191502	MIMAT0005951	hsa-miR-1307-3p	-4.01	7.08e-05	-0.24	-0.18	Birth weight;	chr10:103005737	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs74444347	MIMAT0005951	hsa-miR-1307-3p	-4.01	7.08e-05	-0.24	-0.18	Birth weight;	chr10:103009518	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs12221335	MIMAT0005951	hsa-miR-1307-3p	-4.01	7.08e-05	-0.24	-0.18	Birth weight;	chr10:103009635	chr10:103394301~103394322:-
LUAD	cis	rs17151904	0.895	rs11973605	MIMAT0000243	hsa-miR-148a-3p	-4.01	7.1e-05	-0.19	-0.18	Carotid atherosclerosis in HIV infection;	chr7:25568185	chr7:25949922~25949943:-
LUAD	cis	rs4921799	0.711	rs3862091	MIMAT0015020	hsa-miR-548v	4.01	7.13e-05	0.19	0.18	Lung cancer;Adenocarcinoma;	chr8:17673680	chr8:17681588~17681609:-
LUAD	cis	rs953492	0.644	rs12124014	MIMAT0019761	hsa-miR-4677-3p	-4	7.23e-05	-0.18	-0.18	Diastolic blood pressure;	chr1:243213455	chr1:243346225~243346246:+
LUAD	cis	rs12712133	0.552	rs11123915	MIMAT0019927	hsa-miR-4772-3p	4	7.39e-05	0.17	0.18	Primary biliary cholangitis;	chr2:102264363	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.701	rs76943877	MIMAT0019927	hsa-miR-4772-3p	-3.99	7.5e-05	-0.27	-0.18	Gut microbiota (bacterial taxa);	chr2:102354217	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.576	rs11902044	MIMAT0019927	hsa-miR-4772-3p	-3.99	7.5e-05	-0.27	-0.18	Gut microbiota (bacterial taxa);	chr2:102356074	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.745	rs7572284	MIMAT0019926	hsa-miR-4772-5p	-3.99	7.56e-05	-0.31	-0.18	Gut microbiota (bacterial taxa);	chr2:102502964	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs11191499	MIMAT0005951	hsa-miR-1307-3p	-3.99	7.59e-05	-0.22	-0.18	Birth weight;	chr10:103004514	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs11191560	MIMAT0005951	hsa-miR-1307-3p	-3.99	7.6e-05	-0.23	-0.18	Birth weight;	chr10:103109281	chr10:103394301~103394322:-
LUAD	cis	rs6681460	0.932	rs523132	MIMAT0014979	hsa-miR-3117-3p	3.99	7.6e-05	0.22	0.18	Presence of antiphospholipid antibodies;	chr1:66708757	chr1:66628485~66628505:+
LUAD	cis	rs75358501	0.636	rs3815686	MIMAT0014994	hsa-miR-3130-3p	3.99	7.66e-05	0.25	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs3815686	MIMAT0014994_1	hsa-miR-3130-3p	3.99	7.66e-05	0.25	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783277~206783297:+
LUAD	cis	rs6681460	0.966	rs7542924	MIMAT0014979	hsa-miR-3117-3p	-3.99	7.76e-05	-0.22	-0.18	Presence of antiphospholipid antibodies;	chr1:66677372	chr1:66628485~66628505:+
LUAD	cis	rs4700319	0.941	rs1498604	MIMAT0004797	hsa-miR-582-3p	-3.98	7.85e-05	-0.28	-0.18	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59037333	chr5:59703630~59703651:-
LUAD	cis	rs79387448	0.638	rs116055209	MIMAT0019927	hsa-miR-4772-3p	-3.98	7.87e-05	-0.26	-0.18	Gut microbiota (bacterial taxa);	chr2:102415729	chr2:102432336~102432357:+
LUAD	cis	rs74233809	1	rs11191519	MIMAT0005951	hsa-miR-1307-3p	-3.98	7.92e-05	-0.24	-0.18	Birth weight;	chr10:103025161	chr10:103394301~103394322:-
LUAD	cis	rs4700319	1	rs4699934	MIMAT0003247	hsa-miR-582-5p	-3.98	7.95e-05	-0.27	-0.18	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59037944	chr5:59703666~59703688:-
LUAD	cis	rs2081015	0.668	rs2112689	MIMAT0005884	hsa-miR-1294	3.98	7.99e-05	0.2	0.18	Carotid artery intima media thickness (sex interaction);	chr5:154211160	chr5:154347153~154347174:+
LUAD	cis	rs1018697	1	rs10748830	MIMAT0022727	hsa-miR-1307-5p	3.98	8.01e-05	0.13	0.18	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394341~103394361:-
LUAD	cis	rs2277912	0.762	rs72960734	MIMAT0014995	hsa-miR-3130-5p	3.98	8.03e-05	0.23	0.18	Height;	chr2:206713279	chr2:206783276~206783296:-
LUAD	cis	rs2277912	0.762	rs72960734	MIMAT0014995_1	hsa-miR-3130-5p	3.98	8.03e-05	0.23	0.18	Height;	chr2:206713279	chr2:206783246~206783266:+
LUAD	cis	rs6429422	0.803	rs12741781	MIMAT0019761	hsa-miR-4677-3p	-3.98	8.03e-05	-0.17	-0.18	Cognitive ability (multi-trait analysis);	chr1:243264850	chr1:243346225~243346246:+
LUAD	cis	rs74233809	1	rs77787671	MIMAT0005951	hsa-miR-1307-3p	-3.98	8.11e-05	-0.24	-0.18	Birth weight;	chr10:103016448	chr10:103394301~103394322:-
LUAD	cis	rs79387448	0.745	rs72993722	MIMAT0019926	hsa-miR-4772-5p	-3.97	8.22e-05	-0.31	-0.18	Gut microbiota (bacterial taxa);	chr2:102508457	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs76746266	MIMAT0019926	hsa-miR-4772-5p	-3.97	8.22e-05	-0.31	-0.18	Gut microbiota (bacterial taxa);	chr2:102508461	chr2:102432300~102432321:+
LUAD	cis	rs6681460	0.671	rs628655	MIMAT0014979	hsa-miR-3117-3p	3.97	8.29e-05	0.23	0.18	Presence of antiphospholipid antibodies;	chr1:66747890	chr1:66628485~66628505:+
LUAD	cis	rs79387448	0.745	rs7575867	MIMAT0019926	hsa-miR-4772-5p	-3.97	8.29e-05	-0.3	-0.18	Gut microbiota (bacterial taxa);	chr2:102503720	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs11191514	MIMAT0005951	hsa-miR-1307-3p	-3.97	8.32e-05	-0.23	-0.18	Birth weight;	chr10:103013607	chr10:103394301~103394322:-
LUAD	cis	rs7123876	0.587	rs11602616	MIMAT0000250	hsa-miR-139-5p	-3.97	8.33e-05	-0.24	-0.18	Body mass index;	chr11:72653033	chr11:72615102~72615124:-
LUAD	cis	rs79387448	0.638	rs11465698	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.47e-05	-0.26	-0.18	Gut microbiota (bacterial taxa);	chr2:102438117	chr2:102432336~102432357:+
LUAD	cis	rs4700319	0.838	rs11738454	MIMAT0004797	hsa-miR-582-3p	-3.96	8.61e-05	-0.27	-0.18	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59046293	chr5:59703630~59703651:-
LUAD	cis	rs4921799	0.711	rs2269697	MIMAT0015020	hsa-miR-548v	-3.96	8.64e-05	-0.19	-0.18	Lung cancer;Adenocarcinoma;	chr8:17674945	chr8:17681588~17681609:-
LUAD	cis	rs79387448	0.745	rs17027341	MIMAT0019926	hsa-miR-4772-5p	-3.96	8.78e-05	-0.3	-0.18	Gut microbiota (bacterial taxa);	chr2:102520100	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs10883808	MIMAT0005951	hsa-miR-1307-3p	-3.95	9.1e-05	-0.23	-0.18	Birth weight;	chr10:102961369	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs11191479	MIMAT0005951	hsa-miR-1307-3p	-3.95	9.1e-05	-0.23	-0.18	Birth weight;	chr10:102963863	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs10883806	MIMAT0005951	hsa-miR-1307-3p	-3.95	9.1e-05	-0.23	-0.18	Birth weight;	chr10:102953319	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs78260931	MIMAT0005951	hsa-miR-1307-3p	-3.95	9.1e-05	-0.23	-0.18	Birth weight;	chr10:102962205	chr10:103394301~103394322:-
LUAD	cis	rs4921799	0.711	rs36001975	MIMAT0015020	hsa-miR-548v	-3.95	9.12e-05	-0.19	-0.18	Lung cancer;Adenocarcinoma;	chr8:17675856	chr8:17681588~17681609:-
LUAD	cis	rs74233809	1	rs75970938	MIMAT0005951	hsa-miR-1307-3p	-3.95	9.16e-05	-0.24	-0.18	Birth weight;	chr10:103033891	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs79668541	MIMAT0005951	hsa-miR-1307-3p	-3.95	9.16e-05	-0.24	-0.18	Birth weight;	chr10:103034147	chr10:103394301~103394322:-
LUAD	cis	rs4660456	0.504	rs542214	MIMAT0000693	hsa-miR-30e-3p	3.94	9.23e-05	0.16	0.18	Platelet count;	chr1:40632806	chr1:40754413~40754434:+
LUAD	cis	rs1018697	0.966	rs10748832	MIMAT0022727	hsa-miR-1307-5p	3.94	9.25e-05	0.13	0.18	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394341~103394361:-
LUAD	cis	rs1712517	0.838	rs1891293	MIMAT0022727	hsa-miR-1307-5p	3.94	9.27e-05	0.13	0.18	Migraine;	chr10:103242040	chr10:103394341~103394361:-
LUAD	cis	rs6429422	0.761	rs67686929	MIMAT0019761	hsa-miR-4677-3p	3.94	9.38e-05	0.17	0.18	Cognitive ability (multi-trait analysis);	chr1:243143149	chr1:243346225~243346246:+
LUAD	cis	rs953492	0.51	rs35214822	MIMAT0019761	hsa-miR-4677-3p	3.94	9.39e-05	0.17	0.18	Diastolic blood pressure;	chr1:243203628	chr1:243346225~243346246:+
LUAD	cis	rs7586879	0.796	rs11684619	MIMAT0005797	hsa-miR-1301-3p	3.94	9.46e-05	0.15	0.18	Body mass index;	chr2:24855990	chr2:25328651~25328674:-
LUAD	cis	rs7586879	0.796	rs36071142	MIMAT0005797	hsa-miR-1301-3p	3.94	9.46e-05	0.15	0.18	Body mass index;	chr2:24857701	chr2:25328651~25328674:-
LUAD	cis	rs75358501	0.636	rs10932164	MIMAT0014994	hsa-miR-3130-3p	3.94	9.54e-05	0.27	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs10932164	MIMAT0014994_1	hsa-miR-3130-3p	3.94	9.54e-05	0.27	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783277~206783297:+
LUAD	cis	rs74233809	1	rs3781285	MIMAT0005951	hsa-miR-1307-3p	-3.93	9.58e-05	-0.24	-0.18	Birth weight;	chr10:103065908	chr10:103394301~103394322:-
LUAD	cis	rs7894407	0.892	rs10883859	MIMAT0005951	hsa-miR-1307-3p	3.93	9.62e-05	0.14	0.18	White matter hyperintensity burden;	chr10:103368377	chr10:103394301~103394322:-
LUAD	cis	rs6681460	1	rs10889634	MIMAT0014979	hsa-miR-3117-3p	3.93	9.64e-05	0.22	0.18	Presence of antiphospholipid antibodies;	chr1:66600228	chr1:66628485~66628505:+
LUAD	cis	rs17151904	0.725	rs10486407	MIMAT0000243	hsa-miR-148a-3p	3.93	9.67e-05	0.22	0.18	Carotid atherosclerosis in HIV infection;	chr7:25615431	chr7:25949922~25949943:-
LUAD	cis	rs74233809	1	rs11191607	MIMAT0005951	hsa-miR-1307-3p	-3.93	9.7e-05	-0.24	-0.18	Birth weight;	chr10:103199431	chr10:103394301~103394322:-
LUAD	cis	rs7586879	0.663	rs6760328	MIMAT0005797	hsa-miR-1301-3p	3.93	9.8e-05	0.15	0.18	Body mass index;	chr2:24855122	chr2:25328651~25328674:-
LUAD	cis	rs79387448	0.745	rs7601773	MIMAT0019926	hsa-miR-4772-5p	-3.93	9.82e-05	-0.3	-0.18	Gut microbiota (bacterial taxa);	chr2:102504024	chr2:102432300~102432321:+
LUAD	cis	rs7586879	0.796	rs916484	MIMAT0005797	hsa-miR-1301-3p	3.92	0.000101	0.15	0.18	Body mass index;	chr2:24859719	chr2:25328651~25328674:-
LUAD	cis	rs7586879	0.796	rs916486	MIMAT0005797	hsa-miR-1301-3p	3.92	0.000101	0.15	0.18	Body mass index;	chr2:24859760	chr2:25328651~25328674:-
LUAD	cis	rs2150052	0.6	rs2026801	MIMAT0030017	hsa-miR-7702	-3.92	0.000101	-0.17	-0.18	Neutrophil percentage of white cells;Birth weight;	chr9:111143171	chr9:111271193~111271214:-
LUAD	cis	rs74233809	1	rs11191472	MIMAT0005951	hsa-miR-1307-3p	-3.92	0.000103	-0.23	-0.18	Birth weight;	chr10:102947259	chr10:103394301~103394322:-
LUAD	cis	rs4921799	0.711	rs2301542	MIMAT0015020	hsa-miR-548v	-3.92	0.000103	-0.19	-0.18	Lung cancer;Adenocarcinoma;	chr8:17676124	chr8:17681588~17681609:-
LUAD	cis	rs953492	0.591	rs10803128	MIMAT0019761	hsa-miR-4677-3p	-3.91	0.000106	-0.17	-0.18	Diastolic blood pressure;	chr1:243230540	chr1:243346225~243346246:+
LUAD	cis	rs7477	0.818	rs3112524	MIMAT0005942	hsa-miR-1288-3p	3.91	0.000106	0.2	0.18	Amyotrophic lateral sclerosis;	chr17:16342464	chr17:16282058~16282078:+
LUAD	cis	rs75358501	0.636	rs11895370	MIMAT0014994	hsa-miR-3130-3p	3.91	0.000107	0.25	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs11895370	MIMAT0014994_1	hsa-miR-3130-3p	3.91	0.000107	0.25	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783277~206783297:+
LUAD	cis	rs12712133	0.552	rs10469856	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000109	-0.17	-0.18	Primary biliary cholangitis;	chr2:102272369	chr2:102432336~102432357:+
LUAD	cis	rs75358501	0.636	rs16838834	MIMAT0014994	hsa-miR-3130-3p	3.9	0.00011	0.25	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs16838834	MIMAT0014994_1	hsa-miR-3130-3p	3.9	0.00011	0.25	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783277~206783297:+
LUAD	cis	rs17151904	0.666	rs2188859	MIMAT0000243	hsa-miR-148a-3p	3.9	0.00011	0.23	0.18	Carotid atherosclerosis in HIV infection;	chr7:25621307	chr7:25949922~25949943:-
LUAD	cis	rs10021731	0.577	rs6819048	MIMAT0003242	hsa-miR-577	-3.9	0.000112	-0.24	-0.18	Optic disc area;	chr4:114559153	chr4:114656774~114656794:+
LUAD	cis	rs74233809	1	rs943037	MIMAT0005951	hsa-miR-1307-3p	-3.9	0.000112	-0.24	-0.18	Birth weight;	chr10:103076162	chr10:103394301~103394322:-
LUAD	cis	rs8064299	0.597	rs4789097	MIMAT0017994	hsa-miR-3615	3.9	0.000112	0.17	0.18	Monocyte count;	chr17:74785069	chr17:74748663~74748683:+
LUAD	cis	rs74233809	1	rs77860422	MIMAT0005951	hsa-miR-1307-3p	-3.89	0.000114	-0.23	-0.18	Birth weight;	chr10:102988252	chr10:103394301~103394322:-
LUAD	cis	rs75358501	0.636	rs957414	MIMAT0014994	hsa-miR-3130-3p	3.89	0.000116	0.25	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs957414	MIMAT0014994_1	hsa-miR-3130-3p	3.89	0.000116	0.25	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783277~206783297:+
LUAD	cis	rs74233809	1	rs12219901	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000117	-0.23	-0.17	Birth weight;	chr10:103081210	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs10458729	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000117	-0.23	-0.17	Birth weight;	chr10:103081722	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs10883815	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000117	-0.23	-0.17	Birth weight;	chr10:102979422	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs112390216	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000117	-0.23	-0.17	Birth weight;	chr10:102981274	chr10:103394301~103394322:-
LUAD	cis	rs6681460	0.899	rs502690	MIMAT0014979	hsa-miR-3117-3p	-3.88	0.000117	-0.22	-0.17	Presence of antiphospholipid antibodies;	chr1:66716720	chr1:66628485~66628505:+
LUAD	cis	rs2992632	0.961	rs2256126	MIMAT0019761	hsa-miR-4677-3p	3.88	0.000118	0.19	0.17	Educational attainment (years of education);	chr1:243340806	chr1:243346225~243346246:+
LUAD	cis	rs74233809	1	rs11191453	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000121	-0.22	-0.17	Birth weight;	chr10:102900095	chr10:103394301~103394322:-
LUAD	cis	rs4700319	1	rs4699934	MIMAT0004797	hsa-miR-582-3p	-3.88	0.000121	-0.27	-0.17	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59037944	chr5:59703630~59703651:-
LUAD	cis	rs6681460	0.932	rs523188	MIMAT0014979	hsa-miR-3117-3p	-3.87	0.000122	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66708739	chr1:66628485~66628505:+
LUAD	cis	rs950880	1	rs12470864	MIMAT0019927	hsa-miR-4772-3p	3.87	0.000124	0.17	0.17	Serum protein levels (sST2);	chr2:102309902	chr2:102432336~102432357:+
LUAD	cis	rs6537837	0.762	rs6691984	MIMAT0000227	hsa-miR-197-3p	-3.87	0.000124	-0.16	-0.17	Major depressive disorder;	chr1:109601402	chr1:109598940~109598961:+
LUAD	cis	rs1018697	1	rs7896903	MIMAT0022727	hsa-miR-1307-5p	3.87	0.000125	0.13	0.17	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394341~103394361:-
LUAD	cis	rs4921799	0.711	rs2269695	MIMAT0015020	hsa-miR-548v	-3.87	0.000125	-0.18	-0.17	Lung cancer;Adenocarcinoma;	chr8:17674735	chr8:17681588~17681609:-
LUAD	cis	rs3743200	0.556	rs28758422	MIMAT0000454	hsa-miR-184	3.87	0.000125	0.19	0.17	RR interval (heart rate);	chr15:78974987	chr15:79209840~79209861:+
LUAD	cis	rs1014286	1	rs7581853	MIMAT0019926	hsa-miR-4772-5p	3.87	0.000126	0.21	0.17	Serum protein levels (sST2);	chr2:102551265	chr2:102432300~102432321:+
LUAD	cis	rs7894407	0.76	rs1163072	MIMAT0005951	hsa-miR-1307-3p	3.87	0.000126	0.13	0.17	White matter hyperintensity burden;	chr10:103264621	chr10:103394301~103394322:-
LUAD	cis	rs17151904	0.895	rs12669889	MIMAT0000243	hsa-miR-148a-3p	3.87	0.000126	0.19	0.17	Carotid atherosclerosis in HIV infection;	chr7:25567885	chr7:25949922~25949943:-
LUAD	cis	rs17151904	0.578	rs6978241	MIMAT0000243	hsa-miR-148a-3p	3.87	0.000126	0.18	0.17	Carotid atherosclerosis in HIV infection;	chr7:25610688	chr7:25949922~25949943:-
LUAD	cis	rs4921799	0.711	rs34646323	MIMAT0015020	hsa-miR-548v	-3.86	0.000127	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17673776	chr8:17681588~17681609:-
LUAD	cis	rs4851551	0.867	rs2228139	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000131	0.39	0.17	Blood protein levels;	chr2:102165189	chr2:102432300~102432321:+
LUAD	cis	rs2274459	0.591	rs16868575	MIMAT0018349	hsa-miR-3934-5p	3.86	0.000131	0.24	0.17	Obesity (extreme);	chr6:33661269	chr6:33698152~33698173:+
LUAD	cis	rs74233809	1	rs11191548	MIMAT0005951	hsa-miR-1307-3p	3.85	0.000132	0.23	0.17	Birth weight;	chr10:103086421	chr10:103394301~103394322:-
LUAD	cis	rs6429422	0.725	rs2787232	MIMAT0019761	hsa-miR-4677-3p	3.85	0.000134	0.16	0.17	Cognitive ability (multi-trait analysis);	chr1:243143173	chr1:243346225~243346246:+
LUAD	cis	rs6011674	1	rs75824619	MIMAT0016888	hsa-miR-4326	-3.85	0.000135	-0.37	-0.17	Response to cytadine analogues (cytosine arabinoside);	chr20:63225119	chr20:63286818~63286837:+
LUAD	cis	rs11693697	1	rs11693697	MIMAT0019927	hsa-miR-4772-3p	3.85	0.000136	0.21	0.17	Serum protein levels (sST2);	chr2:102299202	chr2:102432336~102432357:+
LUAD	cis	rs74233809	0.901	rs11191425	MIMAT0005951	hsa-miR-1307-3p	-3.85	0.000136	-0.21	-0.17	Birth weight;	chr10:102866213	chr10:103394301~103394322:-
LUAD	cis	rs79387448	0.638	rs6741230	MIMAT0019927	hsa-miR-4772-3p	-3.84	0.000137	-0.25	-0.17	Gut microbiota (bacterial taxa);	chr2:102453171	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.638	rs78123896	MIMAT0019927	hsa-miR-4772-3p	-3.84	0.000137	-0.25	-0.17	Gut microbiota (bacterial taxa);	chr2:102458957	chr2:102432336~102432357:+
LUAD	cis	rs74233809	1	rs11191531	MIMAT0005951	hsa-miR-1307-3p	-3.84	0.000137	-0.23	-0.17	Birth weight;	chr10:103047141	chr10:103394301~103394322:-
LUAD	cis	rs9469578	0.636	rs16869463	MIMAT0004567	hsa-miR-219a-1-3p	3.84	0.000139	0.32	0.17	Phosphorus levels;	chr6:33747206	chr6:33207896~33207917:+
LUAD	cis	rs17151904	0.614	rs17367619	MIMAT0000243	hsa-miR-148a-3p	3.84	0.000139	0.23	0.17	Carotid atherosclerosis in HIV infection;	chr7:25620965	chr7:25949922~25949943:-
LUAD	cis	rs74233809	1	rs11191543	MIMAT0005951	hsa-miR-1307-3p	-3.84	0.00014	-0.23	-0.17	Birth weight;	chr10:103064630	chr10:103394301~103394322:-
LUAD	cis	rs6011674	1	rs74589786	MIMAT0016888	hsa-miR-4326	-3.84	0.000141	-0.37	-0.17	Response to cytadine analogues (cytosine arabinoside);	chr20:63229587	chr20:63286818~63286837:+
LUAD	cis	rs79387448	0.745	rs17027428	MIMAT0019926	hsa-miR-4772-5p	-3.84	0.000142	-0.31	-0.17	Gut microbiota (bacterial taxa);	chr2:102546716	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs17027430	MIMAT0019926	hsa-miR-4772-5p	-3.84	0.000142	-0.31	-0.17	Gut microbiota (bacterial taxa);	chr2:102546778	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs1523196	MIMAT0019926	hsa-miR-4772-5p	-3.84	0.000142	-0.31	-0.17	Gut microbiota (bacterial taxa);	chr2:102547241	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs1523197	MIMAT0019926	hsa-miR-4772-5p	-3.84	0.000142	-0.31	-0.17	Gut microbiota (bacterial taxa);	chr2:102547273	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs79107058	MIMAT0019926	hsa-miR-4772-5p	-3.84	0.000142	-0.31	-0.17	Gut microbiota (bacterial taxa);	chr2:102547798	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs59126438	MIMAT0019926	hsa-miR-4772-5p	-3.84	0.000142	-0.31	-0.17	Gut microbiota (bacterial taxa);	chr2:102548683	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs2310294	MIMAT0019926	hsa-miR-4772-5p	-3.84	0.000142	-0.31	-0.17	Gut microbiota (bacterial taxa);	chr2:102549247	chr2:102432300~102432321:+
LUAD	cis	rs2992632	1	rs2992632	MIMAT0019761	hsa-miR-4677-3p	-3.84	0.000142	-0.18	-0.17	Educational attainment (years of education);	chr1:243340462	chr1:243346225~243346246:+
LUAD	cis	rs9394169	0.613	rs7774682	MIMAT0022975	hsa-miR-3934-3p	-3.83	0.000144	-0.2	-0.17	Essential tremor;	chr6:33754867	chr6:33698191~33698212:+
LUAD	cis	rs17151904	0.609	rs17151997	MIMAT0000243	hsa-miR-148a-3p	3.83	0.000145	0.17	0.17	Carotid atherosclerosis in HIV infection;	chr7:25597988	chr7:25949922~25949943:-
LUAD	cis	rs9469578	1	rs9469580	MIMAT0004567	hsa-miR-219a-1-3p	3.83	0.000146	0.33	0.17	Phosphorus levels;	chr6:33748060	chr6:33207896~33207917:+
LUAD	cis	rs17151904	0.614	rs17464658	MIMAT0000243	hsa-miR-148a-3p	3.83	0.000146	0.22	0.17	Carotid atherosclerosis in HIV infection;	chr7:25593918	chr7:25949922~25949943:-
LUAD	cis	rs6703335	1	rs10927013	MIMAT0019761	hsa-miR-4677-3p	-3.83	0.000146	-0.16	-0.17	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243425854	chr1:243346225~243346246:+
LUAD	cis	rs7477	0.557	rs12938878	MIMAT0005942	hsa-miR-1288-3p	3.83	0.000146	0.2	0.17	Amyotrophic lateral sclerosis;	chr17:16313291	chr17:16282058~16282078:+
LUAD	cis	rs74233809	1	rs76752100	MIMAT0005951	hsa-miR-1307-3p	-3.82	0.00015	-0.23	-0.17	Birth weight;	chr10:103034329	chr10:103394301~103394322:-
LUAD	cis	rs9527	0.83	rs11191442	MIMAT0022727	hsa-miR-1307-5p	3.82	0.000151	0.14	0.17	Arsenic metabolism;	chr10:102883839	chr10:103394341~103394361:-
LUAD	cis	rs79387448	0.701	rs11465596	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.000151	-0.26	-0.17	Gut microbiota (bacterial taxa);	chr2:102370633	chr2:102432336~102432357:+
LUAD	cis	rs74233809	1	rs12219027	MIMAT0005951	hsa-miR-1307-3p	-3.82	0.000151	-0.22	-0.17	Birth weight;	chr10:103051446	chr10:103394301~103394322:-
LUAD	cis	rs6681460	0.901	rs1373911	MIMAT0014979	hsa-miR-3117-3p	-3.82	0.000152	-0.22	-0.17	Presence of antiphospholipid antibodies;	chr1:66575382	chr1:66628485~66628505:+
LUAD	cis	rs546131	0.642	rs566798	MIMAT0019776	hsa-miR-1343-3p	-3.82	0.000154	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34830730	chr11:34941888~34941909:+
LUAD	cis	rs7477	0.557	rs4792731	MIMAT0005942	hsa-miR-1288-3p	3.81	0.000155	0.2	0.17	Amyotrophic lateral sclerosis;	chr17:16298627	chr17:16282058~16282078:+
LUAD	cis	rs6681460	0.932	rs602513	MIMAT0014979	hsa-miR-3117-3p	-3.81	0.000159	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66711587	chr1:66628485~66628505:+
LUAD	cis	rs7208859	0.623	rs8082537	MIMAT0000459	hsa-miR-193a-3p	3.8	0.000161	0.26	0.17	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30688914	chr17:31560050~31560071:+
LUAD	cis	rs6681460	0.932	rs659291	MIMAT0014979	hsa-miR-3117-3p	-3.8	0.000161	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66715063	chr1:66628485~66628505:+
LUAD	cis	rs79387448	0.745	rs59694233	MIMAT0019926	hsa-miR-4772-5p	-3.8	0.000164	-0.29	-0.17	Gut microbiota (bacterial taxa);	chr2:102500062	chr2:102432300~102432321:+
LUAD	cis	rs75358501	0.636	rs1862089	MIMAT0014994	hsa-miR-3130-3p	3.8	0.000165	0.25	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs1862089	MIMAT0014994_1	hsa-miR-3130-3p	3.8	0.000165	0.25	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783277~206783297:+
LUAD	cis	rs17151904	0.895	rs11973587	MIMAT0000243	hsa-miR-148a-3p	3.8	0.000165	0.18	0.17	Carotid atherosclerosis in HIV infection;	chr7:25568319	chr7:25949922~25949943:-
LUAD	cis	rs74233809	0.748	rs10786736	MIMAT0005951	hsa-miR-1307-3p	-3.8	0.000165	-0.21	-0.17	Birth weight;	chr10:103089359	chr10:103394301~103394322:-
LUAD	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-3.8	0.000166	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
LUAD	cis	rs9527	0.83	rs10883790	MIMAT0022727	hsa-miR-1307-5p	3.79	0.000167	0.14	0.17	Arsenic metabolism;	chr10:102881198	chr10:103394341~103394361:-
LUAD	cis	rs9527	0.83	rs11191440	MIMAT0022727	hsa-miR-1307-5p	3.79	0.000167	0.14	0.17	Arsenic metabolism;	chr10:102881754	chr10:103394341~103394361:-
LUAD	cis	rs9527	0.83	rs12249194	MIMAT0022727	hsa-miR-1307-5p	3.79	0.000167	0.14	0.17	Arsenic metabolism;	chr10:102883941	chr10:103394341~103394361:-
LUAD	cis	rs6011674	1	rs1555337	MIMAT0016888	hsa-miR-4326	3.79	0.000167	0.36	0.17	Response to cytadine analogues (cytosine arabinoside);	chr20:63232289	chr20:63286818~63286837:+
LUAD	cis	rs79387448	0.745	rs1403549	MIMAT0019926	hsa-miR-4772-5p	-3.79	0.000168	-0.29	-0.17	Gut microbiota (bacterial taxa);	chr2:102494286	chr2:102432300~102432321:+
LUAD	cis	rs74233809	0.901	rs17115100	MIMAT0005951	hsa-miR-1307-3p	-3.79	0.000168	-0.21	-0.17	Birth weight;	chr10:102831636	chr10:103394301~103394322:-
LUAD	cis	rs4921799	0.711	rs17125083	MIMAT0015020	hsa-miR-548v	-3.79	0.000172	-0.18	-0.17	Lung cancer;Adenocarcinoma;	chr8:17675959	chr8:17681588~17681609:-
LUAD	cis	rs4921799	0.711	rs2301541	MIMAT0015020	hsa-miR-548v	-3.79	0.000172	-0.18	-0.17	Lung cancer;Adenocarcinoma;	chr8:17676059	chr8:17681588~17681609:-
LUAD	cis	rs79387448	0.81	rs76229479	MIMAT0019926	hsa-miR-4772-5p	-3.79	0.000173	-0.32	-0.17	Gut microbiota (bacterial taxa);	chr2:102507453	chr2:102432300~102432321:+
LUAD	cis	rs17826219	0.561	rs11655876	MIMAT0000459	hsa-miR-193a-3p	3.79	0.000173	0.25	0.17	Body mass index;	chr17:30690132	chr17:31560050~31560071:+
LUAD	cis	rs79387448	0.638	rs6759588	MIMAT0019927	hsa-miR-4772-3p	-3.78	0.000174	-0.26	-0.17	Gut microbiota (bacterial taxa);	chr2:102423699	chr2:102432336~102432357:+
LUAD	cis	rs7208859	0.673	rs9907197	MIMAT0000459	hsa-miR-193a-3p	3.78	0.000174	0.25	0.17	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30691245	chr17:31560050~31560071:+
LUAD	cis	rs7208859	0.673	rs9915963	MIMAT0000459	hsa-miR-193a-3p	3.78	0.000174	0.25	0.17	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30692625	chr17:31560050~31560071:+
LUAD	cis	rs79387448	0.745	rs57942521	MIMAT0019926	hsa-miR-4772-5p	-3.78	0.000174	-0.29	-0.17	Gut microbiota (bacterial taxa);	chr2:102523390	chr2:102432300~102432321:+
LUAD	cis	rs4851551	1	rs4851552	MIMAT0019926	hsa-miR-4772-5p	3.78	0.000175	0.38	0.17	Blood protein levels;	chr2:102185873	chr2:102432300~102432321:+
LUAD	cis	rs7586879	0.796	rs10187348	MIMAT0005797	hsa-miR-1301-3p	3.78	0.000176	0.14	0.17	Body mass index;	chr2:24855546	chr2:25328651~25328674:-
LUAD	cis	rs4660456	0.504	rs542214	MIMAT0000244	hsa-miR-30c-5p	3.78	0.000177	0.11	0.17	Platelet count;	chr1:40632806	chr1:40757300~40757322:+
LUAD	cis	rs4660456	0.504	rs542214	MIMAT0000244_1	hsa-miR-30c-5p	3.78	0.000177	0.11	0.17	Platelet count;	chr1:40632806	chr6:71377003~71377025:-
LUAD	cis	rs4921799	0.711	rs11203890	MIMAT0015020	hsa-miR-548v	-3.78	0.000177	-0.18	-0.17	Lung cancer;Adenocarcinoma;	chr8:17676717	chr8:17681588~17681609:-
LUAD	cis	rs4921799	0.711	rs11203891	MIMAT0015020	hsa-miR-548v	-3.78	0.000177	-0.18	-0.17	Lung cancer;Adenocarcinoma;	chr8:17676783	chr8:17681588~17681609:-
LUAD	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-3.78	0.000177	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
LUAD	cis	rs1014286	1	rs10193009	MIMAT0019926	hsa-miR-4772-5p	3.78	0.000178	0.2	0.17	Serum protein levels (sST2);	chr2:102552518	chr2:102432300~102432321:+
LUAD	cis	rs546131	0.642	rs7946980	MIMAT0019776	hsa-miR-1343-3p	3.78	0.000179	0.19	0.17	Lung disease severity in cystic fibrosis;	chr11:34798891	chr11:34941888~34941909:+
LUAD	cis	rs6681460	0.934	rs10889635	MIMAT0014979	hsa-miR-3117-3p	-3.78	0.000179	-0.22	-0.17	Presence of antiphospholipid antibodies;	chr1:66609892	chr1:66628485~66628505:+
LUAD	cis	rs75358501	0.636	rs12471008	MIMAT0014994	hsa-miR-3130-3p	3.77	0.000182	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs12471008	MIMAT0014994_1	hsa-miR-3130-3p	3.77	0.000182	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783277~206783297:+
LUAD	cis	rs75358501	0.636	rs768533	MIMAT0014994	hsa-miR-3130-3p	3.77	0.000182	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs768533	MIMAT0014994_1	hsa-miR-3130-3p	3.77	0.000182	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783277~206783297:+
LUAD	cis	rs74233809	1	rs732998	MIMAT0005951	hsa-miR-1307-3p	3.77	0.000182	0.21	0.17	Birth weight;	chr10:103138144	chr10:103394301~103394322:-
LUAD	cis	rs7586879	0.828	rs11685125	MIMAT0005797	hsa-miR-1301-3p	3.77	0.000183	0.14	0.17	Body mass index;	chr2:24869235	chr2:25328651~25328674:-
LUAD	cis	rs7586879	0.828	rs2384056	MIMAT0005797	hsa-miR-1301-3p	3.77	0.000183	0.14	0.17	Body mass index;	chr2:24869780	chr2:25328651~25328674:-
LUAD	cis	rs74233809	1	rs5011520	MIMAT0005951	hsa-miR-1307-3p	-3.77	0.000186	-0.22	-0.17	Birth weight;	chr10:102937759	chr10:103394301~103394322:-
LUAD	cis	rs6429422	0.84	rs3943093	MIMAT0019761	hsa-miR-4677-3p	-3.76	0.000188	-0.17	-0.17	Cognitive ability (multi-trait analysis);	chr1:243295200	chr1:243346225~243346246:+
LUAD	cis	rs453301	0.686	rs11787026	MIMAT0019728	hsa-miR-4660	3.76	0.000189	0.21	0.17	Joint mobility (Beighton score);	chr8:9044861	chr8:9048453~9048475:+
LUAD	cis	rs74233809	0.515	rs72841270	MIMAT0005951	hsa-miR-1307-3p	-3.76	0.000192	-0.18	-0.17	Birth weight;	chr10:102882480	chr10:103394301~103394322:-
LUAD	cis	rs75358501	0.636	rs4673363	MIMAT0014994	hsa-miR-3130-3p	3.76	0.000193	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs4673363	MIMAT0014994_1	hsa-miR-3130-3p	3.76	0.000193	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783277~206783297:+
LUAD	cis	rs7851726	0.585	rs7870160	MIMAT0019208	hsa-miR-3074-5p	-3.76	0.000194	-0.16	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94950249	chr9:95086063~95086083:-
LUAD	cis	rs7894407	0.76	rs4917386	MIMAT0005951	hsa-miR-1307-3p	3.75	0.000195	0.13	0.17	White matter hyperintensity burden;	chr10:103247771	chr10:103394301~103394322:-
LUAD	cis	rs6681460	0.966	rs4655506	MIMAT0014979	hsa-miR-3117-3p	-3.75	0.000198	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66685128	chr1:66628485~66628505:+
LUAD	cis	rs8064299	0.655	rs16978176	MIMAT0017994	hsa-miR-3615	-3.75	0.000199	-0.17	-0.17	Monocyte count;	chr17:74765103	chr17:74748663~74748683:+
LUAD	cis	rs7477	0.557	rs3785626	MIMAT0005942	hsa-miR-1288-3p	-3.74	0.000203	-0.2	-0.17	Amyotrophic lateral sclerosis;	chr17:16281934	chr17:16282058~16282078:+
LUAD	cis	rs2288884	0.943	rs1433089	MIMAT0004602	hsa-miR-125a-3p	-3.74	0.000204	-0.22	-0.17	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:52003732	chr19:51693306~51693327:+
LUAD	cis	rs7123876	0.541	rs61895574	MIMAT0000250	hsa-miR-139-5p	-3.74	0.000208	-0.25	-0.17	Body mass index;	chr11:72636944	chr11:72615102~72615124:-
LUAD	cis	rs79387448	0.745	rs1989399	MIMAT0019926	hsa-miR-4772-5p	-3.74	0.000209	-0.3	-0.17	Gut microbiota (bacterial taxa);	chr2:102550283	chr2:102432300~102432321:+
LUAD	cis	rs950880	1	rs1420101	MIMAT0019927	hsa-miR-4772-3p	3.74	0.000209	0.16	0.17	Serum protein levels (sST2);	chr2:102341256	chr2:102432336~102432357:+
LUAD	cis	rs7477	0.557	rs6502498	MIMAT0005942	hsa-miR-1288-3p	3.73	0.000211	0.2	0.17	Amyotrophic lateral sclerosis;	chr17:16295661	chr17:16282058~16282078:+
LUAD	cis	rs1014286	1	rs12712159	MIMAT0019926	hsa-miR-4772-5p	3.73	0.000212	0.2	0.17	Serum protein levels (sST2);	chr2:102553523	chr2:102432300~102432321:+
LUAD	cis	rs8064299	0.655	rs12797	MIMAT0017994	hsa-miR-3615	-3.73	0.000214	-0.16	-0.17	Monocyte count;	chr17:74770854	chr17:74748663~74748683:+
LUAD	cis	rs7477	0.766	rs3112526	MIMAT0005942	hsa-miR-1288-3p	-3.73	0.000214	-0.2	-0.17	Amyotrophic lateral sclerosis;	chr17:16343786	chr17:16282058~16282078:+
LUAD	cis	rs3091242	0.806	rs35189848	MIMAT0018191	hsa-miR-3917	3.73	0.000214	0.17	0.17	Erythrocyte sedimentation rate;	chr1:25461931	chr1:25906384~25906403:-
LUAD	cis	rs3091242	0.836	rs35346083	MIMAT0018191	hsa-miR-3917	3.73	0.000214	0.17	0.17	Erythrocyte sedimentation rate;	chr1:25461934	chr1:25906384~25906403:-
LUAD	cis	rs7477	0.557	rs2109262	MIMAT0005942	hsa-miR-1288-3p	3.73	0.000214	0.2	0.17	Amyotrophic lateral sclerosis;	chr17:16281315	chr17:16282058~16282078:+
LUAD	cis	rs953492	0.624	rs4469702	MIMAT0019761	hsa-miR-4677-3p	-3.73	0.000216	-0.16	-0.17	Diastolic blood pressure;	chr1:243201894	chr1:243346225~243346246:+
LUAD	cis	rs56235845	0.964	rs4075958	MIMAT0005796	hsa-miR-1271-5p	-3.73	0.000217	-0.16	-0.17	Hematocrit;Hemoglobin concentration;	chr5:177357511	chr5:176367960~176367981:+
LUAD	cis	rs1014286	1	rs2015478	MIMAT0019926	hsa-miR-4772-5p	3.73	0.000217	0.2	0.17	Serum protein levels (sST2);	chr2:102524988	chr2:102432300~102432321:+
LUAD	cis	rs1014286	1	rs997056	MIMAT0019926	hsa-miR-4772-5p	3.73	0.000218	0.2	0.17	Serum protein levels (sST2);	chr2:102554460	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs12413409	MIMAT0005951	hsa-miR-1307-3p	-3.72	0.000219	-0.21	-0.17	Birth weight;	chr10:102959339	chr10:103394301~103394322:-
LUAD	cis	rs7477	0.818	rs3112518	MIMAT0005942	hsa-miR-1288-3p	-3.72	0.000219	-0.19	-0.17	Amyotrophic lateral sclerosis;	chr17:16340194	chr17:16282058~16282078:+
LUAD	cis	rs7477	0.557	rs9944524	MIMAT0005942	hsa-miR-1288-3p	3.72	0.000219	0.2	0.17	Amyotrophic lateral sclerosis;	chr17:16309336	chr17:16282058~16282078:+
LUAD	cis	rs7586879	0.828	rs1968482	MIMAT0005797	hsa-miR-1301-3p	3.72	0.00022	0.14	0.17	Body mass index;	chr2:24863989	chr2:25328651~25328674:-
LUAD	cis	rs7586879	0.828	rs7597157	MIMAT0005797	hsa-miR-1301-3p	3.72	0.00022	0.14	0.17	Body mass index;	chr2:24866297	chr2:25328651~25328674:-
LUAD	cis	rs7072216	0.555	rs2296433	MIMAT0005878	hsa-miR-1287-5p	3.72	0.000221	0.18	0.17	Metabolite levels;	chr10:98424305	chr10:98395271~98395292:-
LUAD	cis	rs7072216	0.555	rs2296432	MIMAT0005878	hsa-miR-1287-5p	3.72	0.000221	0.18	0.17	Metabolite levels;	chr10:98424306	chr10:98395271~98395292:-
LUAD	cis	rs17151904	0.895	rs11973620	MIMAT0000243	hsa-miR-148a-3p	3.72	0.000223	0.18	0.17	Carotid atherosclerosis in HIV infection;	chr7:25568450	chr7:25949922~25949943:-
LUAD	cis	rs10216189	0.785	rs4352753	MIMAT0004799	hsa-miR-589-5p	-3.72	0.000223	-0.17	-0.17	Relative hand skill in reading disability;	chr7:5487592	chr7:5495873~5495894:-
LUAD	cis	rs35065479	0.744	rs2240601	MIMAT0000433	hsa-miR-142-5p	-3.72	0.000225	-0.1	-0.17	Schizophrenia;	chr17:57673751	chr17:58331283~58331303:-
LUAD	cis	rs79387448	0.745	rs723292	MIMAT0019926	hsa-miR-4772-5p	-3.72	0.000225	-0.29	-0.17	Gut microbiota (bacterial taxa);	chr2:102550345	chr2:102432300~102432321:+
LUAD	cis	rs74233809	0.901	rs11191416	MIMAT0005951	hsa-miR-1307-3p	3.71	0.000228	0.21	0.17	Birth weight;	chr10:102845159	chr10:103394301~103394322:-
LUAD	cis	rs9324022	0.858	rs1004572	MIMAT0001627	hsa-miR-433-3p	-3.71	0.000232	-0.24	-0.17	Plateletcrit;	chr14:100711993	chr14:100881949~100881970:+
LUAD	cis	rs972540	1	rs13396393	MIMAT0014995	hsa-miR-3130-5p	3.71	0.000232	0.18	0.17	Body mass index;	chr2:206370968	chr2:206783276~206783296:-
LUAD	cis	rs972540	1	rs13396393	MIMAT0014995_1	hsa-miR-3130-5p	3.71	0.000232	0.18	0.17	Body mass index;	chr2:206370968	chr2:206783246~206783266:+
LUAD	cis	rs972540	1	rs13422132	MIMAT0014995	hsa-miR-3130-5p	3.71	0.000232	0.18	0.17	Body mass index;	chr2:206371013	chr2:206783276~206783296:-
LUAD	cis	rs972540	1	rs13422132	MIMAT0014995_1	hsa-miR-3130-5p	3.71	0.000232	0.18	0.17	Body mass index;	chr2:206371013	chr2:206783246~206783266:+
LUAD	cis	rs972540	1	rs113426863	MIMAT0014995	hsa-miR-3130-5p	3.71	0.000232	0.18	0.17	Body mass index;	chr2:206372073	chr2:206783276~206783296:-
LUAD	cis	rs972540	1	rs113426863	MIMAT0014995_1	hsa-miR-3130-5p	3.71	0.000232	0.18	0.17	Body mass index;	chr2:206372073	chr2:206783246~206783266:+
LUAD	cis	rs79387448	0.745	rs6749440	MIMAT0019926	hsa-miR-4772-5p	-3.71	0.000232	-0.29	-0.17	Gut microbiota (bacterial taxa);	chr2:102485387	chr2:102432300~102432321:+
LUAD	cis	rs453301	0.686	rs6601280	MIMAT0019728	hsa-miR-4660	3.71	0.000233	0.21	0.17	Joint mobility (Beighton score);	chr8:9051726	chr8:9048453~9048475:+
LUAD	cis	rs6681460	0.934	rs4655631	MIMAT0014979	hsa-miR-3117-3p	-3.71	0.000233	-0.21	-0.17	Presence of antiphospholipid antibodies;	chr1:66589224	chr1:66628485~66628505:+
LUAD	cis	rs1014286	1	rs2177317	MIMAT0019926	hsa-miR-4772-5p	3.71	0.000234	0.2	0.17	Serum protein levels (sST2);	chr2:102534860	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs12411886	MIMAT0005951	hsa-miR-1307-3p	-3.71	0.000234	-0.22	-0.17	Birth weight;	chr10:102925542	chr10:103394301~103394322:-
LUAD	cis	rs950880	0.961	rs13020553	MIMAT0019927	hsa-miR-4772-3p	3.71	0.000235	0.16	0.17	Serum protein levels (sST2);	chr2:102315366	chr2:102432336~102432357:+
LUAD	cis	rs74233809	1	rs35125602	MIMAT0005951	hsa-miR-1307-3p	-3.71	0.000235	-0.21	-0.17	Birth weight;	chr10:102896282	chr10:103394301~103394322:-
LUAD	cis	rs75358501	0.636	rs2241347	MIMAT0014994	hsa-miR-3130-3p	3.71	0.000236	0.23	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs2241347	MIMAT0014994_1	hsa-miR-3130-3p	3.71	0.000236	0.23	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783277~206783297:+
LUAD	cis	rs75358501	0.636	rs57600974	MIMAT0014994	hsa-miR-3130-3p	3.7	0.000236	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs57600974	MIMAT0014994_1	hsa-miR-3130-3p	3.7	0.000236	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783277~206783297:+
LUAD	cis	rs2302612	0.58	rs11123913	MIMAT0019926	hsa-miR-4772-5p	3.7	0.000238	0.21	0.17	Serum protein levels (sST2);	chr2:102209019	chr2:102432300~102432321:+
LUAD	cis	rs7477	0.652	rs9890867	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000239	0.2	0.17	Amyotrophic lateral sclerosis;	chr17:16327176	chr17:16282058~16282078:+
LUAD	cis	rs4700319	0.887	rs16889129	MIMAT0004797	hsa-miR-582-3p	-3.7	0.000241	-0.26	-0.17	Post bronchodilator FEV1/FVC ratio;Cognitive function;	chr5:59054055	chr5:59703630~59703651:-
LUAD	cis	rs74233809	1	rs74233809	MIMAT0005951	hsa-miR-1307-3p	-3.7	0.000242	-0.21	-0.17	Birth weight;	chr10:103154183	chr10:103394301~103394322:-
LUAD	cis	rs2081015	0.668	rs4958366	MIMAT0005884	hsa-miR-1294	3.69	0.000247	0.18	0.17	Carotid artery intima media thickness (sex interaction);	chr5:154207759	chr5:154347153~154347174:+
LUAD	cis	rs79387448	0.564	rs77375846	MIMAT0019926	hsa-miR-4772-5p	-3.69	0.000251	-0.33	-0.17	Gut microbiota (bacterial taxa);	chr2:102538616	chr2:102432300~102432321:+
LUAD	cis	rs972540	1	rs6757124	MIMAT0014995	hsa-miR-3130-5p	3.69	0.000251	0.18	0.17	Body mass index;	chr2:206366510	chr2:206783276~206783296:-
LUAD	cis	rs972540	1	rs6757124	MIMAT0014995_1	hsa-miR-3130-5p	3.69	0.000251	0.18	0.17	Body mass index;	chr2:206366510	chr2:206783246~206783266:+
LUAD	cis	rs950880	1	rs950880	MIMAT0019927	hsa-miR-4772-3p	3.69	0.000252	0.16	0.17	Serum protein levels (sST2);	chr2:102316102	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.638	rs76255660	MIMAT0019927	hsa-miR-4772-3p	-3.69	0.000254	-0.25	-0.17	Gut microbiota (bacterial taxa);	chr2:102474569	chr2:102432336~102432357:+
LUAD	cis	rs926340	0.553	rs11913875	MIMAT0015085	hsa-miR-3200-3p	3.68	0.000257	0.18	0.17	Colorectal cancer;	chr22:30705098	chr22:30731610~30731631:+
LUAD	cis	rs9527	0.83	rs11191442	MIMAT0005951	hsa-miR-1307-3p	3.68	0.000258	0.14	0.17	Arsenic metabolism;	chr10:102883839	chr10:103394301~103394322:-
LUAD	cis	rs1420098	0.505	rs1921622	MIMAT0019926	hsa-miR-4772-5p	-3.68	0.000259	-0.18	-0.17	Inflammatory bowel disease;	chr2:102349607	chr2:102432300~102432321:+
LUAD	cis	rs4851551	0.867	rs3917299	MIMAT0019926	hsa-miR-4772-5p	3.68	0.000261	0.36	0.17	Blood protein levels;	chr2:102169626	chr2:102432300~102432321:+
LUAD	cis	rs6681460	0.8	rs485543	MIMAT0014979	hsa-miR-3117-3p	3.68	0.000262	0.21	0.17	Presence of antiphospholipid antibodies;	chr1:66728689	chr1:66628485~66628505:+
LUAD	cis	rs972540	0.921	rs6715034	MIMAT0014995	hsa-miR-3130-5p	3.68	0.000264	0.18	0.17	Body mass index;	chr2:206366445	chr2:206783276~206783296:-
LUAD	cis	rs972540	0.921	rs6715034	MIMAT0014995_1	hsa-miR-3130-5p	3.68	0.000264	0.18	0.17	Body mass index;	chr2:206366445	chr2:206783246~206783266:+
LUAD	cis	rs80028505	1	rs61212706	MIMAT0022482	hsa-miR-5690	-3.68	0.000264	-0.3	-0.17	Foot ulcer in diabetes and neuropathy;	chr6:36071654	chr6:35664760~35664780:-
LUAD	cis	rs7477	0.555	rs1476810	MIMAT0005942	hsa-miR-1288-3p	3.67	0.000267	0.2	0.17	Amyotrophic lateral sclerosis;	chr17:16329903	chr17:16282058~16282078:+
LUAD	cis	rs79387448	0.745	rs7593444	MIMAT0019926	hsa-miR-4772-5p	-3.67	0.000268	-0.3	-0.17	Gut microbiota (bacterial taxa);	chr2:102542102	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs17027421	MIMAT0019926	hsa-miR-4772-5p	-3.67	0.000268	-0.3	-0.17	Gut microbiota (bacterial taxa);	chr2:102543423	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs1880000	MIMAT0019926	hsa-miR-4772-5p	-3.67	0.000271	-0.28	-0.17	Gut microbiota (bacterial taxa);	chr2:102483494	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs12412038	MIMAT0005951	hsa-miR-1307-3p	-3.67	0.000272	-0.22	-0.17	Birth weight;	chr10:103096405	chr10:103394301~103394322:-
LUAD	cis	rs9527	0.59	rs7898770	MIMAT0022727	hsa-miR-1307-5p	-3.67	0.000273	-0.13	-0.17	Arsenic metabolism;	chr10:102996879	chr10:103394341~103394361:-
LUAD	cis	rs1014286	1	rs4851614	MIMAT0019926	hsa-miR-4772-5p	3.67	0.000273	0.19	0.17	Serum protein levels (sST2);	chr2:102523939	chr2:102432300~102432321:+
LUAD	cis	rs1014286	1	rs1357471	MIMAT0019926	hsa-miR-4772-5p	3.67	0.000273	0.19	0.17	Serum protein levels (sST2);	chr2:102524013	chr2:102432300~102432321:+
LUAD	cis	rs2288884	0.943	rs11084131	MIMAT0004602	hsa-miR-125a-3p	-3.67	0.000274	-0.22	-0.17	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:52011193	chr19:51693306~51693327:+
LUAD	cis	rs2288884	0.943	rs11084132	MIMAT0004602	hsa-miR-125a-3p	-3.67	0.000274	-0.22	-0.17	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:52011327	chr19:51693306~51693327:+
LUAD	cis	rs953492	0.701	rs1796846	MIMAT0019761	hsa-miR-4677-3p	-3.66	0.000277	-0.15	-0.17	Diastolic blood pressure;	chr1:243143622	chr1:243346225~243346246:+
LUAD	cis	rs890100	0.845	rs62160402	MIMAT0000274	hsa-miR-217-5p	3.66	0.000281	0.22	0.16	Gut microbiome composition (summer);	chr2:56469082	chr2:55983020~55983042:-
LUAD	cis	rs7477	0.557	rs9914734	MIMAT0005942	hsa-miR-1288-3p	3.66	0.000282	0.2	0.16	Amyotrophic lateral sclerosis;	chr17:16278700	chr17:16282058~16282078:+
LUAD	cis	rs7586879	0.828	rs10184813	MIMAT0005797	hsa-miR-1301-3p	3.66	0.000282	0.14	0.16	Body mass index;	chr2:24867367	chr2:25328651~25328674:-
LUAD	cis	rs1014286	1	rs6737119	MIMAT0019926	hsa-miR-4772-5p	3.66	0.000285	0.19	0.16	Serum protein levels (sST2);	chr2:102534650	chr2:102432300~102432321:+
LUAD	cis	rs4921799	0.711	rs2269696	MIMAT0015020	hsa-miR-548v	-3.65	0.000286	-0.17	-0.16	Lung cancer;Adenocarcinoma;	chr8:17674805	chr8:17681588~17681609:-
LUAD	cis	rs17710780	0.803	rs17654574	MIMAT0000435	hsa-miR-143-3p	-3.65	0.000288	-0.15	-0.16	Major depressive disorder;	chr5:149699659	chr5:149428978~149428998:+
LUAD	cis	rs1014286	0.892	rs2110737	MIMAT0019926	hsa-miR-4772-5p	-3.65	0.000289	-0.19	-0.16	Serum protein levels (sST2);	chr2:102555804	chr2:102432300~102432321:+
LUAD	cis	rs9527	0.615	rs1556960	MIMAT0022727	hsa-miR-1307-5p	3.65	0.000292	0.13	0.16	Arsenic metabolism;	chr10:102966916	chr10:103394341~103394361:-
LUAD	cis	rs972540	1	rs7568556	MIMAT0014995	hsa-miR-3130-5p	3.65	0.000294	0.18	0.16	Body mass index;	chr2:206365730	chr2:206783276~206783296:-
LUAD	cis	rs972540	1	rs7568556	MIMAT0014995_1	hsa-miR-3130-5p	3.65	0.000294	0.18	0.16	Body mass index;	chr2:206365730	chr2:206783246~206783266:+
LUAD	cis	rs8064299	0.597	rs3785539	MIMAT0017994	hsa-miR-3615	-3.65	0.000296	-0.16	-0.16	Monocyte count;	chr17:74778960	chr17:74748663~74748683:+
LUAD	cis	rs7586879	0.765	rs6545758	MIMAT0005797	hsa-miR-1301-3p	-3.64	0.000297	-0.13	-0.16	Body mass index;	chr2:24852005	chr2:25328651~25328674:-
LUAD	cis	rs2150052	0.805	rs1888190	MIMAT0030017	hsa-miR-7702	-3.64	0.000299	-0.15	-0.16	Neutrophil percentage of white cells;Birth weight;	chr9:111128720	chr9:111271193~111271214:-
LUAD	cis	rs7072216	0.621	rs11189595	MIMAT0005878	hsa-miR-1287-5p	3.64	0.000299	0.18	0.16	Metabolite levels;	chr10:98407565	chr10:98395271~98395292:-
LUAD	cis	rs7594645	0.59	rs879472	MIMAT0014995	hsa-miR-3130-5p	-3.64	0.000301	-0.26	-0.16	Episodic memory;	chr2:206787058	chr2:206783276~206783296:-
LUAD	cis	rs7594645	0.59	rs879472	MIMAT0014995_1	hsa-miR-3130-5p	-3.64	0.000301	-0.26	-0.16	Episodic memory;	chr2:206787058	chr2:206783246~206783266:+
LUAD	cis	rs74233809	1	rs10509759	MIMAT0005951	hsa-miR-1307-3p	-3.64	0.000303	-0.22	-0.16	Birth weight;	chr10:102929908	chr10:103394301~103394322:-
LUAD	cis	rs79387448	0.745	rs7582378	MIMAT0019926	hsa-miR-4772-5p	-3.64	0.000304	-0.29	-0.16	Gut microbiota (bacterial taxa);	chr2:102545804	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs72995626	MIMAT0019926	hsa-miR-4772-5p	-3.64	0.000304	-0.29	-0.16	Gut microbiota (bacterial taxa);	chr2:102546121	chr2:102432300~102432321:+
LUAD	cis	rs7477	0.818	rs714285	MIMAT0005942	hsa-miR-1288-3p	-3.64	0.000304	-0.19	-0.16	Amyotrophic lateral sclerosis;	chr17:16341070	chr17:16282058~16282078:+
LUAD	cis	rs7477	0.818	rs3112521	MIMAT0005942	hsa-miR-1288-3p	-3.64	0.000304	-0.19	-0.16	Amyotrophic lateral sclerosis;	chr17:16341343	chr17:16282058~16282078:+
LUAD	cis	rs74233809	1	rs12217501	MIMAT0005951	hsa-miR-1307-3p	-3.64	0.000306	-0.22	-0.16	Birth weight;	chr10:103092132	chr10:103394301~103394322:-
LUAD	cis	rs4921799	0.711	rs2269698	MIMAT0015020	hsa-miR-548v	3.64	0.000308	0.17	0.16	Lung cancer;Adenocarcinoma;	chr8:17675064	chr8:17681588~17681609:-
LUAD	cis	rs2302612	0.58	rs11123912	MIMAT0019926	hsa-miR-4772-5p	3.64	0.000308	0.21	0.16	Serum protein levels (sST2);	chr2:102200076	chr2:102432300~102432321:+
LUAD	cis	rs8064299	0.655	rs2305214	MIMAT0017994	hsa-miR-3615	-3.63	0.000308	-0.16	-0.16	Monocyte count;	chr17:74772831	chr17:74748663~74748683:+
LUAD	cis	rs4921799	0.711	rs2269699	MIMAT0015020	hsa-miR-548v	-3.63	0.00031	-0.17	-0.16	Lung cancer;Adenocarcinoma;	chr8:17675110	chr8:17681588~17681609:-
LUAD	cis	rs6674176	0.935	rs4314918	MIMAT0027368	hsa-miR-6733-3p	-3.63	0.00031	-0.24	-0.16	Intelligence (multi-trait analysis);Cognitive ability;Cognitive ability (multi-trait analysis);	chr1:43911831	chr1:43171652~43171671:-
LUAD	cis	rs6674176	1	rs6674176	MIMAT0027368	hsa-miR-6733-3p	-3.63	0.00031	-0.24	-0.16	Intelligence (multi-trait analysis);Cognitive ability;Cognitive ability (multi-trait analysis);	chr1:43914285	chr1:43171652~43171671:-
LUAD	cis	rs2124910	0.815	rs2864102	MIMAT0000066	hsa-let-7e-5p	3.63	0.000313	0.16	0.16	Blood protein levels;	chr19:51526838	chr19:51692793~51692814:+
LUAD	cis	rs4851551	1	rs4851551	MIMAT0019926	hsa-miR-4772-5p	3.63	0.000314	0.36	0.16	Blood protein levels;	chr2:102183770	chr2:102432300~102432321:+
LUAD	cis	rs8064299	0.597	rs6501736	MIMAT0017994	hsa-miR-3615	-3.63	0.000315	-0.16	-0.16	Monocyte count;	chr17:74779219	chr17:74748663~74748683:+
LUAD	cis	rs9527	0.615	rs11191489	MIMAT0022727	hsa-miR-1307-5p	3.63	0.000317	0.13	0.16	Arsenic metabolism;	chr10:102980811	chr10:103394341~103394361:-
LUAD	cis	rs1014286	1	rs11123937	MIMAT0019926	hsa-miR-4772-5p	3.63	0.000318	0.19	0.16	Serum protein levels (sST2);	chr2:102553223	chr2:102432300~102432321:+
LUAD	cis	rs74233809	1	rs77602510	MIMAT0005951	hsa-miR-1307-3p	-3.63	0.00032	-0.21	-0.16	Birth weight;	chr10:102922845	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs78821730	MIMAT0005951	hsa-miR-1307-3p	-3.63	0.00032	-0.21	-0.16	Birth weight;	chr10:102924787	chr10:103394301~103394322:-
LUAD	cis	rs8064299	0.597	rs9944506	MIMAT0017994	hsa-miR-3615	-3.62	0.000321	-0.16	-0.16	Monocyte count;	chr17:74786587	chr17:74748663~74748683:+
LUAD	cis	rs4851551	1	rs3917329	MIMAT0019926	hsa-miR-4772-5p	-3.62	0.000321	-0.35	-0.16	Blood protein levels;	chr2:102179403	chr2:102432300~102432321:+
LUAD	cis	rs8064299	0.597	rs2166703	MIMAT0017994	hsa-miR-3615	-3.62	0.000322	-0.16	-0.16	Monocyte count;	chr17:74785673	chr17:74748663~74748683:+
LUAD	cis	rs6681460	1	rs10789210	MIMAT0014979	hsa-miR-3117-3p	-3.62	0.000322	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66600347	chr1:66628485~66628505:+
LUAD	cis	rs74233809	1	rs12221193	MIMAT0005951	hsa-miR-1307-3p	-3.62	0.000323	-0.21	-0.16	Birth weight;	chr10:102905510	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs77180047	MIMAT0005951	hsa-miR-1307-3p	-3.62	0.000323	-0.21	-0.16	Birth weight;	chr10:102907000	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs12221064	MIMAT0005951	hsa-miR-1307-3p	-3.62	0.000323	-0.21	-0.16	Birth weight;	chr10:102917369	chr10:103394301~103394322:-
LUAD	cis	rs74233809	1	rs17115213	MIMAT0005951	hsa-miR-1307-3p	-3.62	0.000325	-0.21	-0.16	Birth weight;	chr10:102921386	chr10:103394301~103394322:-
LUAD	cis	rs7477	0.56	rs11651578	MIMAT0005942	hsa-miR-1288-3p	3.62	0.000327	0.2	0.16	Amyotrophic lateral sclerosis;	chr17:16284278	chr17:16282058~16282078:+
LUAD	cis	rs7477	0.557	rs4792729	MIMAT0005942	hsa-miR-1288-3p	3.62	0.000327	0.2	0.16	Amyotrophic lateral sclerosis;	chr17:16285105	chr17:16282058~16282078:+
LUAD	cis	rs7477	0.557	rs3785625	MIMAT0005942	hsa-miR-1288-3p	3.62	0.000327	0.2	0.16	Amyotrophic lateral sclerosis;	chr17:16287104	chr17:16282058~16282078:+
LUAD	cis	rs10256972	0.669	rs10229964	MIMAT0004702	hsa-miR-339-3p	3.62	0.000329	0.16	0.16	Endometriosis;Longevity;	chr7:1012140	chr7:1022955~1022977:-
LUAD	cis	rs80028505	0.908	rs7771484	MIMAT0022482	hsa-miR-5690	3.62	0.00033	0.28	0.16	Foot ulcer in diabetes and neuropathy;	chr6:36095214	chr6:35664760~35664780:-
LUAD	cis	rs79387448	0.745	rs6709719	MIMAT0019926	hsa-miR-4772-5p	-3.62	0.000331	-0.29	-0.16	Gut microbiota (bacterial taxa);	chr2:102528494	chr2:102432300~102432321:+
LUAD	cis	rs9527	0.615	rs10883810	MIMAT0022727	hsa-miR-1307-5p	3.61	0.000333	0.13	0.16	Arsenic metabolism;	chr10:102967467	chr10:103394341~103394361:-
LUAD	cis	rs9527	0.615	rs10883811	MIMAT0022727	hsa-miR-1307-5p	3.61	0.000333	0.13	0.16	Arsenic metabolism;	chr10:102967522	chr10:103394341~103394361:-
LUAD	cis	rs9527	0.615	rs11191485	MIMAT0022727	hsa-miR-1307-5p	3.61	0.000333	0.13	0.16	Arsenic metabolism;	chr10:102970059	chr10:103394341~103394361:-
LUAD	cis	rs4921799	0.64	rs11203893	MIMAT0015020	hsa-miR-548v	3.61	0.000334	0.17	0.16	Lung cancer;Adenocarcinoma;	chr8:17677748	chr8:17681588~17681609:-
LUAD	cis	rs7477	0.557	rs4792728	MIMAT0005942	hsa-miR-1288-3p	3.61	0.000335	0.19	0.16	Amyotrophic lateral sclerosis;	chr17:16283501	chr17:16282058~16282078:+
LUAD	cis	rs2288884	0.779	rs10411428	MIMAT0004602	hsa-miR-125a-3p	-3.61	0.000335	-0.2	-0.16	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:52104512	chr19:51693306~51693327:+
LUAD	cis	rs6681460	0.898	rs1032634	MIMAT0014979	hsa-miR-3117-3p	3.61	0.000337	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66729509	chr1:66628485~66628505:+
LUAD	cis	rs1014286	1	rs10210658	MIMAT0019926	hsa-miR-4772-5p	3.61	0.000339	0.19	0.16	Serum protein levels (sST2);	chr2:102559290	chr2:102432300~102432321:+
LUAD	cis	rs926340	0.671	rs136383	MIMAT0015085	hsa-miR-3200-3p	-3.61	0.000342	-0.17	-0.16	Colorectal cancer;	chr22:30717017	chr22:30731610~30731631:+
LUAD	cis	rs1014286	1	rs1829849	MIMAT0019926	hsa-miR-4772-5p	3.61	0.000342	0.19	0.16	Serum protein levels (sST2);	chr2:102533239	chr2:102432300~102432321:+
LUAD	cis	rs75358501	0.636	rs12478466	MIMAT0014994	hsa-miR-3130-3p	3.61	0.000344	0.23	0.16	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.636	rs12478466	MIMAT0014994_1	hsa-miR-3130-3p	3.61	0.000344	0.23	0.16	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783277~206783297:+
LUAD	cis	rs79387448	0.745	rs76720903	MIMAT0019926	hsa-miR-4772-5p	-3.61	0.000344	-0.29	-0.16	Gut microbiota (bacterial taxa);	chr2:102546367	chr2:102432300~102432321:+
LUAD	cis	rs79387448	0.745	rs1159509	MIMAT0019926	hsa-miR-4772-5p	-3.61	0.000345	-0.29	-0.16	Gut microbiota (bacterial taxa);	chr2:102552614	chr2:102432300~102432321:+
LUAD	cis	rs972540	0.921	rs6757701	MIMAT0014995	hsa-miR-3130-5p	3.61	0.000345	0.17	0.16	Body mass index;	chr2:206366818	chr2:206783276~206783296:-
LUAD	cis	rs972540	0.921	rs6757701	MIMAT0014995_1	hsa-miR-3130-5p	3.61	0.000345	0.17	0.16	Body mass index;	chr2:206366818	chr2:206783246~206783266:+
LUAD	cis	rs79387448	0.745	rs72995652	MIMAT0019926	hsa-miR-4772-5p	-3.6	0.000345	-0.29	-0.16	Gut microbiota (bacterial taxa);	chr2:102555192	chr2:102432300~102432321:+
LUAD	cis	rs9527	0.83	rs10883790	MIMAT0005951	hsa-miR-1307-3p	3.6	0.000345	0.14	0.16	Arsenic metabolism;	chr10:102881198	chr10:103394301~103394322:-
LUAD	cis	rs9527	0.83	rs11191440	MIMAT0005951	hsa-miR-1307-3p	3.6	0.000345	0.14	0.16	Arsenic metabolism;	chr10:102881754	chr10:103394301~103394322:-
LUAD	cis	rs9527	0.83	rs12249194	MIMAT0005951	hsa-miR-1307-3p	3.6	0.000345	0.14	0.16	Arsenic metabolism;	chr10:102883941	chr10:103394301~103394322:-
LUAD	cis	rs6681460	0.898	rs1032635	MIMAT0014979	hsa-miR-3117-3p	3.6	0.000346	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66729501	chr1:66628485~66628505:+
LUAD	cis	rs1950626	0.75	rs34144313	MIMAT0001639	hsa-miR-409-3p	3.6	0.000347	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100964879	chr14:101065346~101065367:+
LUAD	cis	rs1950626	0.705	rs34991312	MIMAT0001639	hsa-miR-409-3p	3.6	0.000347	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100968830	chr14:101065346~101065367:+
LUAD	cis	rs1950626	0.75	rs34061904	MIMAT0001639	hsa-miR-409-3p	3.6	0.000347	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100969637	chr14:101065346~101065367:+
LUAD	cis	rs2150052	0.622	rs10817154	MIMAT0030017	hsa-miR-7702	-3.6	0.000347	-0.15	-0.16	Neutrophil percentage of white cells;Birth weight;	chr9:111144945	chr9:111271193~111271214:-
LUAD	cis	rs953492	0.672	rs10926964	MIMAT0019761	hsa-miR-4677-3p	-3.6	0.000348	-0.16	-0.16	Diastolic blood pressure;	chr1:243196045	chr1:243346225~243346246:+
LUAD	cis	rs7477	0.529	rs11656811	MIMAT0005942	hsa-miR-1288-3p	3.6	0.000349	0.19	0.16	Amyotrophic lateral sclerosis;	chr17:16310940	chr17:16282058~16282078:+
LUAD	cis	rs7477	0.557	rs12939078	MIMAT0005942	hsa-miR-1288-3p	3.6	0.000349	0.19	0.16	Amyotrophic lateral sclerosis;	chr17:16313152	chr17:16282058~16282078:+
LUAD	cis	rs1950626	0.75	rs34228453	MIMAT0001639	hsa-miR-409-3p	3.6	0.000351	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100973984	chr14:101065346~101065367:+
LUAD	cis	rs1950626	0.662	rs72700538	MIMAT0001639	hsa-miR-409-3p	3.6	0.000351	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100975574	chr14:101065346~101065367:+
LUAD	cis	rs1950626	0.75	rs12895798	MIMAT0001639	hsa-miR-409-3p	3.6	0.000351	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100976456	chr14:101065346~101065367:+
LUAD	cis	rs9527	0.615	rs7096452	MIMAT0022727	hsa-miR-1307-5p	3.6	0.000352	0.13	0.16	Arsenic metabolism;	chr10:102976806	chr10:103394341~103394361:-
LUAD	cis	rs9527	0.615	rs7080462	MIMAT0022727	hsa-miR-1307-5p	3.6	0.000352	0.13	0.16	Arsenic metabolism;	chr10:102976942	chr10:103394341~103394361:-
LUAD	cis	rs7894407	0.856	rs7093667	MIMAT0005951	hsa-miR-1307-3p	-3.6	0.000353	-0.13	-0.16	White matter hyperintensity burden;	chr10:103320818	chr10:103394301~103394322:-
LUAD	cis	rs9324022	0.858	rs1004573	MIMAT0001627	hsa-miR-433-3p	-3.6	0.000355	-0.23	-0.16	Plateletcrit;	chr14:100711898	chr14:100881949~100881970:+
LUAD	cis	rs79387448	1	rs79387448	MIMAT0019926	hsa-miR-4772-5p	-3.6	0.000356	-0.3	-0.16	Gut microbiota (bacterial taxa);	chr2:102598951	chr2:102432300~102432321:+
LUAD	cis	rs7594645	0.59	rs61258471	MIMAT0014995	hsa-miR-3130-5p	3.59	0.00036	0.26	0.16	Episodic memory;	chr2:206751133	chr2:206783276~206783296:-
LUAD	cis	rs7594645	0.59	rs61258471	MIMAT0014995_1	hsa-miR-3130-5p	3.59	0.00036	0.26	0.16	Episodic memory;	chr2:206751133	chr2:206783246~206783266:+
LUAD	cis	rs9527	0.615	rs9733635	MIMAT0022727	hsa-miR-1307-5p	3.59	0.00036	0.13	0.16	Arsenic metabolism;	chr10:102952183	chr10:103394341~103394361:-
LUAD	cis	rs10256972	0.647	rs10233430	MIMAT0004702	hsa-miR-339-3p	3.59	0.000362	0.16	0.16	Endometriosis;Longevity;	chr7:1012028	chr7:1022955~1022977:-
LUAD	cis	rs6681460	1	rs7524818	MIMAT0014979	hsa-miR-3117-3p	-3.59	0.000367	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66606348	chr1:66628485~66628505:+
LUAD	cis	rs7477	0.818	rs917609	MIMAT0005942	hsa-miR-1288-3p	-3.59	0.000367	-0.19	-0.16	Amyotrophic lateral sclerosis;	chr17:16343294	chr17:16282058~16282078:+
LUAD	cis	rs7477	0.818	rs3112525	MIMAT0005942	hsa-miR-1288-3p	-3.59	0.000367	-0.19	-0.16	Amyotrophic lateral sclerosis;	chr17:16343560	chr17:16282058~16282078:+
LUAD	cis	rs7477	0.818	rs3112527	MIMAT0005942	hsa-miR-1288-3p	-3.59	0.000367	-0.19	-0.16	Amyotrophic lateral sclerosis;	chr17:16345592	chr17:16282058~16282078:+
LUAD	cis	rs6681460	0.8	rs481681	MIMAT0014979	hsa-miR-3117-3p	3.59	0.000369	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66728695	chr1:66628485~66628505:+
LUAD	cis	rs2274459	0.591	rs10947427	MIMAT0018349	hsa-miR-3934-5p	-3.59	0.00037	-0.23	-0.16	Obesity (extreme);	chr6:33676476	chr6:33698152~33698173:+
LUAD	cis	rs6681460	0.898	rs2483704	MIMAT0014979	hsa-miR-3117-3p	3.59	0.000371	0.2	0.16	Presence of antiphospholipid antibodies;	chr1:66729670	chr1:66628485~66628505:+
LUAD	cis	rs953492	0.644	rs4634890	MIMAT0019761	hsa-miR-4677-3p	-3.59	0.000371	-0.15	-0.16	Diastolic blood pressure;	chr1:243227523	chr1:243346225~243346246:+
LUAD	cis	rs453301	0.624	rs2979265	MIMAT0019728	hsa-miR-4660	3.59	0.000371	0.2	0.16	Joint mobility (Beighton score);	chr8:9001207	chr8:9048453~9048475:+
LUAD	cis	rs9324022	0.929	rs72698718	MIMAT0001627	hsa-miR-433-3p	-3.58	0.000372	-0.23	-0.16	Plateletcrit;	chr14:100712218	chr14:100881949~100881970:+
LUAD	cis	rs7477	0.557	rs11868284	MIMAT0005942	hsa-miR-1288-3p	3.58	0.000376	0.19	0.16	Amyotrophic lateral sclerosis;	chr17:16292961	chr17:16282058~16282078:+
LUAD	cis	rs79387448	0.745	rs9677607	MIMAT0019926	hsa-miR-4772-5p	-3.58	0.000378	-0.28	-0.16	Gut microbiota (bacterial taxa);	chr2:102533061	chr2:102432300~102432321:+
LUAD	cis	rs1864585	0.52	rs73200724	MIMAT0003266	hsa-miR-598-3p	-3.58	0.000378	-0.23	-0.16	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr8:10734821	chr8:11035221~11035242:-
LUAD	cis	rs9324022	0.929	rs72698721	MIMAT0001627	hsa-miR-433-3p	-3.58	0.000382	-0.23	-0.16	Plateletcrit;	chr14:100714852	chr14:100881949~100881970:+
LUAD	cis	rs9324022	0.929	rs59488041	MIMAT0001627	hsa-miR-433-3p	-3.58	0.000385	-0.23	-0.16	Plateletcrit;	chr14:100713704	chr14:100881949~100881970:+
LUAD	cis	rs6808694	0.568	rs17006711	MIMAT0019963	hsa-miR-4791	-3.57	0.000387	-0.19	-0.16	Ischemic stroke;	chr3:20186513	chr3:19314907~19314924:-
LUAD	cis	rs55794721	0.509	rs12027135	MIMAT0018191	hsa-miR-3917	-3.57	0.000388	-0.16	-0.16	Mean corpuscular volume;Plateletcrit;	chr1:25449242	chr1:25906384~25906403:-
LUAD	cis	rs9921222	0.521	rs757460	MIMAT0015053	hsa-miR-3176	-3.57	0.000388	-0.21	-0.16	Bone mineral density;Bone mineral density (spine);	chr16:317174	chr16:543336~543354:+
LUAD	cis	rs3091242	0.836	rs34997029	MIMAT0018191	hsa-miR-3917	3.57	0.000388	0.16	0.16	Erythrocyte sedimentation rate;	chr1:25457332	chr1:25906384~25906403:-
LUAD	cis	rs7529925	0.948	rs1434282	MIMAT0000257	hsa-miR-181b-5p	3.57	0.000388	0.19	0.16	Mean corpuscular volume;Red blood cell traits;	chr1:199041592	chr1:198858925~198858947:-
LUAD	cis	rs7529925	0.948	rs1434282	MIMAT0000257_1	hsa-miR-181b-5p	3.57	0.000388	0.19	0.16	Mean corpuscular volume;Red blood cell traits;	chr1:199041592	chr9:124693725~124693747:+
LUAD	cis	rs11784910	0.611	rs73208566	MIMAT0015020	hsa-miR-548v	3.57	0.00039	0.28	0.16	Systolic blood pressure response to hydrochlorothiazide in hypertension;Diastolic blood pressure response to hydrochlorothiazide in hypertension;	chr8:17276106	chr8:17681588~17681609:-
LUAD	cis	rs11784910	0.561	rs73208567	MIMAT0015020	hsa-miR-548v	3.57	0.00039	0.28	0.16	Systolic blood pressure response to hydrochlorothiazide in hypertension;Diastolic blood pressure response to hydrochlorothiazide in hypertension;	chr8:17276146	chr8:17681588~17681609:-
LUAD	cis	rs1867631	1	rs1867631	MIMAT0014979	hsa-miR-3117-3p	-3.57	0.00039	-0.2	-0.16	Menopause (age at onset);	chr1:66580443	chr1:66628485~66628505:+
LUAD	cis	rs9527	0.545	rs7894588	MIMAT0022727	hsa-miR-1307-5p	3.57	0.000391	0.12	0.16	Arsenic metabolism;	chr10:102996273	chr10:103394341~103394361:-
LUAD	cis	rs4851016	0.506	rs6543146	MIMAT0019926	hsa-miR-4772-5p	3.57	0.000391	0.19	0.16	Blood protein levels;	chr2:102480236	chr2:102432300~102432321:+
LUAD	cis	rs1014286	0.505	rs1030026	MIMAT0019926	hsa-miR-4772-5p	3.57	0.000391	0.19	0.16	Serum protein levels (sST2);	chr2:102481719	chr2:102432300~102432321:+
LUAD	cis	rs4851016	0.506	rs2140316	MIMAT0019926	hsa-miR-4772-5p	3.57	0.000391	0.19	0.16	Blood protein levels;	chr2:102482217	chr2:102432300~102432321:+
LUAD	cis	rs4921799	0.64	rs10503602	MIMAT0015020	hsa-miR-548v	3.57	0.000393	0.17	0.16	Lung cancer;Adenocarcinoma;	chr8:17677549	chr8:17681588~17681609:-
LUAD	cis	rs1864585	0.52	rs79813735	MIMAT0003266	hsa-miR-598-3p	-3.57	0.000394	-0.23	-0.16	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr8:10733493	chr8:11035221~11035242:-
LUAD	cis	rs75358501	0.688	rs28365797	MIMAT0014994	hsa-miR-3130-3p	3.57	0.000396	0.23	0.16	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783245~206783265:-
LUAD	cis	rs75358501	0.688	rs28365797	MIMAT0014994_1	hsa-miR-3130-3p	3.57	0.000396	0.23	0.16	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783277~206783297:+
LUAD	cis	rs1864585	0.52	rs17721089	MIMAT0003266	hsa-miR-598-3p	-3.57	0.000396	-0.22	-0.16	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr8:10847928	chr8:11035221~11035242:-
LUAD	cis	rs6681460	0.625	rs2872079	MIMAT0014979	hsa-miR-3117-3p	-3.56	0.000402	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66664388	chr1:66628485~66628505:+
LUAD	cis	rs79387448	0.683	rs7571985	MIMAT0019926	hsa-miR-4772-5p	-3.56	0.000402	-0.28	-0.16	Gut microbiota (bacterial taxa);	chr2:102531102	chr2:102432300~102432321:+
LUAD	cis	rs10021731	0.52	rs10024217	MIMAT0003242	hsa-miR-577	-3.56	0.000404	-0.2	-0.16	Optic disc area;	chr4:114536959	chr4:114656774~114656794:+
LUAD	cis	rs1558648	0.858	rs13014004	MIMAT0019927	hsa-miR-4772-3p	-3.56	0.000404	-0.21	-0.16	Serum protein levels (sST2);	chr2:102224207	chr2:102432336~102432357:+
LUAD	cis	rs6746896	0.708	rs68026712	MIMAT0014990	hsa-miR-3127-5p	3.56	0.000407	0.17	0.16	Bipolar disorder;	chr2:96730666	chr2:96798288~96798310:+
LUAD	cis	rs6681460	1	rs6696927	MIMAT0014979	hsa-miR-3117-3p	-3.56	0.000407	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66604698	chr1:66628485~66628505:+
LUAD	cis	rs6674176	0.932	rs7412307	MIMAT0027368	hsa-miR-6733-3p	3.56	0.000409	0.24	0.16	Intelligence (multi-trait analysis);Cognitive ability;Cognitive ability (multi-trait analysis);	chr1:43968192	chr1:43171652~43171671:-
LUAD	cis	rs10256972	0.626	rs62433138	MIMAT0004702	hsa-miR-339-3p	3.56	0.000409	0.16	0.16	Endometriosis;Longevity;	chr7:1011241	chr7:1022955~1022977:-
LUAD	cis	rs10021731	0.809	rs12650546	MIMAT0003242	hsa-miR-577	3.56	0.000409	0.18	0.16	Optic disc area;	chr4:114578518	chr4:114656774~114656794:+
LUAD	cis	rs9527	0.615	rs7917295	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000412	0.13	0.16	Arsenic metabolism;	chr10:102941430	chr10:103394341~103394361:-
LUAD	cis	rs7894407	0.856	rs10883855	MIMAT0005951	hsa-miR-1307-3p	-3.56	0.000412	-0.12	-0.16	White matter hyperintensity burden;	chr10:103332690	chr10:103394301~103394322:-
LUAD	cis	rs890100	0.967	rs1978531	MIMAT0000274	hsa-miR-217-5p	3.56	0.000413	0.2	0.16	Gut microbiome composition (summer);	chr2:56516532	chr2:55983020~55983042:-
LUAD	cis	rs74233809	1	rs11191454	MIMAT0022727	hsa-miR-1307-5p	-3.56	0.000414	-0.19	-0.16	Birth weight;	chr10:102900247	chr10:103394341~103394361:-
LUAD	cis	rs6681460	0.834	rs544258	MIMAT0014979	hsa-miR-3117-3p	3.56	0.000415	0.21	0.16	Presence of antiphospholipid antibodies;	chr1:66753526	chr1:66628485~66628505:+
LUAD	cis	rs74233809	1	rs12220743	MIMAT0005951	hsa-miR-1307-3p	-3.56	0.000415	-0.21	-0.16	Birth weight;	chr10:103092155	chr10:103394301~103394322:-
LUAD	cis	rs4921799	0.662	rs34174450	MIMAT0015020	hsa-miR-548v	-3.55	0.000417	-0.17	-0.16	Lung cancer;Adenocarcinoma;	chr8:17677385	chr8:17681588~17681609:-
LUAD	cis	rs2288884	0.943	rs75722407	MIMAT0004602	hsa-miR-125a-3p	-3.55	0.000417	-0.22	-0.16	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:52021989	chr19:51693306~51693327:+
LUAD	cis	rs1558648	0.858	rs12996377	MIMAT0019927	hsa-miR-4772-3p	-3.55	0.000419	-0.21	-0.16	Serum protein levels (sST2);	chr2:102214018	chr2:102432336~102432357:+
LUAD	cis	rs546131	0.642	rs508062	MIMAT0019776	hsa-miR-1343-3p	3.55	0.000419	0.18	0.16	Lung disease severity in cystic fibrosis;	chr11:34822273	chr11:34941888~34941909:+
LUAD	cis	rs453301	0.624	rs2288671	MIMAT0019728	hsa-miR-4660	3.55	0.00042	0.2	0.16	Joint mobility (Beighton score);	chr8:9003384	chr8:9048453~9048475:+
LUAD	cis	rs1950626	0.75	rs72700530	MIMAT0001639	hsa-miR-409-3p	3.55	0.000421	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100963122	chr14:101065346~101065367:+
LUAD	cis	rs10131519	1	rs55880273	MIMAT0000772	hsa-miR-345-5p	3.55	0.000425	0.16	0.16	Coronary artery disease;	chr14:99906622	chr14:100307876~100307897:+
LUAD	cis	rs2150052	0.84	rs10817149	MIMAT0030017	hsa-miR-7702	-3.55	0.000425	-0.15	-0.16	Neutrophil percentage of white cells;Birth weight;	chr9:111115131	chr9:111271193~111271214:-
LUAD	cis	rs7147503	1	rs12431682	MIMAT0000772	hsa-miR-345-5p	-3.55	0.000426	-0.13	-0.16	Corneal astigmatism;	chr14:101073662	chr14:100307876~100307897:+
LUAD	cis	rs453301	0.658	rs12114954	MIMAT0019728	hsa-miR-4660	-3.55	0.000428	-0.2	-0.16	Joint mobility (Beighton score);	chr8:9047352	chr8:9048453~9048475:+
LUAD	cis	rs453301	0.624	rs2979256	MIMAT0019728	hsa-miR-4660	3.55	0.000429	0.2	0.16	Joint mobility (Beighton score);	chr8:9014200	chr8:9048453~9048475:+
LUAD	cis	rs74233809	0.892	rs11191447	MIMAT0005951	hsa-miR-1307-3p	-3.55	0.000429	-0.2	-0.16	Birth weight;	chr10:102892566	chr10:103394301~103394322:-
LUAD	cis	rs74233809	0.901	rs3824754	MIMAT0005951	hsa-miR-1307-3p	-3.54	0.000433	-0.21	-0.16	Birth weight;	chr10:102854593	chr10:103394301~103394322:-
LUAD	cis	rs546131	0.642	rs512013	MIMAT0019776	hsa-miR-1343-3p	3.54	0.000436	0.18	0.16	Lung disease severity in cystic fibrosis;	chr11:34820678	chr11:34941888~34941909:+
LUAD	cis	rs546131	0.642	rs2956073	MIMAT0019776	hsa-miR-1343-3p	3.54	0.000436	0.18	0.16	Lung disease severity in cystic fibrosis;	chr11:34821336	chr11:34941888~34941909:+
LUAD	cis	rs6681460	1	rs6588207	MIMAT0014979	hsa-miR-3117-3p	-3.54	0.000436	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66600872	chr1:66628485~66628505:+
LUAD	cis	rs453301	0.624	rs6987558	MIMAT0019728	hsa-miR-4660	3.54	0.000436	0.2	0.16	Joint mobility (Beighton score);	chr8:9005011	chr8:9048453~9048475:+
LUAD	cis	rs1864585	0.52	rs7827270	MIMAT0003266	hsa-miR-598-3p	-3.54	0.00044	-0.23	-0.16	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr8:10733043	chr8:11035221~11035242:-
LUAD	cis	rs2288884	0.943	rs1433089	MIMAT0004678	hsa-miR-99b-3p	-3.54	0.000442	-0.18	-0.16	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:52003732	chr19:51692656~51692677:+
LUAD	cis	rs6681460	1	rs4655636	MIMAT0014979	hsa-miR-3117-3p	-3.54	0.000442	-0.2	-0.16	Presence of antiphospholipid antibodies;	chr1:66602854	chr1:66628485~66628505:+
LUAD	cis	rs1864585	0.52	rs60167323	MIMAT0003266	hsa-miR-598-3p	-3.54	0.000443	-0.23	-0.16	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;	chr8:10733205	chr8:11035221~11035242:-
LUAD	cis	rs886716	0.507	rs35682591	MIMAT0004549	hsa-miR-148a-5p	3.54	0.000446	0.23	0.16	Smoking behavior;	chr7:26527711	chr7:25949960~25949981:-
LUAD	cis	rs453301	0.653	rs11784393	MIMAT0019728	hsa-miR-4660	3.54	0.000446	0.19	0.16	Joint mobility (Beighton score);	chr8:9045624	chr8:9048453~9048475:+
LUAD	cis	rs10131519	1	rs10143910	MIMAT0000772	hsa-miR-345-5p	3.53	0.000449	0.15	0.16	Coronary artery disease;	chr14:99903983	chr14:100307876~100307897:+
LUAD	cis	rs74233809	1	rs74233296	MIMAT0005951	hsa-miR-1307-3p	-3.53	0.00045	-0.2	-0.16	Birth weight;	chr10:102895593	chr10:103394301~103394322:-
LUAD	cis	rs7594645	1	rs75607323	MIMAT0014995	hsa-miR-3130-5p	3.53	0.00045	0.32	0.16	Episodic memory;	chr2:206771046	chr2:206783276~206783296:-
LUAD	cis	rs7594645	1	rs75607323	MIMAT0014995_1	hsa-miR-3130-5p	3.53	0.00045	0.32	0.16	Episodic memory;	chr2:206771046	chr2:206783246~206783266:+
LUAD	cis	rs7594645	1	rs12478819	MIMAT0014995	hsa-miR-3130-5p	3.53	0.00045	0.32	0.16	Episodic memory;	chr2:206780354	chr2:206783276~206783296:-
LUAD	cis	rs7594645	1	rs12478819	MIMAT0014995_1	hsa-miR-3130-5p	3.53	0.00045	0.32	0.16	Episodic memory;	chr2:206780354	chr2:206783246~206783266:+
LUAD	cis	rs7586879	0.828	rs10195271	MIMAT0005797	hsa-miR-1301-3p	-3.53	0.000451	-0.13	-0.16	Body mass index;	chr2:24885781	chr2:25328651~25328674:-
LUAD	cis	rs7072216	0.621	rs3750604	MIMAT0005878	hsa-miR-1287-5p	3.53	0.000452	0.17	0.16	Metabolite levels;	chr10:98415824	chr10:98395271~98395292:-
LUAD	cis	rs1950626	0.716	rs34572720	MIMAT0001639	hsa-miR-409-3p	3.53	0.000453	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100980813	chr14:101065346~101065367:+
LUAD	cis	rs1950626	0.716	rs34158896	MIMAT0001639	hsa-miR-409-3p	3.53	0.000453	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100981036	chr14:101065346~101065367:+
LUAD	cis	rs1950626	0.75	rs35683125	MIMAT0001639	hsa-miR-409-3p	3.53	0.000453	0.11	0.16	Pelvic organ prolapse (moderate/severe);	chr14:100988413	chr14:101065346~101065367:+
LUAD	cis	rs453301	0.624	rs4841083	MIMAT0019728	hsa-miR-4660	3.53	0.000453	0.2	0.16	Joint mobility (Beighton score);	chr8:9012918	chr8:9048453~9048475:+
LUAD	cis	rs9646944	0.636	rs72820194	MIMAT0019927	hsa-miR-4772-3p	3.53	0.000454	0.22	0.16	Blood protein levels;	chr2:102261648	chr2:102432336~102432357:+
LUAD	cis	rs9527	0.64	rs7089061	MIMAT0022727	hsa-miR-1307-5p	3.53	0.000455	0.12	0.16	Arsenic metabolism;	chr10:102963258	chr10:103394341~103394361:-
LUAD	cis	rs9527	0.615	rs7089065	MIMAT0022727	hsa-miR-1307-5p	3.53	0.000455	0.12	0.16	Arsenic metabolism;	chr10:102963265	chr10:103394341~103394361:-
LUAD	cis	rs9527	0.569	rs10786730	MIMAT0022727	hsa-miR-1307-5p	3.53	0.000455	0.12	0.16	Arsenic metabolism;	chr10:102964443	chr10:103394341~103394361:-
LUAD	cis	rs4851016	0.506	rs2310303	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000456	0.19	0.16	Blood protein levels;	chr2:102487420	chr2:102432300~102432321:+
LUAD	cis	rs77106637	0.86	rs1552224	MIMAT0000250	hsa-miR-139-5p	-3.53	0.000457	-0.23	-0.16	Type 2 diabetes;	chr11:72722053	chr11:72615102~72615124:-
LUAD	cis	rs9324022	0.929	rs9635298	MIMAT0001627	hsa-miR-433-3p	-3.53	0.000462	-0.23	-0.16	Plateletcrit;	chr14:100706205	chr14:100881949~100881970:+
LUAD	cis	rs1014286	1	rs1005043	MIMAT0019926	hsa-miR-4772-5p	-3.53	0.000464	-0.19	-0.16	Serum protein levels (sST2);	chr2:102528967	chr2:102432300~102432321:+
LUAD	cis	rs7594645	0.661	rs12463410	MIMAT0014995	hsa-miR-3130-5p	3.52	0.000468	0.33	0.16	Episodic memory;	chr2:206850884	chr2:206783276~206783296:-
LUAD	cis	rs7594645	0.661	rs12463410	MIMAT0014995_1	hsa-miR-3130-5p	3.52	0.000468	0.33	0.16	Episodic memory;	chr2:206850884	chr2:206783246~206783266:+
LUAD	cis	rs79387448	0.81	rs76229479	MIMAT0019927	hsa-miR-4772-3p	-3.52	0.000469	-0.24	-0.16	Gut microbiota (bacterial taxa);	chr2:102507453	chr2:102432336~102432357:+
LUAD	cis	rs79387448	0.745	rs17027413	MIMAT0019926	hsa-miR-4772-5p	3.52	0.000473	0.28	0.16	Gut microbiota (bacterial taxa);	chr2:102537208	chr2:102432300~102432321:+
LUAD	cis	rs6681460	0.898	rs536527	MIMAT0014979	hsa-miR-3117-3p	-3.52	0.000474	-0.19	-0.16	Presence of antiphospholipid antibodies;	chr1:66728110	chr1:66628485~66628505:+
LUAD	cis	rs7123876	0.587	rs184654	MIMAT0000250	hsa-miR-139-5p	-3.52	0.000475	-0.2	-0.16	Body mass index;	chr11:72653361	chr11:72615102~72615124:-
LUAD	cis	rs4921799	0.574	rs7465275	MIMAT0015020	hsa-miR-548v	-3.52	0.000476	-0.17	-0.16	Lung cancer;Adenocarcinoma;	chr8:17648676	chr8:17681588~17681609:-
LUAD	cis	rs7594645	0.661	rs115839833	MIMAT0014995	hsa-miR-3130-5p	3.52	0.000477	0.32	0.16	Episodic memory;	chr2:206754710	chr2:206783276~206783296:-
LUAD	cis	rs7594645	0.661	rs115839833	MIMAT0014995_1	hsa-miR-3130-5p	3.52	0.000477	0.32	0.16	Episodic memory;	chr2:206754710	chr2:206783246~206783266:+
LUAD	cis	rs7594645	1	rs114031213	MIMAT0014995	hsa-miR-3130-5p	3.52	0.000477	0.32	0.16	Episodic memory;	chr2:206754739	chr2:206783276~206783296:-
LUAD	cis	rs7594645	1	rs114031213	MIMAT0014995_1	hsa-miR-3130-5p	3.52	0.000477	0.32	0.16	Episodic memory;	chr2:206754739	chr2:206783246~206783266:+
LUAD	cis	rs4276643	0.602	rs2685303	MIMAT0027587	hsa-miR-6842-3p	3.52	0.000477	0.16	0.16	Low vWF levels;	chr8:27942455	chr8:27433413~27433434:+
LUAD	cis	rs890100	0.706	rs4447644	MIMAT0000274	hsa-miR-217-5p	3.52	0.000478	0.21	0.16	Gut microbiome composition (summer);	chr2:56466157	chr2:55983020~55983042:-
LUAD	cis	rs2150052	0.902	rs877544	MIMAT0030017	hsa-miR-7702	-3.52	0.00048	-0.15	-0.16	Neutrophil percentage of white cells;Birth weight;	chr9:111133465	chr9:111271193~111271214:-
LUAD	trans	rs2498796	0.929	rs2498802	MIMAT0004748	hsa-miR-423-5p	-6.07	2.54e-09	-0.26	-0.27	Endometrial cancer;Endometrial endometrioid carcinoma;	chr14:104768105	chr17:30117095~30117117:+
LUAD	trans	rs7539624	0.529	rs10916646	MIMAT0004757	hsa-miR-431-3p	5.95	5.22e-09	0.24	0.26	Schizophrenia;	chr1:223730205	chr14:100881069~100881090:+
LUAD	trans	rs1904173	0.599	rs35469063	MIMAT0003247	hsa-miR-582-5p	5.94	5.57e-09	0.45	0.26	IgG glycosylation;	chr5:25063697	chr5:59703666~59703688:-
LUAD	trans	rs7539624	0.588	rs1779658	MIMAT0004757	hsa-miR-431-3p	5.94	5.58e-09	0.25	0.26	Schizophrenia;	chr1:223734552	chr14:100881069~100881090:+
LUAD	trans	rs10180496	0.685	rs6740818	MIMAT0004671	hsa-miR-194-3p	-5.9	6.88e-09	-0.34	-0.26	Dental caries;	chr2:12758221	chr11:64891368~64891389:-
LUAD	trans	rs7539624	0.588	rs7547642	MIMAT0004757	hsa-miR-431-3p	-5.86	8.84e-09	-0.24	-0.26	Schizophrenia;	chr1:223733778	chr14:100881069~100881090:+
LUAD	trans	rs9973361	0.592	rs3764998	MIMAT0004774	hsa-miR-501-3p	-5.83	1.04e-08	-0.22	-0.26	Total body bone mineral density;	chr2:165876017	chrX:50009772~50009793:+
LUAD	trans	rs7539624	0.529	rs7525446	MIMAT0004757	hsa-miR-431-3p	5.8	1.23e-08	0.24	0.26	Schizophrenia;	chr1:223726751	chr14:100881069~100881090:+
LUAD	trans	rs7539624	0.588	rs10916634	MIMAT0004757	hsa-miR-431-3p	-5.79	1.26e-08	-0.23	-0.26	Schizophrenia;	chr1:223726156	chr14:100881069~100881090:+
LUAD	trans	rs1819043	0.702	rs8288	MIMAT0004592	hsa-miR-125b-1-3p	5.79	1.3e-08	0.29	0.26	Sex ratio;	chr1:202587889	chr11:122099769~122099790:-
LUAD	trans	rs2134095	0.822	rs3753896	MIMAT0004677	hsa-miR-34c-3p	-5.75	1.6e-08	-0.32	-0.25	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder;	chr1:165424516	chr11:111513484~111513505:+
LUAD	trans	rs34226255	0.957	rs12978678	MIMAT0018349	hsa-miR-3934-5p	5.74	1.66e-08	0.3	0.25	Neutrophil percentage of granulocytes;Eosinophil percentage of white cells;Eosinophil percentage of granulocytes;	chr19:16317587	chr6:33698152~33698173:+
LUAD	trans	rs1922233	0.783	rs13123650	MIMAT0001545	hsa-miR-450a-5p	5.74	1.67e-08	0.32	0.25	Gut microbiome composition (summer and winter);	chr4:91428112	chrX:134540393~134540414:-
LUAD	trans	rs1922233	0.783	rs13123650	MIMAT0001545_1	hsa-miR-450a-5p	5.74	1.67e-08	0.32	0.25	Gut microbiome composition (summer and winter);	chr4:91428112	chrX:134540564~134540585:-
LUAD	trans	rs34746873	1	rs34746873	MIMAT0015378	hsa-miR-3065-3p	-5.73	1.75e-08	-0.27	-0.25	Neurofibrillary tangles;	chr8:61986390	chr17:81125926~81125948:+
LUAD	trans	rs879620	1	rs2531995	MIMAT0019716	hsa-miR-4652-5p	5.72	1.83e-08	0.28	0.25	Hip circumference;Body mass index;	chr16:3963466	chr7:93716937~93716958:+
LUAD	trans	rs2498796	0.964	rs2498797	MIMAT0004748	hsa-miR-423-5p	-5.71	1.97e-08	-0.24	-0.25	Endometrial cancer;Endometrial endometrioid carcinoma;	chr14:104775891	chr17:30117095~30117117:+
LUAD	trans	rs34746873	0.626	rs9643528	MIMAT0015378	hsa-miR-3065-3p	-5.7	2.12e-08	-0.26	-0.25	Neurofibrillary tangles;	chr8:61983676	chr17:81125926~81125948:+
LUAD	trans	rs3758911	0.828	rs1490946	MIMAT0001631	hsa-miR-451a	5.7	2.14e-08	0.28	0.25	Coronary artery disease;	chr11:107325374	chr17:28861403~28861424:-
LUAD	trans	rs17518584	0.934	rs1991872	MIMAT0000067	hsa-let-7f-5p	5.7	2.15e-08	0.28	0.25	Cognitive function;Information processing speed;	chr3:85394643	chr9:94176353~94176374:+
LUAD	trans	rs17518584	0.934	rs1991872	MIMAT0000067_1	hsa-let-7f-5p	5.7	2.15e-08	0.28	0.25	Cognitive function;Information processing speed;	chr3:85394643	chrX:53557246~53557267:-
LUAD	trans	rs17518584	0.934	rs1991872	MIMAT0000434	hsa-miR-142-3p	5.69	2.21e-08	0.13	0.25	Cognitive function;Information processing speed;	chr3:85394643	chr17:58331245~58331267:-
LUAD	trans	rs7765175	0.547	rs1066296	MIMAT0000762	hsa-miR-324-3p	-5.68	2.32e-08	-0.21	-0.25	Coronary artery calcification;	chr6:113251356	chr17:7223308~7223330:-
LUAD	trans	rs3758911	0.828	rs1490946	MIMAT0004600	hsa-miR-144-5p	5.67	2.47e-08	0.29	0.25	Coronary artery disease;	chr11:107325374	chr17:28861583~28861604:-
LUAD	trans	rs2134095	0.786	rs10918179	MIMAT0004677	hsa-miR-34c-3p	-5.67	2.54e-08	-0.31	-0.25	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder;	chr1:165425624	chr11:111513484~111513505:+
LUAD	trans	rs34226255	0.957	rs6512096	MIMAT0018349	hsa-miR-3934-5p	-5.66	2.64e-08	-0.3	-0.25	Neutrophil percentage of granulocytes;Eosinophil percentage of white cells;Eosinophil percentage of granulocytes;	chr19:16316796	chr6:33698152~33698173:+
LUAD	trans	rs10997517	0.568	rs10762135	MIMAT0018976	hsa-miR-4454	5.66	2.65e-08	0.32	0.25	Migraine without aura;	chr10:67083087	chr4:163093607~163093626:-
LUAD	trans	rs3734905	1	rs12526225	MIMAT0003293	hsa-miR-624-5p	5.64	2.9e-08	0.51	0.25	HIV-1 control;	chr6:169461230	chr14:31014706~31014727:-
LUAD	trans	rs1904173	0.599	rs35469063	MIMAT0004797	hsa-miR-582-3p	5.63	3.05e-08	0.44	0.25	IgG glycosylation;	chr5:25063697	chr5:59703630~59703651:-
LUAD	trans	rs3758911	0.894	rs10890717	MIMAT0001631	hsa-miR-451a	5.62	3.2e-08	0.28	0.25	Coronary artery disease;	chr11:107324666	chr17:28861403~28861424:-
LUAD	trans	rs9973361	0.51	rs3815993	MIMAT0004774	hsa-miR-501-3p	-5.61	3.43e-08	-0.21	-0.25	Total body bone mineral density;	chr2:165875827	chrX:50009772~50009793:+